id	sid	tid	token	lemma	pos
dpc-3520	1	1	dermatology	dermatology	NOUN
dpc-3520	1	2	:	:	PUNCT
dpc-3520	1	3	practical	practical	ADJ
dpc-3520	1	4	and	and	CCONJ
dpc-3520	1	5	conceptual	conceptual	ADJ
dpc-3520	1	6	original	original	ADJ
dpc-3520	1	7	article	article	NOUN
dpc-3520	1	8	|	|	ADV
dpc-3520	1	9	dermatol	dermatol	ADJ
dpc-3520	1	10	pract	pract	NOUN
dpc-3520	1	11	concept	concept	NOUN
dpc-3520	1	12	.	.	PUNCT
dpc-3520	2	1	2024;14(1):e2024027	2024;14(1):e2024027	NUM
dpc-3520	2	2	1	1	NUM
dpc-3520	2	3	evaluation	evaluation	NOUN
dpc-3520	2	4	of	of	ADP
dpc-3520	2	5	il-38	il-38	NOUN
dpc-3520	2	6	,	,	PUNCT
dpc-3520	2	7	a	a	DET
dpc-3520	2	8	newly	newly	ADV
dpc-3520	2	9	-	-	PUNCT
dpc-3520	2	10	introduced	introduce	VERB
dpc-3520	2	11	cytokine	cytokine	NOUN
dpc-3520	2	12	,	,	PUNCT
dpc-3520	2	13	in	in	ADP
dpc-3520	2	14	sera	sera	NOUN
dpc-3520	2	15	of	of	ADP
dpc-3520	2	16	vitiligo	vitiligo	ADJ
dpc-3520	2	17	patients	patient	NOUN
dpc-3520	2	18	and	and	CCONJ
dpc-3520	2	19	its	its	PRON
dpc-3520	2	20	relation	relation	NOUN
dpc-3520	2	21	to	to	ADP
dpc-3520	2	22	 	 	SPACE
dpc-3520	2	23	clinical	clinical	ADJ
dpc-3520	2	24	features	feature	NOUN
dpc-3520	2	25	maryam	maryam	PROPN
dpc-3520	2	26	zarrabi1	zarrabi1	PROPN
dpc-3520	2	27	,	,	PUNCT
dpc-3520	2	28	nasser	nasser	PROPN
dpc-3520	2	29	gholijani1	gholijani1	PROPN
dpc-3520	2	30	,	,	PUNCT
dpc-3520	2	31	zahra	zahra	PROPN
dpc-3520	2	32	amirghofran1,2	amirghofran1,2	PROPN
dpc-3520	2	33	,	,	PUNCT
dpc-3520	2	34	maryam	maryam	PROPN
dpc-3520	2	35	sadat	sadat	PROPN
dpc-3520	2	36	sadati3	sadati3	PROPN
dpc-3520	2	37	,	,	PUNCT
dpc-3520	2	38	roya	roya	NOUN
dpc-3520	2	39	radanfar4	radanfar4	NOUN
dpc-3520	2	40	1	1	NUM
dpc-3520	2	41	autoimmune	autoimmune	ADJ
dpc-3520	2	42	diseases	disease	NOUN
dpc-3520	2	43	research	research	NOUN
dpc-3520	2	44	center	center	NOUN
dpc-3520	2	45	,	,	PUNCT
dpc-3520	2	46	shiraz	shiraz	PROPN
dpc-3520	2	47	university	university	PROPN
dpc-3520	2	48	of	of	ADP
dpc-3520	2	49	medical	medical	ADJ
dpc-3520	2	50	sciences	sciences	PROPN
dpc-3520	2	51	,	,	PUNCT
dpc-3520	2	52	shiraz	shiraz	PROPN
dpc-3520	2	53	,	,	PUNCT
dpc-3520	2	54	iran	iran	PROPN
dpc-3520	2	55	2	2	NUM
dpc-3520	2	56	immunology	immunology	NOUN
dpc-3520	2	57	department	department	NOUN
dpc-3520	2	58	,	,	PUNCT
dpc-3520	2	59	shiraz	shiraz	PROPN
dpc-3520	2	60	university	university	PROPN
dpc-3520	2	61	of	of	ADP
dpc-3520	2	62	medical	medical	ADJ
dpc-3520	2	63	sciences	sciences	PROPN
dpc-3520	2	64	,	,	PUNCT
dpc-3520	2	65	shiraz	shiraz	PROPN
dpc-3520	2	66	,	,	PUNCT
dpc-3520	2	67	iran	iran	PROPN
dpc-3520	2	68	3	3	NUM
dpc-3520	2	69	department	department	NOUN
dpc-3520	2	70	of	of	ADP
dpc-3520	2	71	dermatology	dermatology	NOUN
dpc-3520	2	72	,	,	PUNCT
dpc-3520	2	73	shiraz	shiraz	PROPN
dpc-3520	2	74	university	university	PROPN
dpc-3520	2	75	of	of	ADP
dpc-3520	2	76	medical	medical	ADJ
dpc-3520	2	77	sciences	sciences	PROPN
dpc-3520	2	78	,	,	PUNCT
dpc-3520	2	79	shiraz	shiraz	PROPN
dpc-3520	2	80	,	,	PUNCT
dpc-3520	2	81	iran	iran	PROPN
dpc-3520	2	82	4	4	NUM
dpc-3520	2	83	dermatology	dermatology	NOUN
dpc-3520	2	84	department	department	NOUN
dpc-3520	2	85	,	,	PUNCT
dpc-3520	2	86	shiraz	shiraz	PROPN
dpc-3520	2	87	university	university	PROPN
dpc-3520	2	88	of	of	ADP
dpc-3520	2	89	medical	medical	ADJ
dpc-3520	2	90	sciences	sciences	PROPN
dpc-3520	2	91	,	,	PUNCT
dpc-3520	2	92	shiraz	shiraz	PROPN
dpc-3520	2	93	,	,	PUNCT
dpc-3520	2	94	iran	iran	PROPN
dpc-3520	2	95	key	key	ADJ
dpc-3520	2	96	words	word	NOUN
dpc-3520	2	97	:	:	PUNCT
dpc-3520	2	98	vitiligo	vitiligo	NOUN
dpc-3520	2	99	,	,	PUNCT
dpc-3520	2	100	interleukin38	interleukin38	NOUN
dpc-3520	2	101	,	,	PUNCT
dpc-3520	2	102	cytokine	cytokine	NOUN
dpc-3520	2	103	,	,	PUNCT
dpc-3520	2	104	skin	skin	NOUN
dpc-3520	2	105	citation	citation	NOUN
dpc-3520	2	106	:	:	PUNCT
dpc-3520	2	107	zarrabi	zarrabi	PROPN
dpc-3520	2	108	m	m	PROPN
dpc-3520	2	109	,	,	PUNCT
dpc-3520	2	110	gholijani	gholijani	PROPN
dpc-3520	2	111	n	n	CCONJ
dpc-3520	2	112	,	,	PUNCT
dpc-3520	2	113	amirghofran	amirghofran	PROPN
dpc-3520	2	114	z	z	PROPN
dpc-3520	2	115	,	,	PUNCT
dpc-3520	2	116	sadati	sadati	PROPN
dpc-3520	2	117	ms	ms	PROPN
dpc-3520	2	118	,	,	PUNCT
dpc-3520	2	119	radanfar	radanfar	PROPN
dpc-3520	2	120	r.	r.	PROPN
dpc-3520	2	121	evaluation	evaluation	NOUN
dpc-3520	2	122	of	of	ADP
dpc-3520	2	123	il-38	il-38	NOUN
dpc-3520	2	124	,	,	PUNCT
dpc-3520	2	125	a	a	DET
dpc-3520	2	126	newly	newly	ADV
dpc-3520	2	127	-	-	PUNCT
dpc-3520	2	128	introduced	introduce	VERB
dpc-3520	2	129	cytokine	cytokine	NOUN
dpc-3520	2	130	,	,	PUNCT
dpc-3520	2	131	in	in	ADP
dpc-3520	2	132	sera	sera	NOUN
dpc-3520	2	133	of	of	ADP
dpc-3520	2	134	vitiligo	vitiligo	ADJ
dpc-3520	2	135	patients	patient	NOUN
dpc-3520	2	136	and	and	CCONJ
dpc-3520	2	137	its	its	PRON
dpc-3520	2	138	relation	relation	NOUN
dpc-3520	2	139	to	to	ADP
dpc-3520	2	140	clinical	clinical	ADJ
dpc-3520	2	141	features	feature	NOUN
dpc-3520	2	142	.	.	PUNCT
dpc-3520	3	1	dermatol	dermatol	NOUN
dpc-3520	3	2	pract	pract	PROPN
dpc-3520	3	3	concept	concept	NOUN
dpc-3520	3	4	.	.	PUNCT
dpc-3520	4	1	2024;14(1):e2024027	2024;14(1):e2024027	X
dpc-3520	4	2	.	.	PUNCT
dpc-3520	4	3	doi	doi	PROPN
dpc-3520	4	4	:	:	PUNCT
dpc-3520	4	5	https://doi.org/10.5826	https://doi.org/10.5826	PROPN
dpc-3520	4	6	/dpc.1401a27	/dpc.1401a27	PUNCT
dpc-3520	4	7	accepted	accept	VERB
dpc-3520	4	8	:	:	PUNCT
dpc-3520	4	9	july	july	PROPN
dpc-3520	4	10	24	24	NUM
dpc-3520	4	11	,	,	PUNCT
dpc-3520	4	12	2023	2023	NUM
dpc-3520	4	13	;	;	PUNCT
dpc-3520	4	14	published	publish	VERB
dpc-3520	4	15	:	:	PUNCT
dpc-3520	4	16	january	january	PROPN
dpc-3520	4	17	2024	2024	NUM
dpc-3520	5	1	copyright	copyright	NOUN
dpc-3520	5	2	:	:	PUNCT
dpc-3520	5	3	©	©	PROPN
dpc-3520	5	4	2024	2024	NUM
dpc-3520	5	5	zarrabi	zarrabi	NOUN
dpc-3520	5	6	et	et	PROPN
dpc-3520	5	7	al	al	PROPN
dpc-3520	5	8	.	.	PUNCT
dpc-3520	6	1	this	this	PRON
dpc-3520	6	2	is	be	AUX
dpc-3520	6	3	an	an	DET
dpc-3520	6	4	open	open	ADJ
dpc-3520	6	5	-	-	PUNCT
dpc-3520	6	6	access	access	NOUN
dpc-3520	6	7	article	article	NOUN
dpc-3520	6	8	distributed	distribute	VERB
dpc-3520	6	9	under	under	ADP
dpc-3520	6	10	the	the	DET
dpc-3520	6	11	terms	term	NOUN
dpc-3520	6	12	of	of	ADP
dpc-3520	6	13	the	the	DET
dpc-3520	6	14	creative	creative	ADJ
dpc-3520	6	15	commons	common	NOUN
dpc-3520	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3520	6	17	license	license	NOUN
dpc-3520	6	18	(	(	PUNCT
dpc-3520	6	19	by	by	ADP
dpc-3520	6	20	-	-	PUNCT
dpc-3520	6	21	nc-4.0	nc-4.0	NOUN
dpc-3520	6	22	)	)	PUNCT
dpc-3520	6	23	,	,	PUNCT
dpc-3520	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3520	6	25	,	,	PUNCT
dpc-3520	6	26	which	which	PRON
dpc-3520	6	27	permits	permit	VERB
dpc-3520	6	28	unrestricted	unrestricted	ADJ
dpc-3520	6	29	noncommercial	noncommercial	ADJ
dpc-3520	6	30	use	use	NOUN
dpc-3520	6	31	,	,	PUNCT
dpc-3520	6	32	distribution	distribution	NOUN
dpc-3520	6	33	,	,	PUNCT
dpc-3520	6	34	and	and	CCONJ
dpc-3520	6	35	reproduction	reproduction	NOUN
dpc-3520	6	36	in	in	ADP
dpc-3520	6	37	any	any	DET
dpc-3520	6	38	medium	medium	NOUN
dpc-3520	6	39	,	,	PUNCT
dpc-3520	6	40	provided	provide	VERB
dpc-3520	6	41	the	the	DET
dpc-3520	6	42	original	original	ADJ
dpc-3520	6	43	authors	author	NOUN
dpc-3520	6	44	and	and	CCONJ
dpc-3520	6	45	source	source	NOUN
dpc-3520	6	46	are	be	AUX
dpc-3520	6	47	credited	credit	VERB
dpc-3520	6	48	.	.	PUNCT
dpc-3520	7	1	funding	funding	NOUN
dpc-3520	7	2	:	:	PUNCT
dpc-3520	7	3	none	none	NOUN
dpc-3520	7	4	.	.	PUNCT
dpc-3520	8	1	competing	compete	VERB
dpc-3520	8	2	interests	interest	NOUN
dpc-3520	8	3	:	:	PUNCT
dpc-3520	8	4	none	none	NOUN
dpc-3520	8	5	.	.	PUNCT
dpc-3520	9	1	authorship	authorship	NOUN
dpc-3520	9	2	:	:	PUNCT
dpc-3520	9	3	all	all	DET
dpc-3520	9	4	authors	author	NOUN
dpc-3520	9	5	have	have	AUX
dpc-3520	9	6	contributed	contribute	VERB
dpc-3520	9	7	significantly	significantly	ADV
dpc-3520	9	8	to	to	ADP
dpc-3520	9	9	this	this	DET
dpc-3520	9	10	publication	publication	NOUN
dpc-3520	9	11	.	.	PUNCT
dpc-3520	10	1	corresponding	correspond	VERB
dpc-3520	10	2	author	author	NOUN
dpc-3520	10	3	:	:	PUNCT
dpc-3520	10	4	maryam	maryam	PROPN
dpc-3520	10	5	sadat	sadat	PROPN
dpc-3520	10	6	sadati	sadati	PROPN
dpc-3520	10	7	.	.	PUNCT
dpc-3520	11	1	department	department	NOUN
dpc-3520	11	2	of	of	ADP
dpc-3520	11	3	dermatology	dermatology	NOUN
dpc-3520	11	4	,	,	PUNCT
dpc-3520	11	5	shiraz	shiraz	PROPN
dpc-3520	11	6	university	university	PROPN
dpc-3520	11	7	of	of	ADP
dpc-3520	11	8	medical	medical	ADJ
dpc-3520	11	9	sciences	sciences	PROPN
dpc-3520	11	10	,	,	PUNCT
dpc-3520	11	11	shiraz	shiraz	PROPN
dpc-3520	11	12	,	,	PUNCT
dpc-3520	11	13	iran	iran	PROPN
dpc-3520	11	14	.	.	PUNCT
dpc-3520	12	1	e	e	X
dpc-3520	12	2	-	-	NOUN
dpc-3520	12	3	mail	mail	NOUN
dpc-3520	12	4	:	:	PUNCT
dpc-3520	12	5	msadati63@yahoo.com	msadati63@yahoo.com	X
dpc-3520	12	6	introduction	introduction	NOUN
dpc-3520	12	7	:	:	PUNCT
dpc-3520	12	8	vitiligo	vitiligo	PROPN
dpc-3520	12	9	is	be	AUX
dpc-3520	12	10	thought	think	VERB
dpc-3520	12	11	to	to	PART
dpc-3520	12	12	be	be	AUX
dpc-3520	12	13	an	an	DET
dpc-3520	12	14	autoimmune	autoimmune	ADJ
dpc-3520	12	15	disorder	disorder	NOUN
dpc-3520	12	16	caused	cause	VERB
dpc-3520	12	17	by	by	ADP
dpc-3520	12	18	melanocytes	melanocyte	NOUN
dpc-3520	12	19	dysfunction	dysfunction	NOUN
dpc-3520	12	20	and	and	CCONJ
dpc-3520	12	21	depigmentation	depigmentation	NOUN
dpc-3520	12	22	.	.	PUNCT
dpc-3520	13	1	among	among	ADP
dpc-3520	13	2	different	different	ADJ
dpc-3520	13	3	executors	executor	NOUN
dpc-3520	13	4	of	of	ADP
dpc-3520	13	5	the	the	DET
dpc-3520	13	6	immune	immune	ADJ
dpc-3520	13	7	system	system	NOUN
dpc-3520	13	8	in	in	ADP
dpc-3520	13	9	developing	develop	VERB
dpc-3520	13	10	the	the	DET
dpc-3520	13	11	disease	disease	NOUN
dpc-3520	13	12	,	,	PUNCT
dpc-3520	13	13	the	the	DET
dpc-3520	13	14	role	role	NOUN
dpc-3520	13	15	of	of	ADP
dpc-3520	13	16	various	various	ADJ
dpc-3520	13	17	cytokines	cytokine	NOUN
dpc-3520	13	18	has	have	AUX
dpc-3520	13	19	been	be	AUX
dpc-3520	13	20	defined	define	VERB
dpc-3520	13	21	.	.	PUNCT
dpc-3520	14	1	objectives	objective	NOUN
dpc-3520	14	2	:	:	PUNCT
dpc-3520	14	3	we	we	PRON
dpc-3520	14	4	have	have	AUX
dpc-3520	14	5	focused	focus	VERB
dpc-3520	14	6	on	on	ADP
dpc-3520	14	7	il-38	il-38	NOUN
dpc-3520	14	8	,	,	PUNCT
dpc-3520	14	9	the	the	DET
dpc-3520	14	10	tenth	tenth	ADJ
dpc-3520	14	11	member	member	NOUN
dpc-3520	14	12	of	of	ADP
dpc-3520	14	13	il-1	il-1	ADJ
dpc-3520	14	14	cytokine	cytokine	ADJ
dpc-3520	14	15	family	family	NOUN
dpc-3520	14	16	with	with	ADP
dpc-3520	14	17	a	a	DET
dpc-3520	14	18	proposed	propose	VERB
dpc-3520	14	19	anti	anti	ADJ
dpc-3520	14	20	-	-	ADJ
dpc-3520	14	21	inflammatory	inflammatory	ADJ
dpc-3520	14	22	role	role	NOUN
dpc-3520	14	23	,	,	PUNCT
dpc-3520	14	24	which	which	PRON
dpc-3520	14	25	has	have	AUX
dpc-3520	14	26	not	not	PART
dpc-3520	14	27	hitherto	hitherto	NOUN
dpc-3520	14	28	been	be	AUX
dpc-3520	14	29	introduced	introduce	VERB
dpc-3520	14	30	as	as	ADP
dpc-3520	14	31	an	an	DET
dpc-3520	14	32	anti	anti	ADJ
dpc-3520	14	33	-	-	ADJ
dpc-3520	14	34	inflammatory	inflammatory	ADJ
dpc-3520	14	35	factor	factor	NOUN
dpc-3520	14	36	in	in	ADP
dpc-3520	14	37	vitiligo	vitiligo	PROPN
dpc-3520	14	38	.	.	PUNCT
dpc-3520	15	1	methods	method	NOUN
dpc-3520	15	2	:	:	PUNCT
dpc-3520	15	3	sixty	sixty	NUM
dpc-3520	15	4	-	-	PUNCT
dpc-3520	15	5	nine	nine	NUM
dpc-3520	15	6	generalized	generalize	VERB
dpc-3520	15	7	vitiligo	vitiligo	NOUN
dpc-3520	15	8	patients	patient	NOUN
dpc-3520	15	9	and	and	CCONJ
dpc-3520	15	10	72	72	NUM
dpc-3520	15	11	-	-	PUNCT
dpc-3520	15	12	year	year	NOUN
dpc-3520	15	13	-	-	PUNCT
dpc-3520	15	14	oldand	oldand	NOUN
dpc-3520	15	15	sex	sex	NOUN
dpc-3520	15	16	-	-	PUNCT
dpc-3520	15	17	matched	match	VERB
dpc-3520	15	18	healthy	healthy	ADJ
dpc-3520	15	19	individuals	individual	NOUN
dpc-3520	15	20	were	be	AUX
dpc-3520	15	21	included	include	VERB
dpc-3520	15	22	in	in	ADP
dpc-3520	15	23	this	this	DET
dpc-3520	15	24	study	study	NOUN
dpc-3520	15	25	.	.	PUNCT
dpc-3520	16	1	il-38	il-38	NOUN
dpc-3520	16	2	level	level	NOUN
dpc-3520	16	3	was	be	AUX
dpc-3520	16	4	evaluated	evaluate	VERB
dpc-3520	16	5	in	in	ADP
dpc-3520	16	6	sera	sera	NOUN
dpc-3520	16	7	of	of	ADP
dpc-3520	16	8	all	all	DET
dpc-3520	16	9	participants	participant	NOUN
dpc-3520	16	10	using	use	VERB
dpc-3520	16	11	elisa	elisa	NOUN
dpc-3520	16	12	assay	assay	VERB
dpc-3520	16	13	.	.	PUNCT
dpc-3520	17	1	the	the	DET
dpc-3520	17	2	relation	relation	NOUN
dpc-3520	17	3	of	of	ADP
dpc-3520	17	4	il-38	il-38	NOUN
dpc-3520	17	5	level	level	NOUN
dpc-3520	17	6	to	to	ADP
dpc-3520	17	7	patients	patient	NOUN
dpc-3520	17	8	characteristics	characteristic	NOUN
dpc-3520	17	9	was	be	AUX
dpc-3520	17	10	evaluated	evaluate	VERB
dpc-3520	17	11	.	.	PUNCT
dpc-3520	18	1	results	result	NOUN
dpc-3520	18	2	:	:	PUNCT
dpc-3520	18	3	il-38	il-38	NOUN
dpc-3520	18	4	serum	serum	NOUN
dpc-3520	18	5	level	level	NOUN
dpc-3520	18	6	in	in	ADP
dpc-3520	18	7	vitiligo	vitiligo	ADJ
dpc-3520	18	8	patients	patient	NOUN
dpc-3520	18	9	(	(	PUNCT
dpc-3520	18	10	159.5±39.7	159.5±39.7	NOUN
dpc-3520	18	11	pg	pg	NOUN
dpc-3520	18	12	/	/	SYM
dpc-3520	18	13	ml	ml	VERB
dpc-3520	18	14	)	)	PUNCT
dpc-3520	18	15	was	be	AUX
dpc-3520	18	16	lower	low	ADJ
dpc-3520	18	17	than	than	ADP
dpc-3520	18	18	the	the	DET
dpc-3520	18	19	healthy	healthy	ADJ
dpc-3520	18	20	controls	control	NOUN
dpc-3520	18	21	(	(	PUNCT
dpc-3520	18	22	166.7±34.8pg	166.7±34.8pg	NUM
dpc-3520	18	23	/	/	SYM
dpc-3520	18	24	ml	ml	NOUN
dpc-3520	18	25	)	)	PUNCT
dpc-3520	18	26	(	(	PUNCT
dpc-3520	18	27	p	p	X
dpc-3520	18	28	=	=	NOUN
dpc-3520	18	29	0.039	0.039	NUM
dpc-3520	18	30	)	)	PUNCT
dpc-3520	18	31	.	.	PUNCT
dpc-3520	19	1	a	a	DET
dpc-3520	19	2	weak	weak	ADJ
dpc-3520	19	3	negative	negative	ADJ
dpc-3520	19	4	correlation	correlation	NOUN
dpc-3520	19	5	between	between	ADP
dpc-3520	19	6	the	the	DET
dpc-3520	19	7	age	age	NOUN
dpc-3520	19	8	of	of	ADP
dpc-3520	19	9	male	male	ADJ
dpc-3520	19	10	patients	patient	NOUN
dpc-3520	19	11	and	and	CCONJ
dpc-3520	19	12	their	their	PRON
dpc-3520	19	13	il-38	il-38	NOUN
dpc-3520	19	14	serum	serum	NOUN
dpc-3520	19	15	levels	level	NOUN
dpc-3520	19	16	was	be	AUX
dpc-3520	19	17	identified	identify	VERB
dpc-3520	19	18	(	(	PUNCT
dpc-3520	19	19	r	r	NOUN
dpc-3520	19	20	=	=	NOUN
dpc-3520	19	21	0.38	0.38	NUM
dpc-3520	19	22	,	,	PUNCT
dpc-3520	19	23	p	p	X
dpc-3520	19	24	=	=	NOUN
dpc-3520	19	25	0.058	0.058	NUM
dpc-3520	19	26	)	)	PUNCT
dpc-3520	19	27	.	.	PUNCT
dpc-3520	20	1	evaluation	evaluation	NOUN
dpc-3520	20	2	of	of	ADP
dpc-3520	20	3	the	the	DET
dpc-3520	20	4	il-38	il-38	NOUN
dpc-3520	20	5	serum	serum	NOUN
dpc-3520	20	6	levels	level	NOUN
dpc-3520	20	7	relationship	relationship	VERB
dpc-3520	20	8	with	with	ADP
dpc-3520	20	9	patients	patient	NOUN
dpc-3520	20	10	clinical	clinical	ADJ
dpc-3520	20	11	characteristics	characteristic	NOUN
dpc-3520	20	12	showed	show	VERB
dpc-3520	20	13	no	no	DET
dpc-3520	20	14	correlation	correlation	NOUN
dpc-3520	20	15	with	with	ADP
dpc-3520	20	16	disease	disease	NOUN
dpc-3520	20	17	onset	onset	VERB
dpc-3520	20	18	,	,	PUNCT
dpc-3520	20	19	stage	stage	NOUN
dpc-3520	20	20	of	of	ADP
dpc-3520	20	21	depigmentation	depigmentation	NOUN
dpc-3520	20	22	,	,	PUNCT
dpc-3520	20	23	and	and	CCONJ
dpc-3520	20	24	disease	disease	NOUN
dpc-3520	20	25	activity	activity	NOUN
dpc-3520	20	26	status	status	NOUN
dpc-3520	20	27	.	.	PUNCT
dpc-3520	21	1	abstract	abstract	ADJ
dpc-3520	21	2	2	2	NUM
dpc-3520	21	3	original	original	ADJ
dpc-3520	21	4	article	article	NOUN
dpc-3520	21	5	|	|	ADV
dpc-3520	21	6	dermatol	dermatol	ADJ
dpc-3520	21	7	pract	pract	NOUN
dpc-3520	21	8	concept	concept	NOUN
dpc-3520	21	9	.	.	PUNCT
dpc-3520	22	1	2024;14(1):e2024027	2024;14(1):e2024027	NUM
dpc-3520	22	2	introduction	introduction	NOUN
dpc-3520	22	3	vitiligo	vitiligo	NOUN
dpc-3520	22	4	is	be	AUX
dpc-3520	22	5	an	an	DET
dpc-3520	22	6	acquired	acquire	VERB
dpc-3520	22	7	and	and	CCONJ
dpc-3520	22	8	progressive	progressive	ADJ
dpc-3520	22	9	disorder	disorder	NOUN
dpc-3520	22	10	,	,	PUNCT
dpc-3520	22	11	caused	cause	VERB
dpc-3520	22	12	by	by	ADP
dpc-3520	22	13	melanocytes	melanocyte	NOUN
dpc-3520	22	14	dysfunction	dysfunction	NOUN
dpc-3520	22	15	and	and	CCONJ
dpc-3520	22	16	chronic	chronic	ADJ
dpc-3520	22	17	depigmentation	depigmentation	NOUN
dpc-3520	22	18	,	,	PUNCT
dpc-3520	22	19	resulting	result	VERB
dpc-3520	22	20	in	in	ADP
dpc-3520	22	21	the	the	DET
dpc-3520	22	22	formation	formation	NOUN
dpc-3520	22	23	of	of	ADP
dpc-3520	22	24	demarcated	demarcate	VERB
dpc-3520	22	25	white	white	ADJ
dpc-3520	22	26	macules	macule	NOUN
dpc-3520	22	27	in	in	ADP
dpc-3520	22	28	the	the	DET
dpc-3520	22	29	epidermis	epidermis	NOUN
dpc-3520	23	1	[	[	X
dpc-3520	23	2	1	1	NUM
dpc-3520	23	3	]	]	PUNCT
dpc-3520	23	4	.	.	PUNCT
dpc-3520	24	1	the	the	DET
dpc-3520	24	2	prevalence	prevalence	NOUN
dpc-3520	24	3	of	of	ADP
dpc-3520	24	4	vitiligo	vitiligo	NOUN
dpc-3520	24	5	estimated	estimate	VERB
dpc-3520	24	6	to	to	PART
dpc-3520	24	7	be	be	AUX
dpc-3520	24	8	in	in	ADP
dpc-3520	24	9	the	the	DET
dpc-3520	24	10	range	range	NOUN
dpc-3520	24	11	of	of	ADP
dpc-3520	24	12	0.4	0.4	NUM
dpc-3520	24	13	%	%	NOUN
dpc-3520	24	14	to	to	ADP
dpc-3520	24	15	2.0	2.0	NUM
dpc-3520	24	16	%	%	NOUN
dpc-3520	24	17	worldwide	worldwide	ADV
dpc-3520	25	1	[	[	X
dpc-3520	25	2	2	2	NUM
dpc-3520	25	3	]	]	PUNCT
dpc-3520	25	4	with	with	ADP
dpc-3520	25	5	a	a	DET
dpc-3520	25	6	reported	report	VERB
dpc-3520	25	7	greater	great	ADJ
dpc-3520	25	8	predilection	predilection	NOUN
dpc-3520	25	9	to	to	PART
dpc-3520	25	10	arise	arise	VERB
dpc-3520	25	11	in	in	ADP
dpc-3520	25	12	childhood	childhood	NOUN
dpc-3520	25	13	and	and	CCONJ
dpc-3520	25	14	based	base	VERB
dpc-3520	25	15	on	on	ADP
dpc-3520	25	16	some	some	DET
dpc-3520	25	17	studies	study	NOUN
dpc-3520	25	18	in	in	ADP
dpc-3520	25	19	females	female	NOUN
dpc-3520	25	20	[	[	X
dpc-3520	25	21	1	1	NUM
dpc-3520	25	22	,	,	PUNCT
dpc-3520	25	23	3	3	NUM
dpc-3520	25	24	]	]	PUNCT
dpc-3520	25	25	.	.	PUNCT
dpc-3520	26	1	this	this	DET
dpc-3520	26	2	disease	disease	NOUN
dpc-3520	26	3	is	be	AUX
dpc-3520	26	4	classified	classify	VERB
dpc-3520	26	5	into	into	ADP
dpc-3520	26	6	three	three	NUM
dpc-3520	26	7	main	main	ADJ
dpc-3520	26	8	clinical	clinical	ADJ
dpc-3520	26	9	types	type	NOUN
dpc-3520	26	10	according	accord	VERB
dpc-3520	26	11	to	to	ADP
dpc-3520	26	12	international	international	ADJ
dpc-3520	26	13	consensus	consensus	NOUN
dpc-3520	26	14	;	;	PUNCT
dpc-3520	26	15	namely	namely	ADV
dpc-3520	26	16	,	,	PUNCT
dpc-3520	26	17	non	non	ADJ
dpc-3520	26	18	-	-	ADJ
dpc-3520	26	19	segmental	segmental	ADJ
dpc-3520	26	20	or	or	CCONJ
dpc-3520	26	21	generalized	generalized	ADJ
dpc-3520	26	22	vitiligo	vitiligo	NOUN
dpc-3520	26	23	,	,	PUNCT
dpc-3520	26	24	segmental	segmental	ADJ
dpc-3520	26	25	vitiligo	vitiligo	NOUN
dpc-3520	26	26	and	and	CCONJ
dpc-3520	26	27	mixed	mixed	ADJ
dpc-3520	26	28	vitiligo	vitiligo	NOUN
dpc-3520	26	29	[	[	X
dpc-3520	26	30	4	4	NUM
dpc-3520	26	31	]	]	PUNCT
dpc-3520	26	32	.	.	PUNCT
dpc-3520	27	1	these	these	DET
dpc-3520	27	2	subtypes	subtype	NOUN
dpc-3520	27	3	are	be	AUX
dpc-3520	27	4	distinguished	distinguish	VERB
dpc-3520	27	5	based	base	VERB
dpc-3520	27	6	on	on	ADP
dpc-3520	27	7	their	their	PRON
dpc-3520	27	8	onset	onset	NOUN
dpc-3520	27	9	and	and	CCONJ
dpc-3520	27	10	distribution	distribution	NOUN
dpc-3520	27	11	patterns	pattern	NOUN
dpc-3520	27	12	[	[	X
dpc-3520	27	13	4	4	NUM
dpc-3520	27	14	]	]	PUNCT
dpc-3520	27	15	.	.	PUNCT
dpc-3520	28	1	the	the	DET
dpc-3520	28	2	mechanisms	mechanism	NOUN
dpc-3520	28	3	underlying	underlie	VERB
dpc-3520	28	4	the	the	DET
dpc-3520	28	5	etiopathogenesis	etiopathogenesis	NOUN
dpc-3520	28	6	of	of	ADP
dpc-3520	28	7	vitiligo	vitiligo	NOUN
dpc-3520	28	8	are	be	AUX
dpc-3520	28	9	not	not	PART
dpc-3520	28	10	clearly	clearly	ADV
dpc-3520	28	11	identified	identify	VERB
dpc-3520	28	12	;	;	PUNCT
dpc-3520	28	13	however	however	ADV
dpc-3520	28	14	,	,	PUNCT
dpc-3520	28	15	in	in	ADP
dpc-3520	28	16	genetically	genetically	ADV
dpc-3520	28	17	susceptible	susceptible	ADJ
dpc-3520	28	18	individuals	individual	NOUN
dpc-3520	28	19	,	,	PUNCT
dpc-3520	28	20	several	several	ADJ
dpc-3520	28	21	phenomena	phenomenon	NOUN
dpc-3520	28	22	have	have	AUX
dpc-3520	28	23	been	be	AUX
dpc-3520	28	24	supposed	suppose	VERB
dpc-3520	28	25	to	to	PART
dpc-3520	28	26	be	be	AUX
dpc-3520	28	27	associated	associate	VERB
dpc-3520	28	28	with	with	ADP
dpc-3520	28	29	the	the	DET
dpc-3520	28	30	disease	disease	NOUN
dpc-3520	28	31	onset	onset	NOUN
dpc-3520	28	32	and	and	CCONJ
dpc-3520	28	33	development	development	NOUN
dpc-3520	28	34	.	.	PUNCT
dpc-3520	29	1	autoimmunity	autoimmunity	NOUN
dpc-3520	29	2	,	,	PUNCT
dpc-3520	29	3	oxidative	oxidative	ADJ
dpc-3520	29	4	stress	stress	NOUN
dpc-3520	29	5	,	,	PUNCT
dpc-3520	29	6	impairment	impairment	NOUN
dpc-3520	29	7	of	of	ADP
dpc-3520	29	8	melanocytes	melanocyte	NOUN
dpc-3520	29	9	growth	growth	NOUN
dpc-3520	29	10	and	and	CCONJ
dpc-3520	29	11	development	development	NOUN
dpc-3520	29	12	,	,	PUNCT
dpc-3520	29	13	viral	viral	ADJ
dpc-3520	29	14	infections	infection	NOUN
dpc-3520	29	15	and	and	CCONJ
dpc-3520	29	16	neurological	neurological	ADJ
dpc-3520	29	17	damages	damage	NOUN
dpc-3520	29	18	are	be	AUX
dpc-3520	29	19	among	among	ADP
dpc-3520	29	20	the	the	DET
dpc-3520	29	21	main	main	ADJ
dpc-3520	29	22	theories	theory	NOUN
dpc-3520	29	23	proposed	propose	VERB
dpc-3520	29	24	in	in	ADP
dpc-3520	29	25	the	the	DET
dpc-3520	29	26	etiology	etiology	NOUN
dpc-3520	29	27	of	of	ADP
dpc-3520	29	28	vitiligo	vitiligo	NOUN
dpc-3520	29	29	[	[	X
dpc-3520	29	30	4	4	NUM
dpc-3520	29	31	]	]	PUNCT
dpc-3520	29	32	.	.	PUNCT
dpc-3520	30	1	autoimmune	autoimmune	PROPN
dpc-3520	30	2	theory	theory	NOUN
dpc-3520	30	3	implicates	implicate	VERB
dpc-3520	30	4	the	the	DET
dpc-3520	30	5	remarkable	remarkable	ADJ
dpc-3520	30	6	presence	presence	NOUN
dpc-3520	30	7	of	of	ADP
dpc-3520	30	8	immune	immune	ADJ
dpc-3520	30	9	system	system	NOUN
dpc-3520	30	10	footprints	footprint	NOUN
dpc-3520	30	11	in	in	ADP
dpc-3520	30	12	the	the	DET
dpc-3520	30	13	context	context	NOUN
dpc-3520	30	14	of	of	ADP
dpc-3520	30	15	the	the	DET
dpc-3520	30	16	disease	disease	NOUN
dpc-3520	30	17	,	,	PUNCT
dpc-3520	30	18	as	as	ADP
dpc-3520	30	19	high	high	ADJ
dpc-3520	30	20	serum	serum	NOUN
dpc-3520	30	21	levels	level	NOUN
dpc-3520	30	22	of	of	ADP
dpc-3520	30	23	autoantibodies	autoantibody	NOUN
dpc-3520	30	24	against	against	ADP
dpc-3520	30	25	tyrosine	tyrosine	NOUN
dpc-3520	30	26	hydroxylase	hydroxylase	NOUN
dpc-3520	30	27	(	(	PUNCT
dpc-3520	30	28	th	th	X
dpc-3520	30	29	)	)	PUNCT
dpc-3520	30	30	which	which	PRON
dpc-3520	30	31	cause	cause	VERB
dpc-3520	30	32	the	the	DET
dpc-3520	30	33	melanocytes	melanocyte	NOUN
dpc-3520	30	34	and	and	CCONJ
dpc-3520	30	35	keratinocytes	keratinocyte	VERB
dpc-3520	30	36	destruction	destruction	NOUN
dpc-3520	30	37	are	be	AUX
dpc-3520	30	38	detectable	detectable	ADJ
dpc-3520	30	39	in	in	ADP
dpc-3520	30	40	vitiligo	vitiligo	ADJ
dpc-3520	30	41	patients	patient	NOUN
dpc-3520	30	42	[	[	X
dpc-3520	30	43	5	5	NUM
dpc-3520	30	44	]	]	PUNCT
dpc-3520	30	45	.	.	PUNCT
dpc-3520	31	1	moreover	moreover	ADV
dpc-3520	31	2	,	,	PUNCT
dpc-3520	31	3	it	it	PRON
dpc-3520	31	4	has	have	AUX
dpc-3520	31	5	been	be	AUX
dpc-3520	31	6	found	find	VERB
dpc-3520	31	7	that	that	SCONJ
dpc-3520	31	8	skin	skin	NOUN
dpc-3520	31	9	-	-	PUNCT
dpc-3520	31	10	homing	home	VERB
dpc-3520	31	11	cytotoxic	cytotoxic	ADJ
dpc-3520	31	12	t	t	PROPN
dpc-3520	31	13	-	-	PUNCT
dpc-3520	31	14	cells	cell	NOUN
dpc-3520	31	15	specific	specific	ADJ
dpc-3520	31	16	for	for	ADP
dpc-3520	31	17	some	some	DET
dpc-3520	31	18	peptides	peptide	NOUN
dpc-3520	31	19	of	of	ADP
dpc-3520	31	20	melanocytic	melanocytic	ADJ
dpc-3520	31	21	proteins	protein	NOUN
dpc-3520	31	22	gp100	gp100	NOUN
dpc-3520	31	23	and	and	CCONJ
dpc-3520	31	24	melan	melan	NOUN
dpc-3520	31	25	a	a	DET
dpc-3520	31	26	or	or	CCONJ
dpc-3520	31	27	melanoma	melanoma	NOUN
dpc-3520	31	28	antigen	antigen	NOUN
dpc-3520	31	29	recognized	recognize	VERB
dpc-3520	31	30	by	by	ADP
dpc-3520	31	31	t	t	PROPN
dpc-3520	31	32	cells	cell	NOUN
dpc-3520	31	33	(	(	PUNCT
dpc-3520	31	34	mart)-1	mart)-1	PROPN
dpc-3520	31	35	,	,	PUNCT
dpc-3520	31	36	are	be	AUX
dpc-3520	31	37	related	relate	VERB
dpc-3520	31	38	to	to	PART
dpc-3520	31	39	vitiligo	vitiligo	VERB
dpc-3520	31	40	disease	disease	NOUN
dpc-3520	31	41	activity	activity	NOUN
dpc-3520	31	42	[	[	X
dpc-3520	31	43	6	6	NUM
dpc-3520	31	44	]	]	PUNCT
dpc-3520	31	45	.	.	PUNCT
dpc-3520	32	1	also	also	ADV
dpc-3520	32	2	,	,	PUNCT
dpc-3520	32	3	a	a	DET
dpc-3520	32	4	significant	significant	ADJ
dpc-3520	32	5	rise	rise	NOUN
dpc-3520	32	6	in	in	ADP
dpc-3520	32	7	serum	serum	NOUN
dpc-3520	32	8	levels	level	NOUN
dpc-3520	32	9	of	of	ADP
dpc-3520	32	10	cytokines	cytokine	NOUN
dpc-3520	32	11	such	such	ADJ
dpc-3520	32	12	as	as	ADP
dpc-3520	32	13	tumor	tumor	NOUN
dpc-3520	32	14	necrosis	necrosis	NOUN
dpc-3520	32	15	factor	factor	NOUN
dpc-3520	32	16	(	(	PUNCT
dpc-3520	32	17	tnf)-α	tnf)-α	PROPN
dpc-3520	32	18	,	,	PUNCT
dpc-3520	32	19	interferon	interferon	NOUN
dpc-3520	32	20	(	(	PUNCT
dpc-3520	32	21	ifn)-γ	ifn)-γ	NOUN
dpc-3520	32	22	,	,	PUNCT
dpc-3520	32	23	interleukin	interleukin	NOUN
dpc-3520	32	24	(	(	PUNCT
dpc-3520	32	25	il)-1β	il)-1β	PROPN
dpc-3520	32	26	,	,	PUNCT
dpc-3520	32	27	il-2	il-2	NUM
dpc-3520	32	28	,	,	PUNCT
dpc-3520	32	29	il-6	il-6	PRON
dpc-3520	32	30	,	,	PUNCT
dpc-3520	32	31	il-17	il-17	X
dpc-3520	32	32	,	,	PUNCT
dpc-3520	32	33	il-22	il-22	NOUN
dpc-3520	32	34	,	,	PUNCT
dpc-3520	32	35	il-8	il-8	PUNCT
dpc-3520	32	36	and	and	CCONJ
dpc-3520	32	37	il-10	il-10	PRON
dpc-3520	32	38	was	be	AUX
dpc-3520	32	39	observed	observe	VERB
dpc-3520	32	40	in	in	ADP
dpc-3520	32	41	these	these	DET
dpc-3520	32	42	patients	patient	NOUN
dpc-3520	32	43	[	[	X
dpc-3520	32	44	7	7	NUM
dpc-3520	32	45	-	-	SYM
dpc-3520	32	46	11	11	NUM
dpc-3520	32	47	]	]	PUNCT
dpc-3520	32	48	.	.	PUNCT
dpc-3520	33	1	il-38	il-38	NOUN
dpc-3520	33	2	,	,	PUNCT
dpc-3520	33	3	with	with	ADP
dpc-3520	33	4	the	the	DET
dpc-3520	33	5	previous	previous	ADJ
dpc-3520	33	6	name	name	NOUN
dpc-3520	33	7	,	,	PUNCT
dpc-3520	33	8	il-1hy2	il-1hy2	PROPN
dpc-3520	33	9	is	be	AUX
dpc-3520	33	10	a	a	DET
dpc-3520	33	11	member	member	NOUN
dpc-3520	33	12	of	of	ADP
dpc-3520	33	13	il-1	il-1	ADJ
dpc-3520	33	14	cytokine	cytokine	ADJ
dpc-3520	33	15	family	family	NOUN
dpc-3520	33	16	(	(	PUNCT
dpc-3520	33	17	il-1α	il-1α	PROPN
dpc-3520	33	18	,	,	PUNCT
dpc-3520	33	19	il-1β	il-1β	PROPN
dpc-3520	33	20	,	,	PUNCT
dpc-3520	33	21	il-1	il-1	ADP
dpc-3520	33	22	receptor	receptor	NOUN
dpc-3520	33	23	antagonist	antagonist	NOUN
dpc-3520	33	24	[	[	X
dpc-3520	33	25	il-1ra	il-1ra	NOUN
dpc-3520	33	26	]	]	X
dpc-3520	33	27	,	,	PUNCT
dpc-3520	33	28	il-18	il-18	ADP
dpc-3520	33	29	,	,	PUNCT
dpc-3520	33	30	il-36	il-36	NOUN
dpc-3520	33	31	receptor	receptor	NOUN
dpc-3520	33	32	antagonist	antagonist	NOUN
dpc-3520	33	33	[	[	X
dpc-3520	33	34	il-36ra	il-36ra	PROPN
dpc-3520	33	35	]	]	X
dpc-3520	33	36	,	,	PUNCT
dpc-3520	33	37	il-36α	il-36α	PROPN
dpc-3520	33	38	,	,	PUNCT
dpc-3520	33	39	il-37	il-37	NOUN
dpc-3520	33	40	,	,	PUNCT
dpc-3520	33	41	il-36β	il-36β	PROPN
dpc-3520	33	42	,	,	PUNCT
dpc-3520	33	43	il-36γ	il-36γ	NOUN
dpc-3520	33	44	,	,	PUNCT
dpc-3520	33	45	il-38	il-38	NOUN
dpc-3520	33	46	and	and	CCONJ
dpc-3520	33	47	il-33	il-33	NUM
dpc-3520	33	48	)	)	PUNCT
dpc-3520	34	1	[	[	X
dpc-3520	34	2	12	12	NUM
dpc-3520	34	3	]	]	PUNCT
dpc-3520	34	4	.	.	PUNCT
dpc-3520	35	1	this	this	DET
dpc-3520	35	2	cytokine	cytokine	NOUN
dpc-3520	35	3	is	be	AUX
dpc-3520	35	4	expressed	express	VERB
dpc-3520	35	5	in	in	ADP
dpc-3520	35	6	a	a	DET
dpc-3520	35	7	variety	variety	NOUN
dpc-3520	35	8	of	of	ADP
dpc-3520	35	9	organs	organ	NOUN
dpc-3520	35	10	and	and	CCONJ
dpc-3520	35	11	tissues	tissue	NOUN
dpc-3520	35	12	including	include	VERB
dpc-3520	35	13	heart	heart	NOUN
dpc-3520	35	14	,	,	PUNCT
dpc-3520	35	15	placenta	placenta	NOUN
dpc-3520	35	16	,	,	PUNCT
dpc-3520	35	17	skin	skin	NOUN
dpc-3520	35	18	,	,	PUNCT
dpc-3520	35	19	spleen	spleen	NOUN
dpc-3520	35	20	,	,	PUNCT
dpc-3520	35	21	thymus	thymus	VERB
dpc-3520	35	22	,	,	PUNCT
dpc-3520	35	23	fetal	fetal	ADJ
dpc-3520	35	24	liver	liver	NOUN
dpc-3520	35	25	and	and	CCONJ
dpc-3520	35	26	proliferating	proliferate	VERB
dpc-3520	35	27	b	b	PROPN
dpc-3520	35	28	cells	cell	NOUN
dpc-3520	35	29	of	of	ADP
dpc-3520	35	30	the	the	DET
dpc-3520	35	31	tonsil	tonsil	NOUN
dpc-3520	36	1	[	[	X
dpc-3520	36	2	12	12	NUM
dpc-3520	36	3	]	]	PUNCT
dpc-3520	36	4	.	.	PUNCT
dpc-3520	37	1	the	the	DET
dpc-3520	37	2	genomic	genomic	ADJ
dpc-3520	37	3	position	position	NOUN
dpc-3520	37	4	of	of	ADP
dpc-3520	37	5	il-38	il-38	NOUN
dpc-3520	37	6	is	be	AUX
dpc-3520	37	7	near	near	ADP
dpc-3520	37	8	the	the	DET
dpc-3520	37	9	il-1ra	il-1ra	NOUN
dpc-3520	37	10	and	and	CCONJ
dpc-3520	37	11	il-36ra	il-36ra	PROPN
dpc-3520	37	12	locus	locus	NOUN
dpc-3520	37	13	on	on	ADP
dpc-3520	37	14	human	human	ADJ
dpc-3520	37	15	chromosome	chromosome	NOUN
dpc-3520	37	16	2p13	2p13	NUM
dpc-3520	37	17	[	[	X
dpc-3520	37	18	13	13	NUM
dpc-3520	37	19	]	]	PUNCT
dpc-3520	37	20	.	.	PUNCT
dpc-3520	38	1	furthermore	furthermore	ADV
dpc-3520	38	2	,	,	PUNCT
dpc-3520	38	3	the	the	DET
dpc-3520	38	4	structural	structural	ADJ
dpc-3520	38	5	homology	homology	NOUN
dpc-3520	38	6	of	of	ADP
dpc-3520	38	7	il-38	il-38	NOUN
dpc-3520	38	8	with	with	ADP
dpc-3520	38	9	il-1ra	il-1ra	NOUN
dpc-3520	38	10	and	and	CCONJ
dpc-3520	38	11	il-36ra	il-36ra	PROPN
dpc-3520	38	12	is	be	AUX
dpc-3520	38	13	about	about	ADV
dpc-3520	38	14	41	41	NUM
dpc-3520	38	15	%	%	NOUN
dpc-3520	38	16	and	and	CCONJ
dpc-3520	38	17	43	43	NUM
dpc-3520	38	18	%	%	NOUN
dpc-3520	38	19	,	,	PUNCT
dpc-3520	38	20	respectively	respectively	ADV
dpc-3520	38	21	,	,	PUNCT
dpc-3520	38	22	whereas	whereas	SCONJ
dpc-3520	38	23	this	this	DET
dpc-3520	38	24	homology	homology	NOUN
dpc-3520	38	25	is	be	AUX
dpc-3520	38	26	significantly	significantly	ADV
dpc-3520	38	27	lower	low	ADJ
dpc-3520	38	28	(	(	PUNCT
dpc-3520	38	29	14%-30	14%-30	NUM
dpc-3520	38	30	%	%	NOUN
dpc-3520	38	31	)	)	PUNCT
dpc-3520	38	32	with	with	ADP
dpc-3520	38	33	the	the	DET
dpc-3520	38	34	other	other	ADJ
dpc-3520	38	35	members	member	NOUN
dpc-3520	38	36	of	of	ADP
dpc-3520	38	37	il-1	il-1	ADP
dpc-3520	38	38	cytokine	cytokine	ADJ
dpc-3520	38	39	family	family	NOUN
dpc-3520	39	1	[	[	X
dpc-3520	39	2	14	14	NUM
dpc-3520	39	3	]	]	PUNCT
dpc-3520	39	4	.	.	PUNCT
dpc-3520	40	1	because	because	SCONJ
dpc-3520	40	2	of	of	ADP
dpc-3520	40	3	its	its	PRON
dpc-3520	40	4	structural	structural	ADJ
dpc-3520	40	5	resemblance	resemblance	NOUN
dpc-3520	40	6	with	with	ADP
dpc-3520	40	7	il-36ra	il-36ra	PROPN
dpc-3520	40	8	,	,	PUNCT
dpc-3520	40	9	il-38	il-38	NOUN
dpc-3520	40	10	is	be	AUX
dpc-3520	40	11	supposed	suppose	VERB
dpc-3520	40	12	to	to	PART
dpc-3520	40	13	function	function	VERB
dpc-3520	40	14	through	through	ADP
dpc-3520	40	15	il-36r	il-36r	PROPN
dpc-3520	40	16	downstream	downstream	ADJ
dpc-3520	40	17	signaling	signal	VERB
dpc-3520	40	18	pathways	pathway	NOUN
dpc-3520	40	19	such	such	ADJ
dpc-3520	40	20	as	as	ADP
dpc-3520	40	21	nuclear	nuclear	ADJ
dpc-3520	40	22	factor	factor	NOUN
dpc-3520	40	23	(	(	PUNCT
dpc-3520	40	24	nf)-κb	nf)-κb	NOUN
dpc-3520	40	25	and	and	CCONJ
dpc-3520	40	26	mitogen	mitogen	NOUN
dpc-3520	40	27	-	-	PUNCT
dpc-3520	40	28	activated	activate	VERB
dpc-3520	40	29	protein	protein	NOUN
dpc-3520	40	30	kinase	kinase	NOUN
dpc-3520	40	31	(	(	PUNCT
dpc-3520	40	32	mapk	mapk	NOUN
dpc-3520	40	33	)	)	PUNCT
dpc-3520	40	34	inhibition	inhibition	NOUN
dpc-3520	40	35	[	[	X
dpc-3520	40	36	15,16	15,16	NUM
dpc-3520	40	37	]	]	PUNCT
dpc-3520	40	38	.	.	PUNCT
dpc-3520	41	1	in	in	ADP
dpc-3520	41	2	line	line	NOUN
dpc-3520	41	3	with	with	ADP
dpc-3520	41	4	these	these	DET
dpc-3520	41	5	findings	finding	NOUN
dpc-3520	41	6	about	about	ADP
dpc-3520	41	7	the	the	DET
dpc-3520	41	8	biological	biological	ADJ
dpc-3520	41	9	functions	function	NOUN
dpc-3520	41	10	of	of	ADP
dpc-3520	41	11	il-38	il-38	NOUN
dpc-3520	41	12	,	,	PUNCT
dpc-3520	41	13	several	several	ADJ
dpc-3520	41	14	studies	study	NOUN
dpc-3520	41	15	have	have	AUX
dpc-3520	41	16	focused	focus	VERB
dpc-3520	41	17	on	on	ADP
dpc-3520	41	18	the	the	DET
dpc-3520	41	19	specific	specific	ADJ
dpc-3520	41	20	role	role	NOUN
dpc-3520	41	21	of	of	ADP
dpc-3520	41	22	this	this	DET
dpc-3520	41	23	cytokine	cytokine	NOUN
dpc-3520	41	24	in	in	ADP
dpc-3520	41	25	some	some	DET
dpc-3520	41	26	disorders	disorder	NOUN
dpc-3520	41	27	,	,	PUNCT
dpc-3520	41	28	typically	typically	ADV
dpc-3520	41	29	immune	immune	ADJ
dpc-3520	41	30	-	-	PUNCT
dpc-3520	41	31	mediated	mediate	VERB
dpc-3520	41	32	diseases	disease	NOUN
dpc-3520	41	33	.	.	PUNCT
dpc-3520	42	1	il-38	il-38	NOUN
dpc-3520	42	2	gene	gene	NOUN
dpc-3520	42	3	polymorphisms	polymorphism	NOUN
dpc-3520	42	4	have	have	AUX
dpc-3520	42	5	been	be	AUX
dpc-3520	42	6	studied	study	VERB
dpc-3520	42	7	in	in	ADP
dpc-3520	42	8	ankylosing	ankylose	VERB
dpc-3520	42	9	spondylitis	spondylitis	NOUN
dpc-3520	42	10	,	,	PUNCT
dpc-3520	42	11	rheumatoid	rheumatoid	NOUN
dpc-3520	42	12	arthritis	arthritis	NOUN
dpc-3520	42	13	(	(	PUNCT
dpc-3520	42	14	ra	ra	NOUN
dpc-3520	42	15	)	)	PUNCT
dpc-3520	42	16	,	,	PUNCT
dpc-3520	42	17	psoriatic	psoriatic	ADJ
dpc-3520	42	18	arthritis	arthritis	NOUN
dpc-3520	42	19	and	and	CCONJ
dpc-3520	42	20	heart	heart	NOUN
dpc-3520	42	21	diseases	disease	NOUN
dpc-3520	42	22	[	[	X
dpc-3520	42	23	17	17	NUM
dpc-3520	42	24	-	-	SYM
dpc-3520	42	25	20	20	NUM
dpc-3520	42	26	]	]	PUNCT
dpc-3520	42	27	.	.	PUNCT
dpc-3520	43	1	moreover	moreover	ADV
dpc-3520	43	2	,	,	PUNCT
dpc-3520	43	3	the	the	DET
dpc-3520	43	4	levels	level	NOUN
dpc-3520	43	5	of	of	ADP
dpc-3520	43	6	this	this	DET
dpc-3520	43	7	cytokine	cytokine	NOUN
dpc-3520	43	8	have	have	AUX
dpc-3520	43	9	been	be	AUX
dpc-3520	43	10	raised	raise	VERB
dpc-3520	43	11	in	in	ADP
dpc-3520	43	12	sera	sera	NOUN
dpc-3520	43	13	of	of	ADP
dpc-3520	43	14	patients	patient	NOUN
dpc-3520	43	15	with	with	ADP
dpc-3520	43	16	systemic	systemic	ADJ
dpc-3520	43	17	lupus	lupus	NOUN
dpc-3520	43	18	erythematosus	erythematosus	NOUN
dpc-3520	43	19	(	(	PUNCT
dpc-3520	43	20	sle	sle	PROPN
dpc-3520	43	21	)	)	PUNCT
dpc-3520	43	22	,	,	PUNCT
dpc-3520	43	23	ra	ra	PROPN
dpc-3520	43	24	,	,	PUNCT
dpc-3520	43	25	myocardial	myocardial	ADJ
dpc-3520	43	26	infarction	infarction	NOUN
dpc-3520	43	27	and	and	CCONJ
dpc-3520	43	28	childhood	childhood	NOUN
dpc-3520	43	29	asthma	asthma	NOUN
dpc-3520	44	1	[	[	X
dpc-3520	44	2	21	21	NUM
dpc-3520	44	3	-	-	SYM
dpc-3520	44	4	24	24	NUM
dpc-3520	44	5	]	]	PUNCT
dpc-3520	44	6	.	.	PUNCT
dpc-3520	45	1	objectives	objective	NOUN
dpc-3520	45	2	according	accord	VERB
dpc-3520	45	3	to	to	ADP
dpc-3520	45	4	the	the	DET
dpc-3520	45	5	role	role	NOUN
dpc-3520	45	6	of	of	ADP
dpc-3520	45	7	various	various	ADJ
dpc-3520	45	8	cytokines	cytokine	NOUN
dpc-3520	45	9	in	in	ADP
dpc-3520	45	10	the	the	DET
dpc-3520	45	11	pathogenesis	pathogenesis	NOUN
dpc-3520	45	12	of	of	ADP
dpc-3520	45	13	vitiligo	vitiligo	NOUN
dpc-3520	45	14	,	,	PUNCT
dpc-3520	45	15	focusing	focus	VERB
dpc-3520	45	16	on	on	ADP
dpc-3520	45	17	those	those	PRON
dpc-3520	45	18	with	with	ADP
dpc-3520	45	19	the	the	DET
dpc-3520	45	20	unknown	unknown	ADJ
dpc-3520	45	21	effects	effect	NOUN
dpc-3520	45	22	in	in	ADP
dpc-3520	45	23	this	this	DET
dpc-3520	45	24	disease	disease	NOUN
dpc-3520	45	25	would	would	AUX
dpc-3520	45	26	come	come	VERB
dpc-3520	45	27	into	into	ADP
dpc-3520	45	28	consideration	consideration	NOUN
dpc-3520	45	29	.	.	PUNCT
dpc-3520	46	1	therefore	therefore	ADV
dpc-3520	46	2	,	,	PUNCT
dpc-3520	46	3	we	we	PRON
dpc-3520	46	4	aimed	aim	VERB
dpc-3520	46	5	to	to	PART
dpc-3520	46	6	investigate	investigate	VERB
dpc-3520	46	7	the	the	DET
dpc-3520	46	8	role	role	NOUN
dpc-3520	46	9	of	of	ADP
dpc-3520	46	10	il-38	il-38	NOUN
dpc-3520	46	11	in	in	ADP
dpc-3520	46	12	vitiligo	vitiligo	NOUN
dpc-3520	46	13	as	as	ADP
dpc-3520	46	14	the	the	DET
dpc-3520	46	15	first	first	ADJ
dpc-3520	46	16	report	report	NOUN
dpc-3520	46	17	of	of	ADP
dpc-3520	46	18	the	the	DET
dpc-3520	46	19	lower	low	ADJ
dpc-3520	46	20	level	level	NOUN
dpc-3520	46	21	of	of	ADP
dpc-3520	46	22	this	this	DET
dpc-3520	46	23	cytokine	cytokine	NOUN
dpc-3520	46	24	in	in	ADP
dpc-3520	46	25	the	the	DET
dpc-3520	46	26	context	context	NOUN
dpc-3520	46	27	of	of	ADP
dpc-3520	46	28	vitiligo	vitiligo	ADJ
dpc-3520	46	29	pathogenesis	pathogenesis	NOUN
dpc-3520	46	30	.	.	PUNCT
dpc-3520	47	1	methods	method	NOUN
dpc-3520	47	2	subjects	subject	VERB
dpc-3520	47	3	a	a	DET
dpc-3520	47	4	total	total	NOUN
dpc-3520	47	5	of	of	ADP
dpc-3520	47	6	76	76	NUM
dpc-3520	47	7	patients	patient	NOUN
dpc-3520	47	8	with	with	ADP
dpc-3520	47	9	vitiligo	vitiligo	NOUN
dpc-3520	47	10	(	(	PUNCT
dpc-3520	47	11	69	69	NUM
dpc-3520	47	12	generalized	generalized	ADJ
dpc-3520	47	13	and	and	CCONJ
dpc-3520	47	14	7	7	NUM
dpc-3520	47	15	localized	localized	ADJ
dpc-3520	47	16	)	)	PUNCT
dpc-3520	47	17	who	who	PRON
dpc-3520	47	18	referred	refer	VERB
dpc-3520	47	19	to	to	ADP
dpc-3520	47	20	dermatology	dermatology	NOUN
dpc-3520	47	21	outpatient	outpatient	NOUN
dpc-3520	47	22	clinic	clinic	NOUN
dpc-3520	47	23	of	of	ADP
dpc-3520	47	24	shahid	shahid	PROPN
dpc-3520	47	25	faghihi	faghihi	PROPN
dpc-3520	47	26	hospital	hospital	PROPN
dpc-3520	47	27	,	,	PUNCT
dpc-3520	47	28	shiraz	shiraz	PROPN
dpc-3520	47	29	,	,	PUNCT
dpc-3520	47	30	iran	iran	PROPN
dpc-3520	47	31	,	,	PUNCT
dpc-3520	47	32	were	be	AUX
dpc-3520	47	33	included	include	VERB
dpc-3520	47	34	in	in	ADP
dpc-3520	47	35	this	this	DET
dpc-3520	47	36	study	study	NOUN
dpc-3520	47	37	.	.	PUNCT
dpc-3520	48	1	of	of	ADP
dpc-3520	48	2	69	69	NUM
dpc-3520	48	3	patients	patient	NOUN
dpc-3520	48	4	with	with	ADP
dpc-3520	48	5	generalized	generalized	ADJ
dpc-3520	48	6	vitiligo	vitiligo	NOUN
dpc-3520	48	7	,	,	PUNCT
dpc-3520	48	8	43	43	NUM
dpc-3520	48	9	and	and	CCONJ
dpc-3520	48	10	26	26	NUM
dpc-3520	48	11	patients	patient	NOUN
dpc-3520	48	12	were	be	AUX
dpc-3520	48	13	females	female	NOUN
dpc-3520	48	14	and	and	CCONJ
dpc-3520	48	15	males	male	NOUN
dpc-3520	48	16	,	,	PUNCT
dpc-3520	48	17	respectively	respectively	ADV
dpc-3520	48	18	(	(	PUNCT
dpc-3520	48	19	mean	mean	VERB
dpc-3520	48	20	age	age	NOUN
dpc-3520	48	21	36.00±14.88	36.00±14.88	NUM
dpc-3520	48	22	years	year	NOUN
dpc-3520	48	23	;	;	PUNCT
dpc-3520	48	24	range	range	NOUN
dpc-3520	48	25	13	13	NUM
dpc-3520	48	26	-	-	SYM
dpc-3520	48	27	74	74	NUM
dpc-3520	48	28	years	year	NOUN
dpc-3520	48	29	)	)	PUNCT
dpc-3520	48	30	.	.	PUNCT
dpc-3520	49	1	the	the	DET
dpc-3520	49	2	study	study	NOUN
dpc-3520	49	3	protocol	protocol	NOUN
dpc-3520	49	4	was	be	AUX
dpc-3520	49	5	approved	approve	VERB
dpc-3520	49	6	by	by	ADP
dpc-3520	49	7	elite	elite	ADJ
dpc-3520	49	8	researcher	researcher	NOUN
dpc-3520	49	9	grant	grant	PROPN
dpc-3520	49	10	committee	committee	PROPN
dpc-3520	49	11	under	under	ADP
dpc-3520	49	12	award	award	NOUN
dpc-3520	49	13	number	number	NOUN
dpc-3520	49	14	[	[	X
dpc-3520	49	15	971223	971223	NUM
dpc-3520	49	16	]	]	PUNCT
dpc-3520	49	17	from	from	ADP
dpc-3520	49	18	the	the	DET
dpc-3520	49	19	national	national	PROPN
dpc-3520	49	20	institute	institute	PROPN
dpc-3520	49	21	for	for	ADP
dpc-3520	49	22	medical	medical	ADJ
dpc-3520	49	23	research	research	NOUN
dpc-3520	49	24	development	development	NOUN
dpc-3520	49	25	(	(	PUNCT
dpc-3520	49	26	nimad	nimad	NOUN
dpc-3520	49	27	)	)	PUNCT
dpc-3520	49	28	,	,	PUNCT
dpc-3520	49	29	tehran	tehran	PROPN
dpc-3520	49	30	.	.	PUNCT
dpc-3520	50	1	informed	informed	ADJ
dpc-3520	50	2	consent	consent	NOUN
dpc-3520	50	3	was	be	AUX
dpc-3520	50	4	obtained	obtain	VERB
dpc-3520	50	5	from	from	ADP
dpc-3520	50	6	all	all	DET
dpc-3520	50	7	patients	patient	NOUN
dpc-3520	50	8	.	.	PUNCT
dpc-3520	51	1	information	information	NOUN
dpc-3520	51	2	from	from	ADP
dpc-3520	51	3	the	the	DET
dpc-3520	51	4	patients	patient	NOUN
dpc-3520	51	5	was	be	AUX
dpc-3520	51	6	recorded	record	VERB
dpc-3520	51	7	using	use	VERB
dpc-3520	51	8	a	a	DET
dpc-3520	51	9	special	special	ADJ
dpc-3520	51	10	questioner	questioner	NOUN
dpc-3520	51	11	with	with	ADP
dpc-3520	51	12	respect	respect	NOUN
dpc-3520	51	13	to	to	ADP
dpc-3520	51	14	demographic	demographic	ADJ
dpc-3520	51	15	,	,	PUNCT
dpc-3520	51	16	paraclinical	paraclinical	ADJ
dpc-3520	51	17	and	and	CCONJ
dpc-3520	51	18	clinical	clinical	ADJ
dpc-3520	51	19	presentation	presentation	NOUN
dpc-3520	51	20	of	of	ADP
dpc-3520	51	21	the	the	DET
dpc-3520	51	22	cases	case	NOUN
dpc-3520	51	23	.	.	PUNCT
dpc-3520	52	1	subjects	subject	NOUN
dpc-3520	52	2	with	with	ADP
dpc-3520	52	3	other	other	ADJ
dpc-3520	52	4	autoimmune	autoimmune	ADJ
dpc-3520	52	5	or	or	CCONJ
dpc-3520	52	6	inflammatory	inflammatory	ADJ
dpc-3520	52	7	diseases	disease	NOUN
dpc-3520	52	8	,	,	PUNCT
dpc-3520	52	9	current	current	ADJ
dpc-3520	52	10	infections	infection	NOUN
dpc-3520	52	11	and	and	CCONJ
dpc-3520	52	12	pregnant	pregnant	ADJ
dpc-3520	52	13	women	woman	NOUN
dpc-3520	52	14	were	be	AUX
dpc-3520	52	15	excluded	exclude	VERB
dpc-3520	52	16	from	from	ADP
dpc-3520	52	17	the	the	DET
dpc-3520	52	18	study	study	NOUN
dpc-3520	52	19	.	.	PUNCT
dpc-3520	53	1	conclusions	conclusion	NOUN
dpc-3520	53	2	:	:	PUNCT
dpc-3520	53	3	the	the	DET
dpc-3520	53	4	lower	low	ADJ
dpc-3520	53	5	levels	level	NOUN
dpc-3520	53	6	of	of	ADP
dpc-3520	53	7	il-38	il-38	NOUN
dpc-3520	53	8	as	as	ADP
dpc-3520	53	9	an	an	DET
dpc-3520	53	10	anti	anti	ADJ
dpc-3520	53	11	-	-	ADJ
dpc-3520	53	12	inflammatory	inflammatory	ADJ
dpc-3520	53	13	cytokine	cytokine	NOUN
dpc-3520	53	14	support	support	VERB
dpc-3520	53	15	the	the	DET
dpc-3520	53	16	inflammatory	inflammatory	ADJ
dpc-3520	53	17	nature	nature	NOUN
dpc-3520	53	18	of	of	ADP
dpc-3520	53	19	vitiligo	vitiligo	NOUN
dpc-3520	53	20	.	.	PUNCT
dpc-3520	54	1	it	it	PRON
dpc-3520	54	2	indicates	indicate	VERB
dpc-3520	54	3	the	the	DET
dpc-3520	54	4	difference	difference	NOUN
dpc-3520	54	5	of	of	ADP
dpc-3520	54	6	il-38	il-38	NOUN
dpc-3520	54	7	in	in	ADP
dpc-3520	54	8	sera	sera	NOUN
dpc-3520	54	9	of	of	ADP
dpc-3520	54	10	vitiligo	vitiligo	ADJ
dpc-3520	54	11	patients	patient	NOUN
dpc-3520	54	12	and	and	CCONJ
dpc-3520	54	13	healthy	healthy	ADJ
dpc-3520	54	14	controls	control	NOUN
dpc-3520	54	15	,	,	PUNCT
dpc-3520	54	16	as	as	ADP
dpc-3520	54	17	the	the	DET
dpc-3520	54	18	first	first	ADJ
dpc-3520	54	19	report	report	NOUN
dpc-3520	54	20	of	of	ADP
dpc-3520	54	21	the	the	DET
dpc-3520	54	22	lower	low	ADJ
dpc-3520	54	23	level	level	NOUN
dpc-3520	54	24	of	of	ADP
dpc-3520	54	25	this	this	DET
dpc-3520	54	26	cytokine	cytokine	NOUN
dpc-3520	54	27	in	in	ADP
dpc-3520	54	28	the	the	DET
dpc-3520	54	29	context	context	NOUN
dpc-3520	54	30	of	of	ADP
dpc-3520	54	31	vitiligo	vitiligo	NOUN
dpc-3520	54	32	.	.	PUNCT
dpc-3520	55	1	the	the	DET
dpc-3520	55	2	reason	reason	NOUN
dpc-3520	55	3	of	of	ADP
dpc-3520	55	4	this	this	DET
dpc-3520	55	5	difference	difference	NOUN
dpc-3520	55	6	remains	remain	VERB
dpc-3520	55	7	to	to	PART
dpc-3520	55	8	be	be	AUX
dpc-3520	55	9	clarified	clarify	VERB
dpc-3520	55	10	;	;	PUNCT
dpc-3520	55	11	as	as	SCONJ
dpc-3520	55	12	there	there	PRON
dpc-3520	55	13	are	be	VERB
dpc-3520	55	14	not	not	PART
dpc-3520	55	15	sufficient	sufficient	ADJ
dpc-3520	55	16	study	study	NOUN
dpc-3520	55	17	reports	report	NOUN
dpc-3520	55	18	revealing	reveal	VERB
dpc-3520	55	19	the	the	DET
dpc-3520	55	20	role	role	NOUN
dpc-3520	55	21	of	of	ADP
dpc-3520	55	22	gender	gender	NOUN
dpc-3520	55	23	,	,	PUNCT
dpc-3520	55	24	ethnicity	ethnicity	NOUN
dpc-3520	55	25	and	and	CCONJ
dpc-3520	55	26	inflammation	inflammation	NOUN
dpc-3520	55	27	on	on	ADP
dpc-3520	55	28	the	the	DET
dpc-3520	55	29	cytokine	cytokine	ADJ
dpc-3520	55	30	network	network	NOUN
dpc-3520	55	31	in	in	ADP
dpc-3520	55	32	the	the	DET
dpc-3520	55	33	context	context	NOUN
dpc-3520	55	34	of	of	ADP
dpc-3520	55	35	vitiligo	vitiligo	NOUN
dpc-3520	55	36	.	.	PUNCT
dpc-3520	56	1	original	original	ADJ
dpc-3520	56	2	article	article	NOUN
dpc-3520	56	3	|	|	ADV
dpc-3520	56	4	dermatol	dermatol	ADJ
dpc-3520	56	5	pract	pract	NOUN
dpc-3520	56	6	concept	concept	NOUN
dpc-3520	56	7	.	.	PUNCT
dpc-3520	57	1	2024;14(1):e2024027	2024;14(1):e2024027	NUM
dpc-3520	57	2	3	3	NUM
dpc-3520	57	3	vitiligo	vitiligo	NOUN
dpc-3520	57	4	disease	disease	NOUN
dpc-3520	57	5	activity	activity	NOUN
dpc-3520	57	6	score	score	NOUN
dpc-3520	57	7	(	(	PUNCT
dpc-3520	57	8	vida	vida	NOUN
dpc-3520	57	9	)	)	PUNCT
dpc-3520	57	10	was	be	AUX
dpc-3520	57	11	used	use	VERB
dpc-3520	57	12	to	to	PART
dpc-3520	57	13	evaluate	evaluate	VERB
dpc-3520	57	14	vitiligo	vitiligo	NOUN
dpc-3520	57	15	activity	activity	NOUN
dpc-3520	57	16	[	[	X
dpc-3520	57	17	25	25	NUM
dpc-3520	57	18	]	]	PUNCT
dpc-3520	57	19	.	.	PUNCT
dpc-3520	58	1	in	in	ADP
dpc-3520	58	2	addition	addition	NOUN
dpc-3520	58	3	,	,	PUNCT
dpc-3520	58	4	according	accord	VERB
dpc-3520	58	5	to	to	ADP
dpc-3520	58	6	the	the	DET
dpc-3520	58	7	vitiligo	vitiligo	ADJ
dpc-3520	58	8	european	european	PROPN
dpc-3520	58	9	task	task	PROPN
dpc-3520	58	10	force	force	NOUN
dpc-3520	58	11	(	(	PUNCT
dpc-3520	58	12	vetf	vetf	NOUN
dpc-3520	58	13	)	)	PUNCT
dpc-3520	58	14	system	system	NOUN
dpc-3520	58	15	,	,	PUNCT
dpc-3520	58	16	the	the	DET
dpc-3520	58	17	extent	extent	NOUN
dpc-3520	58	18	,	,	PUNCT
dpc-3520	58	19	stage	stage	NOUN
dpc-3520	58	20	(	(	PUNCT
dpc-3520	58	21	cutaneous	cutaneous	ADJ
dpc-3520	58	22	and	and	CCONJ
dpc-3520	58	23	hair	hair	NOUN
dpc-3520	58	24	pigmentation	pigmentation	NOUN
dpc-3520	58	25	in	in	ADP
dpc-3520	58	26	vitiligo	vitiligo	ADJ
dpc-3520	58	27	patches	patch	NOUN
dpc-3520	58	28	)	)	PUNCT
dpc-3520	58	29	and	and	CCONJ
dpc-3520	58	30	progression	progression	NOUN
dpc-3520	58	31	of	of	ADP
dpc-3520	58	32	the	the	DET
dpc-3520	58	33	disease	disease	NOUN
dpc-3520	58	34	was	be	AUX
dpc-3520	58	35	determined	determine	VERB
dpc-3520	58	36	for	for	ADP
dpc-3520	58	37	each	each	DET
dpc-3520	58	38	patient	patient	NOUN
dpc-3520	58	39	.	.	PUNCT
dpc-3520	59	1	the	the	DET
dpc-3520	59	2	patients	patient	NOUN
dpc-3520	59	3	were	be	AUX
dpc-3520	59	4	classified	classify	VERB
dpc-3520	59	5	into	into	ADP
dpc-3520	59	6	progressive	progressive	ADJ
dpc-3520	59	7	,	,	PUNCT
dpc-3520	59	8	stable	stable	ADJ
dpc-3520	59	9	or	or	CCONJ
dpc-3520	59	10	regressive	regressive	ADJ
dpc-3520	59	11	according	accord	VERB
dpc-3520	59	12	to	to	ADP
dpc-3520	59	13	the	the	DET
dpc-3520	59	14	spreading	spreading	NOUN
dpc-3520	59	15	of	of	ADP
dpc-3520	59	16	the	the	DET
dpc-3520	59	17	lesions	lesion	NOUN
dpc-3520	59	18	or	or	CCONJ
dpc-3520	59	19	white	white	ADJ
dpc-3520	59	20	macules	macule	NOUN
dpc-3520	59	21	at	at	ADP
dpc-3520	59	22	the	the	DET
dpc-3520	59	23	time	time	NOUN
dpc-3520	59	24	of	of	ADP
dpc-3520	59	25	blood	blood	NOUN
dpc-3520	59	26	sampling	sample	VERB
dpc-3520	59	27	[	[	X
dpc-3520	59	28	26	26	NUM
dpc-3520	59	29	]	]	PUNCT
dpc-3520	59	30	.	.	PUNCT
dpc-3520	60	1	skin	skin	NOUN
dpc-3520	60	2	type	type	NOUN
dpc-3520	60	3	of	of	ADP
dpc-3520	60	4	the	the	DET
dpc-3520	60	5	patients	patient	NOUN
dpc-3520	60	6	was	be	AUX
dpc-3520	60	7	also	also	ADV
dpc-3520	60	8	determined	determine	VERB
dpc-3520	60	9	according	accord	VERB
dpc-3520	60	10	to	to	ADP
dpc-3520	60	11	fitzpatrick	fitzpatrick	PROPN
dpc-3520	60	12	classification	classification	PROPN
dpc-3520	60	13	[	[	X
dpc-3520	60	14	27	27	NUM
dpc-3520	60	15	]	]	PUNCT
dpc-3520	60	16	.	.	PUNCT
dpc-3520	61	1	seventy	seventy	NUM
dpc-3520	61	2	-	-	PUNCT
dpc-3520	61	3	two	two	NUM
dpc-3520	61	4	ageand	ageand	NOUN
dpc-3520	61	5	sex	sex	NOUN
dpc-3520	61	6	-	-	PUNCT
dpc-3520	61	7	matched	match	VERB
dpc-3520	61	8	healthy	healthy	ADJ
dpc-3520	61	9	subjects	subject	NOUN
dpc-3520	61	10	(	(	PUNCT
dpc-3520	61	11	42	42	NUM
dpc-3520	61	12	females	female	NOUN
dpc-3520	61	13	and	and	CCONJ
dpc-3520	61	14	30	30	NUM
dpc-3520	61	15	males	male	NOUN
dpc-3520	61	16	;	;	PUNCT
dpc-3520	61	17	mean	mean	VERB
dpc-3520	61	18	age	age	NOUN
dpc-3520	61	19	39.54±10.35	39.54±10.35	NUM
dpc-3520	61	20	years	year	NOUN
dpc-3520	61	21	;	;	PUNCT
dpc-3520	61	22	range	range	NOUN
dpc-3520	61	23	24	24	NUM
dpc-3520	61	24	-	-	SYM
dpc-3520	61	25	62	62	NUM
dpc-3520	61	26	years	year	NOUN
dpc-3520	61	27	)	)	PUNCT
dpc-3520	61	28	were	be	AUX
dpc-3520	61	29	considered	consider	VERB
dpc-3520	61	30	as	as	ADP
dpc-3520	61	31	the	the	DET
dpc-3520	61	32	control	control	NOUN
dpc-3520	61	33	group	group	NOUN
dpc-3520	61	34	.	.	PUNCT
dpc-3520	62	1	controls	control	NOUN
dpc-3520	62	2	were	be	AUX
dpc-3520	62	3	healthy	healthy	ADJ
dpc-3520	62	4	individuals	individual	NOUN
dpc-3520	62	5	who	who	PRON
dpc-3520	62	6	had	have	VERB
dpc-3520	62	7	no	no	DET
dpc-3520	62	8	history	history	NOUN
dpc-3520	62	9	of	of	ADP
dpc-3520	62	10	autoimmune	autoimmune	ADJ
dpc-3520	62	11	disease	disease	NOUN
dpc-3520	62	12	themselves	themselves	PRON
dpc-3520	62	13	or	or	CCONJ
dpc-3520	62	14	in	in	ADP
dpc-3520	62	15	their	their	PRON
dpc-3520	62	16	relatives	relative	NOUN
dpc-3520	62	17	.	.	PUNCT
dpc-3520	63	1	sample	sample	NOUN
dpc-3520	63	2	preparation	preparation	NOUN
dpc-3520	63	3	and	and	CCONJ
dpc-3520	63	4	cytokine	cytokine	ADJ
dpc-3520	63	5	measurement	measurement	NOUN
dpc-3520	63	6	through	through	ADP
dpc-3520	63	7	enzyme	enzyme	NOUN
dpc-3520	63	8	-	-	PUNCT
dpc-3520	63	9	linked	link	VERB
dpc-3520	63	10	immunosorbent	immunosorbent	NOUN
dpc-3520	63	11	assay	assay	PROPN
dpc-3520	63	12	(	(	PUNCT
dpc-3520	63	13	elisa	elisa	NOUN
dpc-3520	63	14	)	)	PUNCT
dpc-3520	63	15	three	three	NUM
dpc-3520	63	16	milliliters	milliliter	NOUN
dpc-3520	63	17	of	of	ADP
dpc-3520	63	18	blood	blood	NOUN
dpc-3520	63	19	were	be	AUX
dpc-3520	63	20	taken	take	VERB
dpc-3520	63	21	from	from	ADP
dpc-3520	63	22	each	each	DET
dpc-3520	63	23	patients	patient	NOUN
dpc-3520	63	24	and	and	CCONJ
dpc-3520	63	25	controls	control	NOUN
dpc-3520	63	26	.	.	PUNCT
dpc-3520	64	1	in	in	ADP
dpc-3520	64	2	order	order	NOUN
dpc-3520	64	3	to	to	PART
dpc-3520	64	4	isolate	isolate	VERB
dpc-3520	64	5	sera	sera	NOUN
dpc-3520	64	6	,	,	PUNCT
dpc-3520	64	7	the	the	DET
dpc-3520	64	8	samples	sample	NOUN
dpc-3520	64	9	were	be	AUX
dpc-3520	64	10	centrifuged	centrifuge	VERB
dpc-3520	64	11	at	at	ADP
dpc-3520	64	12	4000	4000	NUM
dpc-3520	64	13	rpm	rpm	NOUN
dpc-3520	64	14	for	for	ADP
dpc-3520	64	15	15	15	NUM
dpc-3520	64	16	minutes	minute	NOUN
dpc-3520	64	17	.	.	PUNCT
dpc-3520	65	1	sera	sera	NOUN
dpc-3520	65	2	were	be	AUX
dpc-3520	65	3	stored	store	VERB
dpc-3520	65	4	at	at	ADP
dpc-3520	65	5	-70ºc	-70ºc	PROPN
dpc-3520	65	6	until	until	SCONJ
dpc-3520	65	7	used	use	VERB
dpc-3520	65	8	.	.	PUNCT
dpc-3520	66	1	serum	serum	NOUN
dpc-3520	66	2	level	level	NOUN
dpc-3520	66	3	of	of	ADP
dpc-3520	66	4	il-38	il-38	NOUN
dpc-3520	66	5	in	in	ADP
dpc-3520	66	6	all	all	DET
dpc-3520	66	7	individuals	individual	NOUN
dpc-3520	66	8	was	be	AUX
dpc-3520	66	9	measured	measure	VERB
dpc-3520	66	10	through	through	ADP
dpc-3520	66	11	a	a	DET
dpc-3520	66	12	specific	specific	ADJ
dpc-3520	66	13	elisa	elisa	NOUN
dpc-3520	66	14	kit	kit	NOUN
dpc-3520	66	15	(	(	PUNCT
dpc-3520	66	16	r&d	r&d	NOUN
dpc-3520	66	17	systemscat	systemscat	NOUN
dpc-3520	66	18	.	.	PUNCT
dpc-3520	67	1	no	no	INTJ
dpc-3520	67	2	.	.	PUNCT
dpc-3520	68	1	dy9110	dy9110	PROPN
dpc-3520	68	2	-	-	PUNCT
dpc-3520	68	3	05	05	NUM
dpc-3520	68	4	)	)	PUNCT
dpc-3520	69	1	according	accord	VERB
dpc-3520	69	2	to	to	ADP
dpc-3520	69	3	the	the	DET
dpc-3520	69	4	manufacturer	manufacturer	NOUN
dpc-3520	69	5	instructions	instruction	NOUN
dpc-3520	69	6	.	.	PUNCT
dpc-3520	70	1	briefly	briefly	NOUN
dpc-3520	70	2	,	,	PUNCT
dpc-3520	70	3	anti	anti	ADJ
dpc-3520	70	4	-	-	ADJ
dpc-3520	70	5	il-38	il-38	NOUN
dpc-3520	70	6	monoclonal	monoclonal	NOUN
dpc-3520	70	7	antibodies	antibody	NOUN
dpc-3520	70	8	were	be	AUX
dpc-3520	70	9	pre	pre	ADJ
dpc-3520	70	10	-	-	ADJ
dpc-3520	70	11	coated	coated	ADJ
dpc-3520	70	12	on	on	ADP
dpc-3520	70	13	to	to	PART
dpc-3520	70	14	elisa	elisa	VERB
dpc-3520	70	15	microplates	microplate	NOUN
dpc-3520	70	16	.	.	PUNCT
dpc-3520	71	1	serum	serum	NOUN
dpc-3520	71	2	samples	sample	NOUN
dpc-3520	71	3	(	(	PUNCT
dpc-3520	71	4	100	100	NUM
dpc-3520	71	5	μl	μl	PRON
dpc-3520	71	6	)	)	PUNCT
dpc-3520	71	7	were	be	AUX
dpc-3520	71	8	added	add	VERB
dpc-3520	71	9	to	to	ADP
dpc-3520	71	10	each	each	DET
dpc-3520	71	11	well	well	NOUN
dpc-3520	71	12	.	.	PUNCT
dpc-3520	72	1	afterwards	afterwards	ADV
dpc-3520	72	2	,	,	PUNCT
dpc-3520	72	3	100	100	NUM
dpc-3520	72	4	μl	μl	ADP
dpc-3520	72	5	of	of	ADP
dpc-3520	72	6	the	the	DET
dpc-3520	72	7	working	work	VERB
dpc-3520	72	8	solution	solution	NOUN
dpc-3520	72	9	of	of	ADP
dpc-3520	72	10	streptavidin	streptavidin	NOUN
dpc-3520	72	11	-	-	ADJ
dpc-3520	72	12	horseradish	horseradish	ADJ
dpc-3520	72	13	peroxidase	peroxidase	NOUN
dpc-3520	72	14	(	(	PUNCT
dpc-3520	72	15	hrp	hrp	PROPN
dpc-3520	72	16	)	)	PUNCT
dpc-3520	72	17	conjugated	conjugate	VERB
dpc-3520	72	18	antibodies	antibody	NOUN
dpc-3520	72	19	were	be	AUX
dpc-3520	72	20	added	add	VERB
dpc-3520	72	21	and	and	CCONJ
dpc-3520	72	22	after	after	ADP
dpc-3520	72	23	addition	addition	NOUN
dpc-3520	72	24	of	of	ADP
dpc-3520	72	25	substrate	substrate	NOUN
dpc-3520	72	26	the	the	DET
dpc-3520	72	27	optical	optical	ADJ
dpc-3520	72	28	density	density	NOUN
dpc-3520	72	29	of	of	ADP
dpc-3520	72	30	each	each	PRON
dpc-3520	72	31	well	well	ADV
dpc-3520	72	32	was	be	AUX
dpc-3520	72	33	determined	determine	VERB
dpc-3520	72	34	using	use	VERB
dpc-3520	72	35	a	a	DET
dpc-3520	72	36	microplate	microplate	NOUN
dpc-3520	72	37	reader	reader	NOUN
dpc-3520	72	38	(	(	PUNCT
dpc-3520	72	39	biotech	biotech	NOUN
dpc-3520	72	40	)	)	PUNCT
dpc-3520	72	41	at	at	ADP
dpc-3520	72	42	450	450	NUM
dpc-3520	72	43	nm	nm	NOUN
dpc-3520	72	44	.	.	PUNCT
dpc-3520	73	1	statistical	statistical	ADJ
dpc-3520	73	2	analysis	analysis	NOUN
dpc-3520	73	3	statistical	statistical	ADJ
dpc-3520	73	4	analysis	analysis	NOUN
dpc-3520	73	5	was	be	AUX
dpc-3520	73	6	performed	perform	VERB
dpc-3520	73	7	using	use	VERB
dpc-3520	73	8	spss	spss	PROPN
dpc-3520	73	9	v.	v.	ADP
dpc-3520	73	10	25	25	NUM
dpc-3520	73	11	software	software	NOUN
dpc-3520	73	12	(	(	PUNCT
dpc-3520	73	13	spss	spss	PROPN
dpc-3520	73	14	,	,	PUNCT
dpc-3520	73	15	inc	inc	PROPN
dpc-3520	73	16	.	.	PROPN
dpc-3520	73	17	)	)	PUNCT
dpc-3520	73	18	and	and	CCONJ
dpc-3520	73	19	graphpad	graphpad	NOUN
dpc-3520	73	20	prism	prism	NOUN
dpc-3520	73	21	v.8	v.8	PROPN
dpc-3520	73	22	software	software	NOUN
dpc-3520	73	23	.	.	PUNCT
dpc-3520	74	1	data	datum	NOUN
dpc-3520	74	2	were	be	AUX
dpc-3520	74	3	presented	present	VERB
dpc-3520	74	4	as	as	ADP
dpc-3520	74	5	mean	mean	NOUN
dpc-3520	74	6	±	±	NUM
dpc-3520	74	7	standard	standard	ADJ
dpc-3520	74	8	deviation	deviation	NOUN
dpc-3520	74	9	(	(	PUNCT
dpc-3520	74	10	sd	sd	NOUN
dpc-3520	74	11	)	)	PUNCT
dpc-3520	74	12	.	.	PUNCT
dpc-3520	75	1	mannwhitney	mannwhitney	NOUN
dpc-3520	75	2	u	u	PROPN
dpc-3520	75	3	test	test	NOUN
dpc-3520	75	4	was	be	AUX
dpc-3520	75	5	used	use	VERB
dpc-3520	75	6	to	to	PART
dpc-3520	75	7	evaluate	evaluate	VERB
dpc-3520	75	8	il-38	il-38	NOUN
dpc-3520	75	9	serum	serum	NOUN
dpc-3520	75	10	level	level	NOUN
dpc-3520	75	11	differences	difference	NOUN
dpc-3520	75	12	between	between	ADP
dpc-3520	75	13	the	the	DET
dpc-3520	75	14	groups	group	NOUN
dpc-3520	75	15	.	.	PUNCT
dpc-3520	76	1	spearman	spearman	NOUN
dpc-3520	76	2	correlation	correlation	NOUN
dpc-3520	76	3	test	test	NOUN
dpc-3520	76	4	(	(	PUNCT
dpc-3520	76	5	rho	rho	ADJ
dpc-3520	76	6	)	)	PUNCT
dpc-3520	76	7	was	be	AUX
dpc-3520	76	8	done	do	VERB
dpc-3520	76	9	to	to	PART
dpc-3520	76	10	assess	assess	VERB
dpc-3520	76	11	any	any	DET
dpc-3520	76	12	correlation	correlation	NOUN
dpc-3520	76	13	between	between	ADP
dpc-3520	76	14	two	two	NUM
dpc-3520	76	15	quantitative	quantitative	ADJ
dpc-3520	76	16	variables	variable	NOUN
dpc-3520	76	17	with	with	ADP
dpc-3520	76	18	no	no	DET
dpc-3520	76	19	normal	normal	ADJ
dpc-3520	76	20	distribution	distribution	NOUN
dpc-3520	76	21	.	.	PUNCT
dpc-3520	77	1	p	p	X
dpc-3520	77	2	<	<	X
dpc-3520	77	3	0.05	0.05	NUM
dpc-3520	77	4	was	be	AUX
dpc-3520	77	5	regarded	regard	VERB
dpc-3520	77	6	as	as	ADP
dpc-3520	77	7	statistically	statistically	ADV
dpc-3520	77	8	significant	significant	ADJ
dpc-3520	77	9	value	value	NOUN
dpc-3520	77	10	.	.	PUNCT
dpc-3520	78	1	results	result	VERB
dpc-3520	78	2	demographic	demographic	ADJ
dpc-3520	78	3	and	and	CCONJ
dpc-3520	78	4	clinical	clinical	ADJ
dpc-3520	78	5	data	datum	NOUN
dpc-3520	78	6	the	the	DET
dpc-3520	78	7	participant	participant	ADJ
dpc-3520	78	8	clinical	clinical	ADJ
dpc-3520	78	9	and	and	CCONJ
dpc-3520	78	10	demographic	demographic	ADJ
dpc-3520	78	11	data	datum	NOUN
dpc-3520	78	12	are	be	AUX
dpc-3520	78	13	summarized	summarize	VERB
dpc-3520	78	14	in	in	ADP
dpc-3520	78	15	table	table	NOUN
dpc-3520	78	16	1	1	NUM
dpc-3520	78	17	.	.	PUNCT
dpc-3520	79	1	a	a	DET
dpc-3520	79	2	total	total	NOUN
dpc-3520	79	3	of	of	ADP
dpc-3520	79	4	76	76	NUM
dpc-3520	79	5	patients	patient	NOUN
dpc-3520	79	6	were	be	AUX
dpc-3520	79	7	included	include	VERB
dpc-3520	79	8	in	in	ADP
dpc-3520	79	9	this	this	DET
dpc-3520	79	10	study	study	NOUN
dpc-3520	79	11	.	.	PUNCT
dpc-3520	80	1	among	among	ADP
dpc-3520	80	2	them	they	PRON
dpc-3520	80	3	,	,	PUNCT
dpc-3520	80	4	69	69	NUM
dpc-3520	80	5	cases	case	NOUN
dpc-3520	80	6	presented	present	VERB
dpc-3520	80	7	with	with	ADP
dpc-3520	80	8	generalized	generalized	ADJ
dpc-3520	80	9	and	and	CCONJ
dpc-3520	80	10	7	7	NUM
dpc-3520	80	11	cases	case	NOUN
dpc-3520	80	12	with	with	ADP
dpc-3520	80	13	localized	localized	ADJ
dpc-3520	80	14	type	type	NOUN
dpc-3520	80	15	of	of	ADP
dpc-3520	80	16	vitiligo	vitiligo	NOUN
dpc-3520	80	17	.	.	PUNCT
dpc-3520	81	1	comparison	comparison	NOUN
dpc-3520	81	2	of	of	ADP
dpc-3520	81	3	il-38	il-38	NOUN
dpc-3520	81	4	serum	serum	NOUN
dpc-3520	81	5	levels	level	NOUN
dpc-3520	81	6	in	in	ADP
dpc-3520	81	7	generalized	generalized	ADJ
dpc-3520	81	8	(	(	PUNCT
dpc-3520	81	9	159.53±39.66	159.53±39.66	NUM
dpc-3520	81	10	pg	pg	NOUN
dpc-3520	81	11	/	/	SYM
dpc-3520	81	12	ml	ml	VERB
dpc-3520	81	13	)	)	PUNCT
dpc-3520	81	14	and	and	CCONJ
dpc-3520	81	15	localized	localize	VERB
dpc-3520	81	16	(	(	PUNCT
dpc-3520	81	17	158.99±31.42	158.99±31.42	NUM
dpc-3520	81	18	pg	pg	NOUN
dpc-3520	81	19	/	/	SYM
dpc-3520	81	20	ml	ml	NOUN
dpc-3520	81	21	)	)	PUNCT
dpc-3520	81	22	patients	patient	NOUN
dpc-3520	81	23	showed	show	VERB
dpc-3520	81	24	no	no	DET
dpc-3520	81	25	significant	significant	ADJ
dpc-3520	81	26	differences	difference	NOUN
dpc-3520	81	27	.	.	PUNCT
dpc-3520	82	1	due	due	ADP
dpc-3520	82	2	to	to	ADP
dpc-3520	82	3	limited	limited	ADJ
dpc-3520	82	4	number	number	NOUN
dpc-3520	82	5	of	of	ADP
dpc-3520	82	6	the	the	DET
dpc-3520	82	7	localized	localized	ADJ
dpc-3520	82	8	patients	patient	NOUN
dpc-3520	82	9	,	,	PUNCT
dpc-3520	82	10	the	the	DET
dpc-3520	82	11	rest	rest	NOUN
dpc-3520	82	12	of	of	ADP
dpc-3520	82	13	analysis	analysis	NOUN
dpc-3520	82	14	was	be	AUX
dpc-3520	82	15	performed	perform	VERB
dpc-3520	82	16	only	only	ADV
dpc-3520	82	17	on	on	ADP
dpc-3520	82	18	generalized	generalized	ADJ
dpc-3520	82	19	patients	patient	NOUN
dpc-3520	82	20	.	.	PUNCT
dpc-3520	83	1	the	the	DET
dpc-3520	83	2	beginning	beginning	NOUN
dpc-3520	83	3	of	of	ADP
dpc-3520	83	4	the	the	DET
dpc-3520	83	5	disease	disease	NOUN
dpc-3520	83	6	was	be	AUX
dpc-3520	83	7	around	around	ADV
dpc-3520	83	8	27	27	NUM
dpc-3520	83	9	years	year	NOUN
dpc-3520	83	10	old	old	ADJ
dpc-3520	83	11	.	.	PUNCT
dpc-3520	84	1	family	family	NOUN
dpc-3520	84	2	history	history	NOUN
dpc-3520	84	3	of	of	ADP
dpc-3520	84	4	vitiligo	vitiligo	NOUN
dpc-3520	84	5	was	be	AUX
dpc-3520	84	6	seen	see	VERB
dpc-3520	84	7	in	in	ADP
dpc-3520	84	8	26.2	26.2	NUM
dpc-3520	84	9	%	%	NOUN
dpc-3520	84	10	of	of	ADP
dpc-3520	84	11	the	the	DET
dpc-3520	84	12	patients	patient	NOUN
dpc-3520	84	13	.	.	PUNCT
dpc-3520	85	1	more	more	ADJ
dpc-3520	85	2	than	than	ADP
dpc-3520	85	3	95	95	NUM
dpc-3520	85	4	%	%	NOUN
dpc-3520	85	5	of	of	ADP
dpc-3520	85	6	the	the	DET
dpc-3520	85	7	patients	patient	NOUN
dpc-3520	85	8	had	have	AUX
dpc-3520	85	9	generalized	generalize	VERB
dpc-3520	85	10	bilateral	bilateral	ADJ
dpc-3520	85	11	symmetrical	symmetrical	ADJ
dpc-3520	85	12	vitiligo	vitiligo	NOUN
dpc-3520	85	13	.	.	PUNCT
dpc-3520	86	1	most	most	ADJ
dpc-3520	86	2	patients	patient	NOUN
dpc-3520	86	3	(	(	PUNCT
dpc-3520	86	4	85.5	85.5	NUM
dpc-3520	86	5	%	%	NOUN
dpc-3520	86	6	)	)	PUNCT
dpc-3520	86	7	had	have	VERB
dpc-3520	86	8	complete	complete	ADJ
dpc-3520	86	9	depigmentation	depigmentation	NOUN
dpc-3520	86	10	with	with	ADP
dpc-3520	86	11	less	less	ADJ
dpc-3520	86	12	than	than	ADP
dpc-3520	86	13	30	30	NUM
dpc-3520	86	14	%	%	NOUN
dpc-3520	86	15	hair	hair	NOUN
dpc-3520	86	16	whitening	whitening	NOUN
dpc-3520	86	17	,	,	PUNCT
dpc-3520	86	18	and	and	CCONJ
dpc-3520	86	19	86.8	86.8	NUM
dpc-3520	86	20	%	%	NOUN
dpc-3520	86	21	were	be	AUX
dpc-3520	86	22	categorized	categorize	VERB
dpc-3520	86	23	in	in	ADP
dpc-3520	86	24	type	type	NOUN
dpc-3520	86	25	iii	iii	NOUN
dpc-3520	86	26	skin	skin	NOUN
dpc-3520	86	27	type	type	NOUN
dpc-3520	86	28	.	.	PUNCT
dpc-3520	87	1	the	the	DET
dpc-3520	87	2	disease	disease	NOUN
dpc-3520	87	3	was	be	AUX
dpc-3520	87	4	progressive	progressive	ADJ
dpc-3520	87	5	in	in	ADP
dpc-3520	87	6	25	25	NUM
dpc-3520	87	7	(	(	PUNCT
dpc-3520	87	8	36.2	36.2	NUM
dpc-3520	87	9	%	%	NOUN
dpc-3520	87	10	)	)	PUNCT
dpc-3520	87	11	patients	patient	NOUN
dpc-3520	87	12	,	,	PUNCT
dpc-3520	87	13	stable	stable	ADJ
dpc-3520	87	14	in	in	ADP
dpc-3520	87	15	20	20	NUM
dpc-3520	87	16	(	(	PUNCT
dpc-3520	87	17	29	29	NUM
dpc-3520	87	18	%	%	NOUN
dpc-3520	87	19	)	)	PUNCT
dpc-3520	87	20	cases	case	NOUN
dpc-3520	87	21	and	and	CCONJ
dpc-3520	87	22	regressive	regressive	ADJ
dpc-3520	87	23	in	in	ADP
dpc-3520	87	24	24	24	NUM
dpc-3520	87	25	patients	patient	NOUN
dpc-3520	87	26	(	(	PUNCT
dpc-3520	87	27	34.8	34.8	NUM
dpc-3520	87	28	%	%	NOUN
dpc-3520	87	29	)	)	PUNCT
dpc-3520	87	30	.	.	PUNCT
dpc-3520	88	1	il-38	il-38	NOUN
dpc-3520	88	2	serum	serum	NOUN
dpc-3520	88	3	level	level	NOUN
dpc-3520	88	4	differences	difference	NOUN
dpc-3520	88	5	between	between	ADP
dpc-3520	88	6	patients	patient	NOUN
dpc-3520	88	7	and	and	CCONJ
dpc-3520	88	8	healthy	healthy	ADJ
dpc-3520	88	9	controls	control	NOUN
dpc-3520	88	10	we	we	PRON
dpc-3520	88	11	found	find	VERB
dpc-3520	88	12	a	a	DET
dpc-3520	88	13	significant	significant	ADJ
dpc-3520	88	14	difference	difference	NOUN
dpc-3520	88	15	in	in	ADP
dpc-3520	88	16	il-38	il-38	NOUN
dpc-3520	88	17	serum	serum	NOUN
dpc-3520	88	18	levels	level	NOUN
dpc-3520	88	19	between	between	ADP
dpc-3520	88	20	patients	patient	NOUN
dpc-3520	88	21	(	(	PUNCT
dpc-3520	88	22	159.5±39.7	159.5±39.7	NOUN
dpc-3520	88	23	pg	pg	NOUN
dpc-3520	88	24	/	/	SYM
dpc-3520	88	25	ml	ml	VERB
dpc-3520	88	26	)	)	PUNCT
dpc-3520	88	27	with	with	ADP
dpc-3520	88	28	range	range	NOUN
dpc-3520	88	29	of	of	ADP
dpc-3520	88	30	122.1331.6	122.1331.6	NUM
dpc-3520	88	31	pg	pg	NOUN
dpc-3520	88	32	/	/	SYM
dpc-3520	88	33	ml	ml	PROPN
dpc-3520	88	34	and	and	CCONJ
dpc-3520	88	35	healthy	healthy	ADJ
dpc-3520	88	36	control	control	NOUN
dpc-3520	88	37	group	group	NOUN
dpc-3520	88	38	(	(	PUNCT
dpc-3520	88	39	166.7±34.8	166.7±34.8	NUM
dpc-3520	88	40	pg	pg	NOUN
dpc-3520	88	41	/	/	SYM
dpc-3520	88	42	ml	ml	VERB
dpc-3520	88	43	)	)	PUNCT
dpc-3520	88	44	with	with	ADP
dpc-3520	88	45	range	range	NOUN
dpc-3520	88	46	of	of	ADP
dpc-3520	88	47	113.1	113.1	NUM
dpc-3520	88	48	-	-	SYM
dpc-3520	88	49	293.0	293.0	NUM
dpc-3520	88	50	pg	pg	NOUN
dpc-3520	88	51	/	/	SYM
dpc-3520	88	52	ml	ml	PROPN
dpc-3520	88	53	(	(	PUNCT
dpc-3520	88	54	p	p	NOUN
dpc-3520	88	55	=	=	NOUN
dpc-3520	88	56	0.039	0.039	NUM
dpc-3520	88	57	)	)	PUNCT
dpc-3520	88	58	(	(	PUNCT
dpc-3520	88	59	figure	figure	NOUN
dpc-3520	88	60	1	1	NUM
dpc-3520	88	61	)	)	PUNCT
dpc-3520	88	62	.	.	PUNCT
dpc-3520	89	1	we	we	PRON
dpc-3520	89	2	did	do	AUX
dpc-3520	89	3	not	not	PART
dpc-3520	89	4	find	find	VERB
dpc-3520	89	5	any	any	DET
dpc-3520	89	6	significant	significant	ADJ
dpc-3520	89	7	difference	difference	NOUN
dpc-3520	89	8	in	in	ADP
dpc-3520	89	9	il-38	il-38	NOUN
dpc-3520	89	10	levels	level	NOUN
dpc-3520	89	11	between	between	ADP
dpc-3520	89	12	the	the	DET
dpc-3520	89	13	female	female	ADJ
dpc-3520	89	14	(	(	PUNCT
dpc-3520	89	15	163.8±46.5	163.8±46.5	NUM
dpc-3520	89	16	pg	pg	NOUN
dpc-3520	89	17	/	/	SYM
dpc-3520	89	18	ml	ml	NOUN
dpc-3520	89	19	)	)	PUNCT
dpc-3520	89	20	and	and	CCONJ
dpc-3520	89	21	male	male	ADJ
dpc-3520	89	22	(	(	PUNCT
dpc-3520	89	23	152.5±23.6	152.5±23.6	NUM
dpc-3520	89	24	pg	pg	NOUN
dpc-3520	89	25	/	/	SYM
dpc-3520	89	26	ml	ml	NOUN
dpc-3520	89	27	)	)	PUNCT
dpc-3520	89	28	patients	patient	NOUN
dpc-3520	89	29	(	(	PUNCT
dpc-3520	89	30	p	p	X
dpc-3520	89	31	=	=	NOUN
dpc-3520	89	32	0.31	0.31	NUM
dpc-3520	89	33	)	)	PUNCT
dpc-3520	89	34	or	or	CCONJ
dpc-3520	89	35	female	female	ADJ
dpc-3520	89	36	(	(	PUNCT
dpc-3520	89	37	169.5±40.4	169.5±40.4	NUM
dpc-3520	89	38	pg	pg	NOUN
dpc-3520	89	39	/	/	SYM
dpc-3520	89	40	ml	ml	NOUN
dpc-3520	89	41	)	)	PUNCT
dpc-3520	89	42	and	and	CCONJ
dpc-3520	89	43	male	male	ADJ
dpc-3520	89	44	(	(	PUNCT
dpc-3520	89	45	162.8±24.3	162.8±24.3	NUM
dpc-3520	89	46	pg	pg	NOUN
dpc-3520	89	47	/	/	SYM
dpc-3520	89	48	ml	ml	NOUN
dpc-3520	89	49	)	)	PUNCT
dpc-3520	89	50	controls	control	NOUN
dpc-3520	89	51	(	(	PUNCT
dpc-3520	89	52	p	p	X
dpc-3520	89	53	=	=	NOUN
dpc-3520	89	54	0.92	0.92	NUM
dpc-3520	89	55	)	)	PUNCT
dpc-3520	89	56	.	.	PUNCT
dpc-3520	90	1	correlation	correlation	NOUN
dpc-3520	90	2	between	between	ADP
dpc-3520	90	3	il-38	il-38	NOUN
dpc-3520	90	4	serum	serum	NOUN
dpc-3520	90	5	levels	level	NOUN
dpc-3520	90	6	and	and	CCONJ
dpc-3520	90	7	patients	patient	NOUN
dpc-3520	90	8	characteristics	characteristics	PROPN
dpc-3520	90	9	il-38	il-38	NOUN
dpc-3520	90	10	serum	serum	NOUN
dpc-3520	90	11	levels	level	NOUN
dpc-3520	90	12	showed	show	VERB
dpc-3520	90	13	no	no	DET
dpc-3520	90	14	correlation	correlation	NOUN
dpc-3520	90	15	with	with	ADP
dpc-3520	90	16	the	the	DET
dpc-3520	90	17	age	age	NOUN
dpc-3520	90	18	of	of	ADP
dpc-3520	90	19	patients	patient	NOUN
dpc-3520	90	20	,	,	PUNCT
dpc-3520	90	21	however	however	ADV
dpc-3520	90	22	when	when	SCONJ
dpc-3520	90	23	patients	patient	NOUN
dpc-3520	90	24	were	be	AUX
dpc-3520	90	25	evaluated	evaluate	VERB
dpc-3520	90	26	according	accord	VERB
dpc-3520	90	27	to	to	ADP
dpc-3520	90	28	the	the	DET
dpc-3520	90	29	sex	sex	NOUN
dpc-3520	90	30	,	,	PUNCT
dpc-3520	90	31	il-38	il-38	NOUN
dpc-3520	90	32	serum	serum	NOUN
dpc-3520	90	33	levels	level	NOUN
dpc-3520	90	34	showed	show	VERB
dpc-3520	90	35	a	a	DET
dpc-3520	90	36	weak	weak	ADJ
dpc-3520	90	37	negative	negative	ADJ
dpc-3520	90	38	correlation	correlation	NOUN
dpc-3520	90	39	with	with	ADP
dpc-3520	90	40	the	the	DET
dpc-3520	90	41	age	age	NOUN
dpc-3520	90	42	of	of	ADP
dpc-3520	90	43	male	male	ADJ
dpc-3520	90	44	patients	patient	NOUN
dpc-3520	90	45	(	(	PUNCT
dpc-3520	90	46	p	p	X
dpc-3520	90	47	=	=	NOUN
dpc-3520	90	48	0.058	0.058	NUM
dpc-3520	90	49	,	,	PUNCT
dpc-3520	90	50	r	r	NOUN
dpc-3520	90	51	=	=	PUNCT
dpc-3520	90	52	-0.38	-0.38	X
dpc-3520	90	53	)	)	PUNCT
dpc-3520	90	54	(	(	PUNCT
dpc-3520	90	55	figure	figure	NOUN
dpc-3520	90	56	2	2	NUM
dpc-3520	90	57	)	)	PUNCT
dpc-3520	90	58	.	.	PUNCT
dpc-3520	91	1	this	this	DET
dpc-3520	91	2	correlation	correlation	NOUN
dpc-3520	91	3	was	be	AUX
dpc-3520	91	4	not	not	PART
dpc-3520	91	5	observed	observe	VERB
dpc-3520	91	6	in	in	ADP
dpc-3520	91	7	relation	relation	NOUN
dpc-3520	91	8	to	to	PART
dpc-3520	91	9	male	male	VERB
dpc-3520	91	10	healthy	healthy	ADJ
dpc-3520	91	11	controls	control	NOUN
dpc-3520	91	12	(	(	PUNCT
dpc-3520	91	13	p	p	X
dpc-3520	91	14	=	=	NOUN
dpc-3520	91	15	0.21	0.21	NUM
dpc-3520	91	16	,	,	PUNCT
dpc-3520	91	17	r	r	NOUN
dpc-3520	91	18	=	=	PUNCT
dpc-3520	91	19	-0.233	-0.233	X
dpc-3520	91	20	)	)	PUNCT
dpc-3520	91	21	.	.	PUNCT
dpc-3520	92	1	as	as	ADP
dpc-3520	92	2	the	the	DET
dpc-3520	92	3	next	next	ADJ
dpc-3520	92	4	step	step	NOUN
dpc-3520	92	5	,	,	PUNCT
dpc-3520	92	6	analysis	analysis	NOUN
dpc-3520	92	7	of	of	ADP
dpc-3520	92	8	the	the	DET
dpc-3520	92	9	relation	relation	NOUN
dpc-3520	92	10	of	of	ADP
dpc-3520	92	11	il-38	il-38	NOUN
dpc-3520	92	12	serum	serum	NOUN
dpc-3520	92	13	levels	level	NOUN
dpc-3520	92	14	to	to	ADP
dpc-3520	92	15	other	other	ADJ
dpc-3520	92	16	patients	patient	NOUN
dpc-3520	92	17	characteristics	characteristic	NOUN
dpc-3520	92	18	showed	show	VERB
dpc-3520	92	19	no	no	DET
dpc-3520	92	20	significant	significant	ADJ
dpc-3520	92	21	correlation	correlation	NOUN
dpc-3520	92	22	with	with	ADP
dpc-3520	92	23	disease	disease	NOUN
dpc-3520	92	24	onset	onset	VERB
dpc-3520	92	25	,	,	PUNCT
dpc-3520	92	26	disease	disease	NOUN
dpc-3520	92	27	duration	duration	NOUN
dpc-3520	92	28	.	.	PUNCT
dpc-3520	93	1	and	and	CCONJ
dpc-3520	93	2	the	the	DET
dpc-3520	93	3	comparison	comparison	NOUN
dpc-3520	93	4	of	of	ADP
dpc-3520	93	5	il-38	il-38	NOUN
dpc-3520	93	6	serum	serum	NOUN
dpc-3520	93	7	levels	level	NOUN
dpc-3520	93	8	in	in	ADP
dpc-3520	93	9	patients	patient	NOUN
dpc-3520	93	10	with	with	ADP
dpc-3520	93	11	positive	positive	ADJ
dpc-3520	93	12	family	family	NOUN
dpc-3520	93	13	history	history	NOUN
dpc-3520	93	14	of	of	ADP
dpc-3520	93	15	vitiligo	vitiligo	NOUN
dpc-3520	93	16	and	and	CCONJ
dpc-3520	93	17	patients	patient	NOUN
dpc-3520	93	18	with	with	ADP
dpc-3520	93	19	negative	negative	ADJ
dpc-3520	93	20	family	family	NOUN
dpc-3520	93	21	history	history	NOUN
dpc-3520	93	22	showed	show	VERB
dpc-3520	93	23	no	no	DET
dpc-3520	93	24	significant	significant	ADJ
dpc-3520	93	25	differences	difference	NOUN
dpc-3520	93	26	.	.	PUNCT
dpc-3520	94	1	we	we	PRON
dpc-3520	94	2	did	do	AUX
dpc-3520	94	3	not	not	PART
dpc-3520	94	4	find	find	VERB
dpc-3520	94	5	any	any	DET
dpc-3520	94	6	difference	difference	NOUN
dpc-3520	94	7	in	in	ADP
dpc-3520	94	8	il-38	il-38	NOUN
dpc-3520	94	9	level	level	NOUN
dpc-3520	94	10	in	in	ADP
dpc-3520	94	11	patients	patient	NOUN
dpc-3520	94	12	with	with	ADP
dpc-3520	94	13	generalized	generalized	ADJ
dpc-3520	94	14	bilateral	bilateral	ADJ
dpc-3520	94	15	symmetrical	symmetrical	ADJ
dpc-3520	94	16	vitiligo	vitiligo	NOUN
dpc-3520	94	17	(	(	PUNCT
dpc-3520	94	18	160.32±40.38	160.32±40.38	NUM
dpc-3520	94	19	pg	pg	PROPN
dpc-3520	94	20	/	/	SYM
dpc-3520	94	21	ml	ml	VERB
dpc-3520	94	22	)	)	PUNCT
dpc-3520	94	23	compared	compare	VERB
dpc-3520	94	24	to	to	ADP
dpc-3520	94	25	other	other	ADJ
dpc-3520	94	26	types	type	NOUN
dpc-3520	94	27	(	(	PUNCT
dpc-3520	94	28	142.23±4.13	142.23±4.13	NUM
dpc-3520	94	29	pg	pg	NOUN
dpc-3520	94	30	/	/	SYM
dpc-3520	94	31	ml	ml	PROPN
dpc-3520	94	32	,	,	PUNCT
dpc-3520	94	33	p	p	NOUN
dpc-3520	94	34	=	=	NOUN
dpc-3520	94	35	0.41	0.41	NUM
dpc-3520	94	36	)	)	PUNCT
dpc-3520	94	37	.	.	PUNCT
dpc-3520	95	1	stage	stage	NOUN
dpc-3520	95	2	of	of	ADP
dpc-3520	95	3	depigmentation	depigmentation	NOUN
dpc-3520	95	4	also	also	ADV
dpc-3520	95	5	showed	show	VERB
dpc-3520	95	6	no	no	DET
dpc-3520	95	7	significant	significant	ADJ
dpc-3520	95	8	effect	effect	NOUN
dpc-3520	95	9	on	on	ADP
dpc-3520	95	10	il-38	il-38	NOUN
dpc-3520	95	11	level	level	NOUN
dpc-3520	95	12	(	(	PUNCT
dpc-3520	95	13	p	p	NOUN
dpc-3520	95	14	=	=	NOUN
dpc-3520	95	15	0.85	0.85	NUM
dpc-3520	95	16	)	)	PUNCT
dpc-3520	95	17	.	.	PUNCT
dpc-3520	96	1	il-38	il-38	NOUN
dpc-3520	96	2	did	do	AUX
dpc-3520	96	3	not	not	PART
dpc-3520	96	4	differ	differ	VERB
dpc-3520	96	5	between	between	ADP
dpc-3520	96	6	patients	patient	NOUN
dpc-3520	96	7	with	with	ADP
dpc-3520	96	8	progressive	progressive	ADJ
dpc-3520	96	9	(	(	PUNCT
dpc-3520	96	10	148.83±21.50	148.83±21.50	NUM
dpc-3520	96	11	pg	pg	NOUN
dpc-3520	96	12	/	/	SYM
dpc-3520	96	13	ml	ml	VERB
dpc-3520	96	14	)	)	PUNCT
dpc-3520	96	15	,	,	PUNCT
dpc-3520	96	16	stable	stable	ADJ
dpc-3520	96	17	(	(	PUNCT
dpc-3520	96	18	160.90±44.79	160.90±44.79	NUM
dpc-3520	96	19	pg/	pg/	NOUN
dpc-3520	96	20	ml	ml	VERB
dpc-3520	96	21	)	)	PUNCT
dpc-3520	96	22	or	or	CCONJ
dpc-3520	96	23	regressive	regressive	ADJ
dpc-3520	96	24	(	(	PUNCT
dpc-3520	96	25	169.54±47.75	169.54±47.75	NUM
dpc-3520	96	26	pg	pg	PROPN
dpc-3520	96	27	/	/	SYM
dpc-3520	96	28	ml	ml	NOUN
dpc-3520	96	29	)	)	PUNCT
dpc-3520	96	30	disease	disease	NOUN
dpc-3520	96	31	,	,	PUNCT
dpc-3520	96	32	p	p	NOUN
dpc-3520	96	33	=	=	NOUN
dpc-3520	96	34	0.23	0.23	NUM
dpc-3520	96	35	)	)	PUNCT
dpc-3520	96	36	.	.	PUNCT
dpc-3520	97	1	vida	vida	PROPN
dpc-3520	97	2	score	score	PROPN
dpc-3520	97	3	had	have	VERB
dpc-3520	97	4	no	no	DET
dpc-3520	97	5	effects	effect	NOUN
dpc-3520	97	6	on	on	ADP
dpc-3520	97	7	the	the	DET
dpc-3520	97	8	level	level	NOUN
dpc-3520	97	9	of	of	ADP
dpc-3520	97	10	cytokine	cytokine	NOUN
dpc-3520	97	11	.	.	PUNCT
dpc-3520	98	1	however	however	ADV
dpc-3520	98	2	,	,	PUNCT
dpc-3520	98	3	evaluation	evaluation	NOUN
dpc-3520	98	4	of	of	ADP
dpc-3520	98	5	the	the	DET
dpc-3520	98	6	relationship	relationship	NOUN
dpc-3520	98	7	between	between	ADP
dpc-3520	98	8	skin	skin	NOUN
dpc-3520	98	9	type	type	NOUN
dpc-3520	98	10	and	and	CCONJ
dpc-3520	98	11	il-38	il-38	NOUN
dpc-3520	98	12	serum	serum	NOUN
dpc-3520	98	13	levels	level	NOUN
dpc-3520	98	14	,	,	PUNCT
dpc-3520	98	15	showed	show	VERB
dpc-3520	98	16	significant	significant	ADJ
dpc-3520	98	17	differences	difference	NOUN
dpc-3520	98	18	in	in	ADP
dpc-3520	98	19	both	both	CCONJ
dpc-3520	98	20	male	male	ADJ
dpc-3520	98	21	and	and	CCONJ
dpc-3520	98	22	female	female	ADJ
dpc-3520	98	23	patients	patient	NOUN
dpc-3520	98	24	.	.	PUNCT
dpc-3520	99	1	as	as	SCONJ
dpc-3520	99	2	,	,	PUNCT
dpc-3520	99	3	comparison	comparison	NOUN
dpc-3520	99	4	of	of	ADP
dpc-3520	99	5	il-38	il-38	NOUN
dpc-3520	99	6	serum	serum	NOUN
dpc-3520	99	7	levels	level	NOUN
dpc-3520	99	8	between	between	ADP
dpc-3520	99	9	two	two	NUM
dpc-3520	99	10	skin	skin	NOUN
dpc-3520	99	11	type	type	NOUN
dpc-3520	99	12	groups	group	NOUN
dpc-3520	99	13	of	of	ADP
dpc-3520	99	14	male	male	ADJ
dpc-3520	99	15	patients	patient	NOUN
dpc-3520	99	16	,	,	PUNCT
dpc-3520	99	17	ie	ie	X
dpc-3520	99	18	type	type	NOUN
dpc-3520	99	19	iii	iii	PROPN
dpc-3520	99	20	(	(	PUNCT
dpc-3520	99	21	24	24	NUM
dpc-3520	99	22	patients	patient	NOUN
dpc-3520	99	23	)	)	PUNCT
dpc-3520	99	24	and	and	CCONJ
dpc-3520	99	25	type	type	NOUN
dpc-3520	99	26	iv	iv	NUM
dpc-3520	99	27	(	(	PUNCT
dpc-3520	99	28	2	2	NUM
dpc-3520	99	29	patients	patient	NOUN
dpc-3520	99	30	)	)	PUNCT
dpc-3520	99	31	resulted	result	VERB
dpc-3520	99	32	in	in	ADP
dpc-3520	99	33	the	the	DET
dpc-3520	99	34	evidence	evidence	NOUN
dpc-3520	99	35	of	of	ADP
dpc-3520	99	36	a	a	DET
dpc-3520	99	37	difference	difference	NOUN
dpc-3520	99	38	between	between	ADP
dpc-3520	99	39	these	these	DET
dpc-3520	99	40	two	two	NUM
dpc-3520	99	41	groups	group	NOUN
dpc-3520	99	42	(	(	PUNCT
dpc-3520	99	43	p	p	X
dpc-3520	99	44	=	=	NOUN
dpc-3520	99	45	0.045	0.045	NUM
dpc-3520	99	46	)	)	PUNCT
dpc-3520	99	47	(	(	PUNCT
dpc-3520	99	48	figure	figure	NOUN
dpc-3520	99	49	3	3	NUM
dpc-3520	99	50	)	)	PUNCT
dpc-3520	99	51	.	.	PUNCT
dpc-3520	100	1	the	the	DET
dpc-3520	100	2	level	level	NOUN
dpc-3520	100	3	of	of	ADP
dpc-3520	100	4	this	this	DET
dpc-3520	100	5	cytokine	cytokine	NOUN
dpc-3520	100	6	was	be	AUX
dpc-3520	100	7	lower	low	ADJ
dpc-3520	100	8	in	in	ADP
dpc-3520	100	9	male	male	ADJ
dpc-3520	100	10	patients	patient	NOUN
dpc-3520	100	11	with	with	ADP
dpc-3520	100	12	type	type	NOUN
dpc-3520	100	13	iii	iii	X
dpc-3520	100	14	(	(	PUNCT
dpc-3520	100	15	149.4±21.7	149.4±21.7	NOUN
dpc-3520	100	16	pg	pg	PROPN
dpc-3520	100	17	/	/	SYM
dpc-3520	100	18	ml	ml	NOUN
dpc-3520	100	19	)	)	PUNCT
dpc-3520	100	20	than	than	ADP
dpc-3520	100	21	those	those	PRON
dpc-3520	100	22	with	with	ADP
dpc-3520	100	23	type	type	NOUN
dpc-3520	100	24	iv	iv	ADP
dpc-3520	100	25	(	(	PUNCT
dpc-3520	100	26	190.2±5.45	190.2±5.45	NUM
dpc-3520	100	27	pg	pg	PROPN
dpc-3520	100	28	/	/	SYM
dpc-3520	100	29	ml	ml	VERB
dpc-3520	100	30	)	)	PUNCT
dpc-3520	100	31	.	.	PUNCT
dpc-3520	101	1	we	we	PRON
dpc-3520	101	2	compared	compare	VERB
dpc-3520	101	3	the	the	DET
dpc-3520	101	4	il-38	il-38	NOUN
dpc-3520	101	5	serum	serum	NOUN
dpc-3520	101	6	levels	level	NOUN
dpc-3520	101	7	4	4	NUM
dpc-3520	101	8	original	original	ADJ
dpc-3520	101	9	article	article	NOUN
dpc-3520	101	10	|	|	ADV
dpc-3520	101	11	dermatol	dermatol	ADJ
dpc-3520	101	12	pract	pract	NOUN
dpc-3520	101	13	concept	concept	NOUN
dpc-3520	101	14	.	.	PUNCT
dpc-3520	102	1	2024;14(1):e2024027	2024;14(1):e2024027	NUM
dpc-3520	102	2	pg	pg	NOUN
dpc-3520	102	3	/	/	SYM
dpc-3520	102	4	ml	ml	VERB
dpc-3520	102	5	)	)	PUNCT
dpc-3520	102	6	,	,	PUNCT
dpc-3520	102	7	phototherapy	phototherapy	NOUN
dpc-3520	102	8	along	along	ADP
dpc-3520	102	9	with	with	ADP
dpc-3520	102	10	topical	topical	ADJ
dpc-3520	102	11	steroids	steroid	NOUN
dpc-3520	102	12	(	(	PUNCT
dpc-3520	102	13	162.9±46.1	162.9±46.1	ADJ
dpc-3520	102	14	pg	pg	NOUN
dpc-3520	102	15	/	/	SYM
dpc-3520	102	16	ml	ml	NOUN
dpc-3520	102	17	)	)	PUNCT
dpc-3520	102	18	,	,	PUNCT
dpc-3520	102	19	and	and	CCONJ
dpc-3520	102	20	only	only	ADV
dpc-3520	102	21	topical	topical	ADJ
dpc-3520	102	22	steroids	steroid	NOUN
dpc-3520	102	23	(	(	PUNCT
dpc-3520	102	24	149.7±20.9	149.7±20.9	PROPN
dpc-3520	102	25	pg	pg	NOUN
dpc-3520	102	26	/	/	SYM
dpc-3520	102	27	ml	ml	VERB
dpc-3520	102	28	)	)	PUNCT
dpc-3520	102	29	.	.	PUNCT
dpc-3520	103	1	conclusions	conclusion	NOUN
dpc-3520	103	2	interleukin	interleukin	NOUN
dpc-3520	103	3	(	(	PUNCT
dpc-3520	103	4	il)-38	il)-38	PROPN
dpc-3520	103	5	,	,	PUNCT
dpc-3520	103	6	the	the	DET
dpc-3520	103	7	tenth	tenth	ADJ
dpc-3520	103	8	member	member	NOUN
dpc-3520	103	9	of	of	ADP
dpc-3520	103	10	il-1	il-1	ADJ
dpc-3520	103	11	cytokine	cytokine	NOUN
dpc-3520	103	12	family	family	NOUN
dpc-3520	103	13	,	,	PUNCT
dpc-3520	103	14	was	be	AUX
dpc-3520	103	15	discovered	discover	VERB
dpc-3520	103	16	in	in	ADP
dpc-3520	103	17	2001	2001	NUM
dpc-3520	103	18	[	[	X
dpc-3520	103	19	12	12	NUM
dpc-3520	103	20	]	]	PUNCT
dpc-3520	103	21	.	.	PUNCT
dpc-3520	104	1	because	because	SCONJ
dpc-3520	104	2	of	of	ADP
dpc-3520	104	3	its	its	PRON
dpc-3520	104	4	sequential	sequential	ADJ
dpc-3520	104	5	homology	homology	NOUN
dpc-3520	104	6	with	with	ADP
dpc-3520	104	7	il-1ra	il-1ra	NOUN
dpc-3520	104	8	and	and	CCONJ
dpc-3520	104	9	il-36ra	il-36ra	PROPN
dpc-3520	104	10	,	,	PUNCT
dpc-3520	104	11	il-38	il-38	NOUN
dpc-3520	104	12	has	have	AUX
dpc-3520	104	13	been	be	AUX
dpc-3520	104	14	supposed	suppose	VERB
dpc-3520	104	15	to	to	PART
dpc-3520	104	16	exert	exert	VERB
dpc-3520	104	17	anti	anti	ADJ
dpc-3520	104	18	-	-	ADJ
dpc-3520	104	19	inflammatory	inflammatory	ADJ
dpc-3520	104	20	properties	property	NOUN
dpc-3520	104	21	[	[	X
dpc-3520	104	22	14	14	NUM
dpc-3520	104	23	]	]	PUNCT
dpc-3520	104	24	.	.	PUNCT
dpc-3520	105	1	various	various	ADJ
dpc-3520	105	2	studies	study	NOUN
dpc-3520	105	3	have	have	AUX
dpc-3520	105	4	focused	focus	VERB
dpc-3520	105	5	on	on	ADP
dpc-3520	105	6	the	the	DET
dpc-3520	105	7	investigation	investigation	NOUN
dpc-3520	105	8	of	of	ADP
dpc-3520	105	9	il-38	il-38	NOUN
dpc-3520	105	10	exact	exact	ADJ
dpc-3520	105	11	role	role	NOUN
dpc-3520	105	12	in	in	ADP
dpc-3520	105	13	different	different	ADJ
dpc-3520	105	14	disorders	disorder	NOUN
dpc-3520	105	15	particularly	particularly	ADV
dpc-3520	105	16	autoimmune	autoimmune	ADJ
dpc-3520	105	17	diseases	disease	NOUN
dpc-3520	105	18	.	.	PUNCT
dpc-3520	106	1	gou	gou	PROPN
dpc-3520	106	2	et	et	PROPN
dpc-3520	106	3	al	al	PROPN
dpc-3520	106	4	have	have	AUX
dpc-3520	106	5	shown	show	VERB
dpc-3520	106	6	that	that	SCONJ
dpc-3520	106	7	il-38	il-38	NOUN
dpc-3520	106	8	-	-	PUNCT
dpc-3520	106	9	related	relate	VERB
dpc-3520	106	10	polymorphisms	polymorphism	NOUN
dpc-3520	106	11	among	among	ADP
dpc-3520	106	12	female	female	ADJ
dpc-3520	106	13	skin	skin	NOUN
dpc-3520	106	14	type	type	NOUN
dpc-3520	106	15	groups	group	NOUN
dpc-3520	106	16	.	.	PUNCT
dpc-3520	107	1	we	we	PRON
dpc-3520	107	2	could	could	AUX
dpc-3520	107	3	find	find	VERB
dpc-3520	107	4	a	a	DET
dpc-3520	107	5	il-38	il-38	NOUN
dpc-3520	107	6	serum	serum	NOUN
dpc-3520	107	7	level	level	NOUN
dpc-3520	107	8	difference	difference	NOUN
dpc-3520	107	9	between	between	ADP
dpc-3520	107	10	two	two	NUM
dpc-3520	107	11	groups	group	NOUN
dpc-3520	107	12	of	of	ADP
dpc-3520	107	13	female	female	ADJ
dpc-3520	107	14	patients	patient	NOUN
dpc-3520	107	15	,	,	PUNCT
dpc-3520	107	16	those	those	DET
dpc-3520	107	17	36	36	NUM
dpc-3520	107	18	patients	patient	NOUN
dpc-3520	107	19	with	with	ADP
dpc-3520	107	20	skin	skin	NOUN
dpc-3520	107	21	type	type	NOUN
dpc-3520	107	22	iii	iii	X
dpc-3520	107	23	(	(	PUNCT
dpc-3520	107	24	168.29±49.43	168.29±49.43	NUM
dpc-3520	107	25	pg	pg	NOUN
dpc-3520	107	26	/	/	SYM
dpc-3520	107	27	ml	ml	NOUN
dpc-3520	107	28	)	)	PUNCT
dpc-3520	107	29	and	and	CCONJ
dpc-3520	107	30	5	5	NUM
dpc-3520	107	31	patients	patient	NOUN
dpc-3520	107	32	with	with	ADP
dpc-3520	107	33	type	type	NOUN
dpc-3520	107	34	iv	iv	NUM
dpc-3520	107	35	(	(	PUNCT
dpc-3520	107	36	135.97±9.68	135.97±9.68	NOUN
dpc-3520	107	37	pg	pg	NOUN
dpc-3520	107	38	/	/	SYM
dpc-3520	107	39	ml	ml	PROPN
dpc-3520	107	40	,	,	PUNCT
dpc-3520	107	41	p	p	NOUN
dpc-3520	107	42	=	=	NOUN
dpc-3520	107	43	0.018	0.018	NUM
dpc-3520	107	44	)	)	PUNCT
dpc-3520	107	45	(	(	PUNCT
dpc-3520	107	46	figure	figure	NOUN
dpc-3520	107	47	3	3	NUM
dpc-3520	107	48	)	)	PUNCT
dpc-3520	107	49	.	.	PUNCT
dpc-3520	108	1	regardless	regardless	ADV
dpc-3520	108	2	of	of	ADP
dpc-3520	108	3	the	the	DET
dpc-3520	108	4	differences	difference	NOUN
dpc-3520	108	5	in	in	ADP
dpc-3520	108	6	il-38	il-38	NOUN
dpc-3520	108	7	level	level	NOUN
dpc-3520	108	8	observed	observe	VERB
dpc-3520	108	9	between	between	ADP
dpc-3520	108	10	male	male	ADJ
dpc-3520	108	11	and	and	CCONJ
dpc-3520	108	12	female	female	ADJ
dpc-3520	108	13	patients	patient	NOUN
dpc-3520	108	14	with	with	ADP
dpc-3520	108	15	type	type	NOUN
dpc-3520	108	16	iv	iv	NUM
dpc-3520	108	17	and	and	CCONJ
dpc-3520	108	18	iii	iii	NUM
dpc-3520	108	19	due	due	ADP
dpc-3520	108	20	to	to	ADP
dpc-3520	108	21	quite	quite	ADV
dpc-3520	108	22	low	low	ADJ
dpc-3520	108	23	number	number	NOUN
dpc-3520	108	24	of	of	ADP
dpc-3520	108	25	type	type	NOUN
dpc-3520	108	26	iv	iv	NUM
dpc-3520	108	27	patients	patient	NOUN
dpc-3520	108	28	,	,	PUNCT
dpc-3520	108	29	statistically	statistically	ADV
dpc-3520	108	30	,	,	PUNCT
dpc-3520	108	31	no	no	DET
dpc-3520	108	32	correlation	correlation	NOUN
dpc-3520	108	33	has	have	AUX
dpc-3520	108	34	been	be	AUX
dpc-3520	108	35	detected	detect	VERB
dpc-3520	108	36	,	,	PUNCT
dpc-3520	108	37	in	in	ADP
dpc-3520	108	38	patients	patient	NOUN
dpc-3520	108	39	with	with	ADP
dpc-3520	108	40	skin	skin	NOUN
dpc-3520	108	41	type	type	NOUN
dpc-3520	108	42	iii	iii	PROPN
dpc-3520	108	43	,	,	PUNCT
dpc-3520	108	44	il-38	il-38	NOUN
dpc-3520	108	45	levels	level	NOUN
dpc-3520	108	46	in	in	ADP
dpc-3520	108	47	male	male	ADJ
dpc-3520	108	48	patients	patient	NOUN
dpc-3520	108	49	(	(	PUNCT
dpc-3520	108	50	149.4±21.73	149.4±21.73	NUM
dpc-3520	108	51	pg	pg	NOUN
dpc-3520	108	52	/	/	SYM
dpc-3520	108	53	ml	ml	VERB
dpc-3520	108	54	)	)	PUNCT
dpc-3520	108	55	were	be	AUX
dpc-3520	108	56	less	less	ADJ
dpc-3520	108	57	than	than	ADP
dpc-3520	108	58	in	in	ADP
dpc-3520	108	59	female	female	ADJ
dpc-3520	108	60	patients	patient	NOUN
dpc-3520	108	61	(	(	PUNCT
dpc-3520	108	62	168.29±49.43	168.29±49.43	NUM
dpc-3520	108	63	pg	pg	NOUN
dpc-3520	108	64	/	/	SYM
dpc-3520	108	65	ml	ml	NOUN
dpc-3520	108	66	)	)	PUNCT
dpc-3520	108	67	(	(	PUNCT
dpc-3520	108	68	p	p	X
dpc-3520	108	69	=	=	NOUN
dpc-3520	108	70	0.046	0.046	NUM
dpc-3520	108	71	)	)	PUNCT
dpc-3520	108	72	.	.	PUNCT
dpc-3520	109	1	the	the	DET
dpc-3520	109	2	il-38	il-38	NOUN
dpc-3520	109	3	serum	serum	NOUN
dpc-3520	109	4	level	level	NOUN
dpc-3520	109	5	did	do	AUX
dpc-3520	109	6	not	not	PART
dpc-3520	109	7	differ	differ	VERB
dpc-3520	109	8	among	among	ADP
dpc-3520	109	9	patients	patient	NOUN
dpc-3520	109	10	with	with	ADP
dpc-3520	109	11	various	various	ADJ
dpc-3520	109	12	treatments	treatment	NOUN
dpc-3520	109	13	.	.	PUNCT
dpc-3520	110	1	patients	patient	NOUN
dpc-3520	110	2	under	under	ADP
dpc-3520	110	3	phototherapy	phototherapy	NOUN
dpc-3520	110	4	(	(	PUNCT
dpc-3520	110	5	154±26.2	154±26.2	NUM
dpc-3520	110	6	table	table	NOUN
dpc-3520	110	7	1	1	NUM
dpc-3520	110	8	.	.	PUNCT
dpc-3520	110	9	demographic	demographic	ADJ
dpc-3520	110	10	and	and	CCONJ
dpc-3520	110	11	clinical	clinical	ADJ
dpc-3520	110	12	data	datum	NOUN
dpc-3520	110	13	of	of	ADP
dpc-3520	110	14	the	the	DET
dpc-3520	110	15	vitiligo	vitiligo	NOUN
dpc-3520	110	16	patients	patient	NOUN
dpc-3520	110	17	.	.	PUNCT
dpc-3520	111	1	characteristics	characteristic	NOUN
dpc-3520	111	2	patients	patient	NOUN
dpc-3520	111	3	with	with	ADP
dpc-3520	111	4	generalized	generalized	ADJ
dpc-3520	111	5	vitiligo	vitiligo	NOUN
dpc-3520	111	6	healthy	healthy	ADJ
dpc-3520	111	7	controls	control	NOUN
dpc-3520	111	8	number	number	NOUN
dpc-3520	111	9	of	of	ADP
dpc-3520	111	10	subjects	subject	NOUN
dpc-3520	111	11	69	69	NUM
dpc-3520	111	12	72	72	NUM
dpc-3520	111	13	age	age	NOUN
dpc-3520	111	14	(	(	PUNCT
dpc-3520	111	15	year	year	NOUN
dpc-3520	111	16	)	)	PUNCT
dpc-3520	111	17	,	,	PUNCT
dpc-3520	111	18	mean±sd	mean±sd	ADP
dpc-3520	111	19	36.00±14.88	36.00±14.88	NUM
dpc-3520	111	20	39.54±10.35	39.54±10.35	NUM
dpc-3520	111	21	gender	gender	NOUN
dpc-3520	111	22	(	(	PUNCT
dpc-3520	111	23	female	female	NOUN
dpc-3520	111	24	/	/	SYM
dpc-3520	111	25	male	male	NOUN
dpc-3520	111	26	)	)	PUNCT
dpc-3520	111	27	,	,	PUNCT
dpc-3520	111	28	n(%	n(%	PROPN
dpc-3520	111	29	)	)	PUNCT
dpc-3520	112	1	43/26	43/26	NUM
dpc-3520	112	2	(	(	PUNCT
dpc-3520	112	3	62.3/37.7	62.3/37.7	PROPN
dpc-3520	112	4	)	)	PUNCT
dpc-3520	112	5	42/30	42/30	NUM
dpc-3520	112	6	(	(	PUNCT
dpc-3520	112	7	58.3/41.7	58.3/41.7	NOUN
dpc-3520	112	8	)	)	PUNCT
dpc-3520	112	9	disease	disease	NOUN
dpc-3520	112	10	onset	onset	NOUN
dpc-3520	112	11	(	(	PUNCT
dpc-3520	112	12	year	year	NOUN
dpc-3520	112	13	)	)	PUNCT
dpc-3520	112	14	)	)	PUNCT
dpc-3520	112	15	,	,	PUNCT
dpc-3520	112	16	mean±sd	mean±sd	ADP
dpc-3520	112	17	27.01±15.76	27.01±15.76	NUM
dpc-3520	112	18	disease	disease	NOUN
dpc-3520	112	19	duration	duration	NOUN
dpc-3520	112	20	(	(	PUNCT
dpc-3520	112	21	year	year	NOUN
dpc-3520	112	22	)	)	PUNCT
dpc-3520	112	23	)	)	PUNCT
dpc-3520	112	24	,	,	PUNCT
dpc-3520	112	25	mean±sd	mean±sd	PROPN
dpc-3520	112	26	8.98±7.93	8.98±7.93	PROPN
dpc-3520	112	27	family	family	NOUN
dpc-3520	112	28	history	history	NOUN
dpc-3520	112	29	of	of	ADP
dpc-3520	112	30	vitiligo	vitiligo	NOUN
dpc-3520	112	31	,	,	PUNCT
dpc-3520	112	32	n(%	n(%	PROPN
dpc-3520	112	33	)	)	PUNCT
dpc-3520	112	34	18	18	NUM
dpc-3520	112	35	(	(	PUNCT
dpc-3520	112	36	26.1	26.1	NUM
dpc-3520	112	37	)	)	PUNCT
dpc-3520	112	38	family	family	NOUN
dpc-3520	112	39	history	history	NOUN
dpc-3520	112	40	of	of	ADP
dpc-3520	112	41	other	other	ADJ
dpc-3520	112	42	autoimmune	autoimmune	ADJ
dpc-3520	112	43	disease	disease	NOUN
dpc-3520	112	44	,	,	PUNCT
dpc-3520	112	45	n(%	n(%	PROPN
dpc-3520	112	46	)	)	PUNCT
dpc-3520	112	47	5	5	NUM
dpc-3520	112	48	(	(	PUNCT
dpc-3520	112	49	7.2	7.2	NUM
dpc-3520	112	50	)	)	PUNCT
dpc-3520	112	51	smoking	smoking	NOUN
dpc-3520	112	52	,	,	PUNCT
dpc-3520	112	53	n(%	n(%	PROPN
dpc-3520	112	54	)	)	PUNCT
dpc-3520	112	55	17	17	NUM
dpc-3520	112	56	(	(	PUNCT
dpc-3520	112	57	24.6	24.6	NUM
dpc-3520	112	58	)	)	PUNCT
dpc-3520	112	59	generalized	generalized	ADJ
dpc-3520	112	60	type	type	NOUN
dpc-3520	112	61	,	,	PUNCT
dpc-3520	112	62	n(%	n(%	PROPN
dpc-3520	112	63	):	):	PUNCT
dpc-3520	112	64	acrofacial	acrofacial	ADJ
dpc-3520	112	65	vulgaris	vulgaris	NOUN
dpc-3520	112	66	mixed	mix	VERB
dpc-3520	112	67	2	2	NUM
dpc-3520	112	68	(	(	PUNCT
dpc-3520	112	69	2.9	2.9	NUM
dpc-3520	112	70	)	)	PUNCT
dpc-3520	112	71	66	66	NUM
dpc-3520	112	72	(	(	PUNCT
dpc-3520	112	73	95.7	95.7	NUM
dpc-3520	112	74	)	)	SYM
dpc-3520	112	75	1	1	NUM
dpc-3520	112	76	(	(	PUNCT
dpc-3520	112	77	1.4	1.4	NUM
dpc-3520	112	78	)	)	PUNCT
dpc-3520	112	79	stage	stage	NOUN
dpc-3520	112	80	of	of	ADP
dpc-3520	112	81	depigmentation	depigmentation	NOUN
dpc-3520	112	82	,	,	PUNCT
dpc-3520	112	83	n(%	n(%	PROPN
dpc-3520	112	84	)	)	PUNCT
dpc-3520	112	85	-0	-0	PUNCT
dpc-3520	112	86	(	(	PUNCT
dpc-3520	112	87	n1	n1	ADJ
dpc-3520	112	88	)	)	PUNCT
dpc-3520	112	89	-incomplete	-incomplete	NOUN
dpc-3520	112	90	-complete	-complete	NOUN
dpc-3520	112	91	with	with	ADP
dpc-3520	112	92	<	<	X
dpc-3520	112	93	30%hair	30%hair	NUM
dpc-3520	112	94	whitening	whiten	VERB
dpc-3520	112	95	-complete	-complete	NOUN
dpc-3520	112	96	with	with	ADP
dpc-3520	112	97	>	>	X
dpc-3520	112	98	30%hair	30%hair	PROPN
dpc-3520	112	99	whitening	whiten	VERB
dpc-3520	112	100	2	2	NUM
dpc-3520	112	101	(	(	PUNCT
dpc-3520	112	102	2.9	2.9	NUM
dpc-3520	112	103	%	%	NOUN
dpc-3520	112	104	)	)	PUNCT
dpc-3520	112	105	6	6	NUM
dpc-3520	112	106	(	(	PUNCT
dpc-3520	112	107	8.7	8.7	NUM
dpc-3520	112	108	%	%	NOUN
dpc-3520	112	109	)	)	PUNCT
dpc-3520	112	110	59	59	NUM
dpc-3520	112	111	(	(	PUNCT
dpc-3520	112	112	85.5	85.5	NUM
dpc-3520	112	113	%	%	NOUN
dpc-3520	112	114	)	)	PUNCT
dpc-3520	112	115	2	2	NUM
dpc-3520	112	116	(	(	PUNCT
dpc-3520	112	117	2.9	2.9	NUM
dpc-3520	112	118	%	%	NOUN
dpc-3520	112	119	)	)	PUNCT
dpc-3520	112	120	skin	skin	NOUN
dpc-3520	112	121	type	type	NOUN
dpc-3520	112	122	,	,	PUNCT
dpc-3520	112	123	n(%	n(%	PROPN
dpc-3520	112	124	)	)	PUNCT
dpc-3520	112	125	-i	-i	NUM
dpc-3520	113	1	-ii	-ii	NOUN
dpc-3520	113	2	-iii	-iii	ADP
dpc-3520	113	3	-iv	-iv	PUNCT
dpc-3520	113	4	-v	-v	X
dpc-3520	113	5	-vi	-vi	NOUN
dpc-3520	113	6	2	2	NUM
dpc-3520	113	7	(	(	PUNCT
dpc-3520	113	8	2.9	2.9	NUM
dpc-3520	113	9	%	%	NOUN
dpc-3520	113	10	)	)	PUNCT
dpc-3520	113	11	60	60	NUM
dpc-3520	113	12	(	(	PUNCT
dpc-3520	113	13	87.0	87.0	NUM
dpc-3520	113	14	%	%	NOUN
dpc-3520	113	15	)	)	PUNCT
dpc-3520	113	16	7	7	NUM
dpc-3520	113	17	(	(	PUNCT
dpc-3520	113	18	10.1	10.1	NUM
dpc-3520	113	19	%	%	NOUN
dpc-3520	113	20	)	)	PUNCT
dpc-3520	113	21	spreading	spread	VERB
dpc-3520	113	22	,	,	PUNCT
dpc-3520	113	23	n(%	n(%	ADJ
dpc-3520	113	24	)	)	PUNCT
dpc-3520	113	25	-progressive	-progressive	ADJ
dpc-3520	113	26	-stable	-stable	ADJ
dpc-3520	113	27	-regressive	-regressive	ADJ
dpc-3520	113	28	25	25	NUM
dpc-3520	113	29	(	(	PUNCT
dpc-3520	113	30	36.2	36.2	NUM
dpc-3520	113	31	%	%	NOUN
dpc-3520	113	32	)	)	PUNCT
dpc-3520	113	33	20	20	NUM
dpc-3520	113	34	(	(	PUNCT
dpc-3520	113	35	29.0	29.0	NUM
dpc-3520	113	36	%	%	NOUN
dpc-3520	113	37	)	)	PUNCT
dpc-3520	113	38	24	24	NUM
dpc-3520	113	39	(	(	PUNCT
dpc-3520	113	40	34.8	34.8	NUM
dpc-3520	113	41	%	%	NOUN
dpc-3520	113	42	)	)	PUNCT
dpc-3520	113	43	vitiligo	vitiligo	NOUN
dpc-3520	113	44	disease	disease	NOUN
dpc-3520	113	45	activity	activity	NOUN
dpc-3520	113	46	score	score	NOUN
dpc-3520	113	47	(	(	PUNCT
dpc-3520	113	48	vida	vida	NOUN
dpc-3520	113	49	)	)	PUNCT
dpc-3520	113	50	,	,	PUNCT
dpc-3520	113	51	n(%	n(%	PROPN
dpc-3520	113	52	)	)	PUNCT
dpc-3520	114	1	+4	+4	NUM
dpc-3520	114	2	activity	activity	NOUN
dpc-3520	114	3	of	of	ADP
dpc-3520	114	4	6	6	NUM
dpc-3520	114	5	weeks	week	NOUN
dpc-3520	114	6	or	or	CCONJ
dpc-3520	114	7	less	less	ADJ
dpc-3520	114	8	+3	+3	ADJ
dpc-3520	114	9	activity	activity	NOUN
dpc-3520	114	10	of	of	ADP
dpc-3520	114	11	6	6	NUM
dpc-3520	114	12	weeks	week	NOUN
dpc-3520	114	13	to	to	ADP
dpc-3520	114	14	3	3	NUM
dpc-3520	114	15	months	month	NOUN
dpc-3520	114	16	+2	+2	PROPN
dpc-3520	114	17	activity	activity	NOUN
dpc-3520	114	18	of	of	ADP
dpc-3520	114	19	3	3	NUM
dpc-3520	114	20	-	-	SYM
dpc-3520	114	21	6	6	NUM
dpc-3520	114	22	months	month	NOUN
dpc-3520	114	23	+1	+1	ADJ
dpc-3520	114	24	activity	activity	NOUN
dpc-3520	114	25	of	of	ADP
dpc-3520	114	26	6	6	NUM
dpc-3520	114	27	-	-	SYM
dpc-3520	114	28	12	12	NUM
dpc-3520	114	29	months	month	NOUN
dpc-3520	114	30	0	0	NUM
dpc-3520	114	31	:	:	PUNCT
dpc-3520	114	32	stable	stable	ADJ
dpc-3520	114	33	for	for	ADP
dpc-3520	114	34	1	1	NUM
dpc-3520	114	35	year	year	NOUN
dpc-3520	114	36	-1	-1	NOUN
dpc-3520	114	37	:	:	PUNCT
dpc-3520	114	38	stable	stable	ADJ
dpc-3520	114	39	at	at	ADV
dpc-3520	114	40	least	least	ADV
dpc-3520	114	41	1	1	NUM
dpc-3520	114	42	year	year	NOUN
dpc-3520	114	43	with	with	ADP
dpc-3520	114	44	spontaneous	spontaneous	ADJ
dpc-3520	114	45	repigmentation	repigmentation	NOUN
dpc-3520	114	46	13	13	NUM
dpc-3520	114	47	(	(	PUNCT
dpc-3520	114	48	19.1	19.1	NUM
dpc-3520	114	49	%	%	NOUN
dpc-3520	114	50	)	)	PUNCT
dpc-3520	114	51	14	14	NUM
dpc-3520	114	52	(	(	PUNCT
dpc-3520	114	53	20.6	20.6	NUM
dpc-3520	114	54	%	%	NOUN
dpc-3520	114	55	)	)	PUNCT
dpc-3520	114	56	12	12	NUM
dpc-3520	114	57	(	(	PUNCT
dpc-3520	114	58	17.6	17.6	NUM
dpc-3520	114	59	%	%	NOUN
dpc-3520	114	60	)	)	PUNCT
dpc-3520	114	61	14	14	NUM
dpc-3520	114	62	(	(	PUNCT
dpc-3520	114	63	20.6	20.6	NUM
dpc-3520	114	64	%	%	NOUN
dpc-3520	114	65	)	)	PUNCT
dpc-3520	114	66	15	15	NUM
dpc-3520	114	67	(	(	PUNCT
dpc-3520	114	68	22.1	22.1	NUM
dpc-3520	114	69	%	%	NOUN
dpc-3520	114	70	)	)	PUNCT
dpc-3520	114	71	sd	sd	NOUN
dpc-3520	114	72	=	=	SYM
dpc-3520	114	73	standard	standard	ADJ
dpc-3520	114	74	deviation	deviation	NOUN
dpc-3520	114	75	.	.	PUNCT
dpc-3520	115	1	original	original	ADJ
dpc-3520	115	2	article	article	NOUN
dpc-3520	115	3	|	|	ADV
dpc-3520	115	4	dermatol	dermatol	ADJ
dpc-3520	115	5	pract	pract	NOUN
dpc-3520	115	6	concept	concept	NOUN
dpc-3520	115	7	.	.	PUNCT
dpc-3520	116	1	2024;14(1):e2024027	2024;14(1):e2024027	NUM
dpc-3520	116	2	5	5	NUM
dpc-3520	116	3	are	be	AUX
dpc-3520	116	4	associated	associate	VERB
dpc-3520	116	5	with	with	ADP
dpc-3520	116	6	the	the	DET
dpc-3520	116	7	increased	increase	VERB
dpc-3520	116	8	risk	risk	NOUN
dpc-3520	116	9	of	of	ADP
dpc-3520	116	10	ankylosing	ankylose	VERB
dpc-3520	116	11	spondylitis	spondylitis	NOUN
dpc-3520	116	12	[	[	X
dpc-3520	116	13	17	17	NUM
dpc-3520	116	14	]	]	PUNCT
dpc-3520	116	15	.	.	PUNCT
dpc-3520	117	1	moreover	moreover	ADV
dpc-3520	117	2	,	,	PUNCT
dpc-3520	117	3	an	an	DET
dpc-3520	117	4	association	association	NOUN
dpc-3520	117	5	of	of	ADP
dpc-3520	117	6	il-38	il-38	NOUN
dpc-3520	117	7	rs7570267	rs7570267	NOUN
dpc-3520	117	8	and	and	CCONJ
dpc-3520	117	9	rs3811058	rs3811058	ADJ
dpc-3520	117	10	single	single	ADJ
dpc-3520	117	11	nucleotide	nucleotide	ADJ
dpc-3520	117	12	polymorphism	polymorphism	NOUN
dpc-3520	117	13	with	with	ADP
dpc-3520	117	14	ra	ra	PROPN
dpc-3520	117	15	susceptibility	susceptibility	NOUN
dpc-3520	117	16	has	have	AUX
dpc-3520	117	17	been	be	AUX
dpc-3520	117	18	shown	show	VERB
dpc-3520	117	19	[	[	PUNCT
dpc-3520	117	20	18	18	NUM
dpc-3520	117	21	]	]	PUNCT
dpc-3520	117	22	.	.	PUNCT
dpc-3520	118	1	in	in	ADP
dpc-3520	118	2	another	another	DET
dpc-3520	118	3	study	study	NOUN
dpc-3520	118	4	on	on	ADP
dpc-3520	118	5	ra	ra	PROPN
dpc-3520	118	6	patients	patient	NOUN
dpc-3520	118	7	,	,	PUNCT
dpc-3520	118	8	elevated	elevated	ADJ
dpc-3520	118	9	levels	level	NOUN
dpc-3520	118	10	of	of	ADP
dpc-3520	118	11	il-38	il-38	NOUN
dpc-3520	118	12	was	be	AUX
dpc-3520	118	13	reported	report	VERB
dpc-3520	118	14	in	in	ADP
dpc-3520	118	15	plasma	plasma	NOUN
dpc-3520	118	16	of	of	ADP
dpc-3520	118	17	patients	patient	NOUN
dpc-3520	118	18	compared	compare	VERB
dpc-3520	118	19	to	to	ADP
dpc-3520	118	20	healthy	healthy	ADJ
dpc-3520	118	21	controls	control	NOUN
dpc-3520	118	22	[	[	X
dpc-3520	118	23	28	28	NUM
dpc-3520	118	24	]	]	PUNCT
dpc-3520	118	25	.	.	PUNCT
dpc-3520	119	1	rudloff	rudloff	PROPN
dpc-3520	119	2	et	et	PROPN
dpc-3520	119	3	al	al	PROPN
dpc-3520	119	4	measured	measure	VERB
dpc-3520	119	5	the	the	DET
dpc-3520	119	6	il-38	il-38	NOUN
dpc-3520	119	7	serum	serum	NOUN
dpc-3520	119	8	level	level	NOUN
dpc-3520	119	9	in	in	ADP
dpc-3520	119	10	patients	patient	NOUN
dpc-3520	119	11	with	with	ADP
dpc-3520	119	12	sle	sle	PROPN
dpc-3520	119	13	.	.	PUNCT
dpc-3520	120	1	they	they	PRON
dpc-3520	120	2	found	find	VERB
dpc-3520	120	3	that	that	SCONJ
dpc-3520	120	4	il-38	il-38	NOUN
dpc-3520	120	5	may	may	AUX
dpc-3520	120	6	play	play	VERB
dpc-3520	120	7	a	a	DET
dpc-3520	120	8	protective	protective	ADJ
dpc-3520	120	9	role	role	NOUN
dpc-3520	120	10	in	in	ADP
dpc-3520	120	11	this	this	DET
dpc-3520	120	12	disorder	disorder	NOUN
dpc-3520	120	13	[	[	X
dpc-3520	120	14	21	21	NUM
dpc-3520	120	15	]	]	PUNCT
dpc-3520	120	16	.	.	PUNCT
dpc-3520	121	1	however	however	ADV
dpc-3520	121	2	,	,	PUNCT
dpc-3520	121	3	the	the	DET
dpc-3520	121	4	probable	probable	ADJ
dpc-3520	121	5	role	role	NOUN
dpc-3520	121	6	of	of	ADP
dpc-3520	121	7	this	this	DET
dpc-3520	121	8	newly	newly	ADV
dpc-3520	121	9	identified	identify	VERB
dpc-3520	121	10	cytokine	cytokine	NOUN
dpc-3520	121	11	in	in	ADP
dpc-3520	121	12	other	other	ADJ
dpc-3520	121	13	autoimmune	autoimmune	ADJ
dpc-3520	121	14	disorders	disorder	NOUN
dpc-3520	121	15	has	have	AUX
dpc-3520	121	16	not	not	PART
dpc-3520	121	17	been	be	AUX
dpc-3520	121	18	clarified	clarify	VERB
dpc-3520	121	19	yet	yet	ADV
dpc-3520	121	20	.	.	PUNCT
dpc-3520	122	1	accordingly	accordingly	ADV
dpc-3520	122	2	,	,	PUNCT
dpc-3520	122	3	we	we	PRON
dpc-3520	122	4	have	have	AUX
dpc-3520	122	5	focused	focus	VERB
dpc-3520	122	6	on	on	ADP
dpc-3520	122	7	vitiligo	vitiligo	NOUN
dpc-3520	122	8	,	,	PUNCT
dpc-3520	122	9	a	a	DET
dpc-3520	122	10	disease	disease	NOUN
dpc-3520	122	11	with	with	ADP
dpc-3520	122	12	an	an	DET
dpc-3520	122	13	auto	auto	NOUN
dpc-3520	122	14	-	-	PUNCT
dpc-3520	122	15	immune	immune	ADJ
dpc-3520	122	16	background	background	NOUN
dpc-3520	122	17	and	and	CCONJ
dpc-3520	122	18	no	no	DET
dpc-3520	122	19	published	publish	VERB
dpc-3520	122	20	report	report	NOUN
dpc-3520	122	21	on	on	ADP
dpc-3520	122	22	the	the	DET
dpc-3520	122	23	anti	anti	ADJ
dpc-3520	122	24	-	-	ADJ
dpc-3520	122	25	inflammatory	inflammatory	ADJ
dpc-3520	122	26	role	role	NOUN
dpc-3520	122	27	of	of	ADP
dpc-3520	122	28	il-38	il-38	NOUN
dpc-3520	122	29	in	in	ADP
dpc-3520	122	30	its	its	PRON
dpc-3520	122	31	pathogenesis	pathogenesis	NOUN
dpc-3520	122	32	.	.	PUNCT
dpc-3520	123	1	we	we	PRON
dpc-3520	123	2	measured	measure	VERB
dpc-3520	123	3	il-38	il-38	NOUN
dpc-3520	123	4	level	level	NOUN
dpc-3520	123	5	in	in	ADP
dpc-3520	123	6	a	a	DET
dpc-3520	123	7	group	group	NOUN
dpc-3520	123	8	of	of	ADP
dpc-3520	123	9	patients	patient	NOUN
dpc-3520	123	10	with	with	ADP
dpc-3520	123	11	vitiligo	vitiligo	ADJ
dpc-3520	123	12	and	and	CCONJ
dpc-3520	123	13	healthy	healthy	ADJ
dpc-3520	123	14	subjects	subject	NOUN
dpc-3520	123	15	to	to	PART
dpc-3520	123	16	evaluate	evaluate	VERB
dpc-3520	123	17	the	the	DET
dpc-3520	123	18	probable	probable	ADJ
dpc-3520	123	19	role	role	NOUN
dpc-3520	123	20	of	of	ADP
dpc-3520	123	21	il-38	il-38	NOUN
dpc-3520	123	22	in	in	ADP
dpc-3520	123	23	disease	disease	NOUN
dpc-3520	123	24	development	development	NOUN
dpc-3520	123	25	.	.	PUNCT
dpc-3520	124	1	the	the	DET
dpc-3520	124	2	results	result	NOUN
dpc-3520	124	3	showed	show	VERB
dpc-3520	124	4	that	that	SCONJ
dpc-3520	124	5	the	the	DET
dpc-3520	124	6	cytokine	cytokine	ADJ
dpc-3520	124	7	level	level	NOUN
dpc-3520	124	8	in	in	ADP
dpc-3520	124	9	patients	patient	NOUN
dpc-3520	124	10	was	be	AUX
dpc-3520	124	11	significantly	significantly	ADV
dpc-3520	124	12	lower	low	ADJ
dpc-3520	124	13	than	than	ADP
dpc-3520	124	14	the	the	DET
dpc-3520	124	15	healthy	healthy	ADJ
dpc-3520	124	16	individuals	individual	NOUN
dpc-3520	124	17	.	.	PUNCT
dpc-3520	125	1	it	it	PRON
dpc-3520	125	2	should	should	AUX
dpc-3520	125	3	be	be	AUX
dpc-3520	125	4	noted	note	VERB
dpc-3520	125	5	that	that	SCONJ
dpc-3520	125	6	.	.	PUNCT
dpc-3520	126	1	this	this	DET
dpc-3520	126	2	result	result	NOUN
dpc-3520	126	3	was	be	AUX
dpc-3520	126	4	in	in	ADP
dpc-3520	126	5	contrary	contrary	ADJ
dpc-3520	126	6	to	to	ADP
dpc-3520	126	7	the	the	DET
dpc-3520	126	8	result	result	NOUN
dpc-3520	126	9	from	from	ADP
dpc-3520	126	10	previous	previous	ADJ
dpc-3520	126	11	study	study	NOUN
dpc-3520	126	12	where	where	SCONJ
dpc-3520	126	13	radwa	radwa	VERB
dpc-3520	126	14	elsayed	elsaye	VERB
dpc-3520	126	15	et	et	NOUN
dpc-3520	126	16	al	al	PROPN
dpc-3520	126	17	measured	measure	VERB
dpc-3520	126	18	the	the	DET
dpc-3520	126	19	il-38	il-38	NOUN
dpc-3520	126	20	serum	serum	NOUN
dpc-3520	126	21	level	level	NOUN
dpc-3520	126	22	in	in	ADP
dpc-3520	126	23	21	21	NUM
dpc-3520	126	24	patients	patient	NOUN
dpc-3520	126	25	with	with	ADP
dpc-3520	126	26	vitiligo	vitiligo	NOUN
dpc-3520	126	27	and	and	CCONJ
dpc-3520	126	28	21	21	NUM
dpc-3520	126	29	 	 	SPACE
dpc-3520	126	30	healthy	healthy	ADJ
dpc-3520	126	31	controls	control	NOUN
dpc-3520	126	32	.	.	PUNCT
dpc-3520	127	1	they	they	PRON
dpc-3520	127	2	found	find	VERB
dpc-3520	127	3	that	that	SCONJ
dpc-3520	127	4	il-38	il-38	NOUN
dpc-3520	127	5	 	 	SPACE
dpc-3520	127	6	serum	serum	NOUN
dpc-3520	127	7	level	level	NOUN
dpc-3520	127	8	was	be	AUX
dpc-3520	127	9	higher	high	ADJ
dpc-3520	127	10	in	in	ADP
dpc-3520	127	11	patients	patient	NOUN
dpc-3520	127	12	with	with	ADP
dpc-3520	127	13	vitiligo	vitiligo	NOUN
dpc-3520	127	14	than	than	ADP
dpc-3520	127	15	in	in	ADP
dpc-3520	127	16	healthy	healthy	ADJ
dpc-3520	127	17	controls	control	NOUN
dpc-3520	127	18	and	and	CCONJ
dpc-3520	127	19	was	be	AUX
dpc-3520	127	20	related	relate	VERB
dpc-3520	127	21	to	to	PART
dpc-3520	127	22	vitiligo	vitiligo	VERB
dpc-3520	127	23	severity	severity	NOUN
dpc-3520	127	24	and	and	CCONJ
dpc-3520	127	25	signs	sign	NOUN
dpc-3520	127	26	of	of	ADP
dpc-3520	127	27	activity	activity	NOUN
dpc-3520	127	28	[	[	X
dpc-3520	127	29	29	29	NUM
dpc-3520	127	30	]	]	PUNCT
dpc-3520	127	31	.	.	PUNCT
dpc-3520	128	1	the	the	DET
dpc-3520	128	2	reasons	reason	NOUN
dpc-3520	128	3	for	for	ADP
dpc-3520	128	4	these	these	DET
dpc-3520	128	5	differences	difference	NOUN
dpc-3520	128	6	may	may	AUX
dpc-3520	128	7	be	be	AUX
dpc-3520	128	8	due	due	ADJ
dpc-3520	128	9	to	to	ADP
dpc-3520	128	10	sample	sample	NOUN
dpc-3520	128	11	size	size	NOUN
dpc-3520	128	12	and	and	CCONJ
dpc-3520	128	13	genetic	genetic	ADJ
dpc-3520	128	14	background	background	NOUN
dpc-3520	128	15	,	,	PUNCT
dpc-3520	128	16	and	and	CCONJ
dpc-3520	128	17	also	also	ADV
dpc-3520	128	18	our	our	PRON
dpc-3520	128	19	result	result	NOUN
dpc-3520	128	20	was	be	AUX
dpc-3520	128	21	different	different	ADJ
dpc-3520	128	22	with	with	ADP
dpc-3520	128	23	the	the	DET
dpc-3520	128	24	results	result	NOUN
dpc-3520	128	25	reported	report	VERB
dpc-3520	128	26	from	from	ADP
dpc-3520	128	27	some	some	DET
dpc-3520	128	28	other	other	ADJ
dpc-3520	128	29	studies	study	NOUN
dpc-3520	128	30	in	in	ADP
dpc-3520	128	31	ra	ra	PROPN
dpc-3520	129	1	[	[	X
dpc-3520	129	2	28	28	NUM
dpc-3520	129	3	]	]	PUNCT
dpc-3520	129	4	and	and	CCONJ
dpc-3520	129	5	sle	sle	PROPN
dpc-3520	130	1	[	[	X
dpc-3520	130	2	21	21	NUM
dpc-3520	130	3	]	]	PUNCT
dpc-3520	130	4	patients	patient	NOUN
dpc-3520	130	5	.	.	PUNCT
dpc-3520	131	1	the	the	DET
dpc-3520	131	2	reason	reason	NOUN
dpc-3520	131	3	for	for	ADP
dpc-3520	131	4	these	these	DET
dpc-3520	131	5	differences	difference	NOUN
dpc-3520	131	6	is	be	AUX
dpc-3520	131	7	not	not	PART
dpc-3520	131	8	exactly	exactly	ADV
dpc-3520	131	9	clear	clear	ADJ
dpc-3520	131	10	but	but	CCONJ
dpc-3520	131	11	may	may	AUX
dpc-3520	131	12	be	be	AUX
dpc-3520	131	13	due	due	ADJ
dpc-3520	131	14	to	to	ADP
dpc-3520	131	15	variation	variation	NOUN
dpc-3520	131	16	in	in	ADP
dpc-3520	131	17	the	the	DET
dpc-3520	131	18	biological	biological	ADJ
dpc-3520	131	19	nature	nature	NOUN
dpc-3520	131	20	of	of	ADP
dpc-3520	131	21	the	the	DET
dpc-3520	131	22	diseases	disease	NOUN
dpc-3520	131	23	as	as	ADP
dpc-3520	131	24	type	type	NOUN
dpc-3520	131	25	and	and	CCONJ
dpc-3520	131	26	the	the	DET
dpc-3520	131	27	extent	extent	NOUN
dpc-3520	131	28	of	of	ADP
dpc-3520	131	29	inflammation	inflammation	NOUN
dpc-3520	131	30	established	establish	VERB
dpc-3520	131	31	in	in	ADP
dpc-3520	131	32	various	various	ADJ
dpc-3520	131	33	disorders	disorder	NOUN
dpc-3520	131	34	may	may	AUX
dpc-3520	131	35	be	be	AUX
dpc-3520	131	36	different	different	ADJ
dpc-3520	131	37	.	.	PUNCT
dpc-3520	132	1	in	in	ADP
dpc-3520	132	2	this	this	DET
dpc-3520	132	3	regard	regard	NOUN
dpc-3520	132	4	,	,	PUNCT
dpc-3520	132	5	we	we	PRON
dpc-3520	132	6	could	could	AUX
dpc-3520	132	7	state	state	VERB
dpc-3520	132	8	the	the	DET
dpc-3520	132	9	increased	increase	VERB
dpc-3520	132	10	serum	serum	NOUN
dpc-3520	132	11	levels	level	NOUN
dpc-3520	132	12	of	of	ADP
dpc-3520	132	13	autoantibodies	autoantibody	NOUN
dpc-3520	132	14	such	such	ADJ
dpc-3520	132	15	as	as	ADP
dpc-3520	132	16	anti	anti	ADJ
dpc-3520	132	17	-	-	ADJ
dpc-3520	132	18	dsdna	dsdna	ADJ
dpc-3520	132	19	,	,	PUNCT
dpc-3520	132	20	anti	anti	ADJ
dpc-3520	132	21	-	-	ADJ
dpc-3520	132	22	ro	ro	ADJ
dpc-3520	132	23	,	,	PUNCT
dpc-3520	132	24	antinuclear	antinuclear	ADJ
dpc-3520	132	25	antibody	antibody	NOUN
dpc-3520	132	26	(	(	PUNCT
dpc-3520	132	27	ana	ana	PROPN
dpc-3520	132	28	)	)	PUNCT
dpc-3520	132	29	and	and	CCONJ
dpc-3520	132	30	low	low	ADJ
dpc-3520	132	31	serum	serum	NOUN
dpc-3520	132	32	levels	level	NOUN
dpc-3520	132	33	of	of	ADP
dpc-3520	132	34	complement	complement	NOUN
dpc-3520	132	35	components	component	NOUN
dpc-3520	132	36	,	,	PUNCT
dpc-3520	132	37	ie	ie	X
dpc-3520	132	38	c3	c3	PROPN
dpc-3520	132	39	and	and	CCONJ
dpc-3520	132	40	c4	c4	NOUN
dpc-3520	132	41	and	and	CCONJ
dpc-3520	132	42	high	high	ADJ
dpc-3520	132	43	serum	serum	NOUN
dpc-3520	132	44	erythrocyte	erythrocyte	PROPN
dpc-3520	132	45	sedimentation	sedimentation	NOUN
dpc-3520	132	46	rate	rate	NOUN
dpc-3520	132	47	(	(	PUNCT
dpc-3520	132	48	esr	esr	PROPN
dpc-3520	132	49	)	)	PUNCT
dpc-3520	132	50	as	as	ADP
dpc-3520	132	51	the	the	DET
dpc-3520	132	52	indicators	indicator	NOUN
dpc-3520	132	53	of	of	ADP
dpc-3520	132	54	inflammatory	inflammatory	ADJ
dpc-3520	132	55	condition	condition	NOUN
dpc-3520	132	56	in	in	ADP
dpc-3520	132	57	sle	sle	PROPN
dpc-3520	132	58	,	,	PUNCT
dpc-3520	132	59	whereas	whereas	SCONJ
dpc-3520	132	60	these	these	DET
dpc-3520	132	61	factors	factor	NOUN
dpc-3520	132	62	are	be	AUX
dpc-3520	132	63	not	not	PART
dpc-3520	132	64	considerable	considerable	ADJ
dpc-3520	132	65	in	in	ADP
dpc-3520	132	66	the	the	DET
dpc-3520	132	67	context	context	NOUN
dpc-3520	132	68	of	of	ADP
dpc-3520	132	69	vitiligo	vitiligo	NOUN
dpc-3520	132	70	.	.	PUNCT
dpc-3520	133	1	moreover	moreover	ADV
dpc-3520	133	2	,	,	PUNCT
dpc-3520	133	3	the	the	DET
dpc-3520	133	4	contribution	contribution	NOUN
dpc-3520	133	5	of	of	ADP
dpc-3520	133	6	genetic	genetic	ADJ
dpc-3520	133	7	background	background	NOUN
dpc-3520	133	8	and	and	CCONJ
dpc-3520	133	9	sample	sample	NOUN
dpc-3520	133	10	size	size	NOUN
dpc-3520	133	11	should	should	AUX
dpc-3520	133	12	not	not	PART
dpc-3520	133	13	be	be	AUX
dpc-3520	133	14	ignored	ignore	VERB
dpc-3520	133	15	as	as	SCONJ
dpc-3520	133	16	these	these	PRON
dpc-3520	133	17	are	be	AUX
dpc-3520	133	18	also	also	ADV
dpc-3520	133	19	important	important	ADJ
dpc-3520	133	20	factors	factor	NOUN
dpc-3520	133	21	that	that	PRON
dpc-3520	133	22	might	might	AUX
dpc-3520	133	23	influence	influence	VERB
dpc-3520	133	24	such	such	ADJ
dpc-3520	133	25	differences	difference	NOUN
dpc-3520	133	26	.	.	PUNCT
dpc-3520	134	1	it	it	PRON
dpc-3520	134	2	should	should	AUX
dpc-3520	134	3	be	be	AUX
dpc-3520	134	4	noted	note	VERB
dpc-3520	134	5	that	that	SCONJ
dpc-3520	134	6	,	,	PUNCT
dpc-3520	134	7	the	the	DET
dpc-3520	134	8	current	current	ADJ
dpc-3520	134	9	finding	finding	NOUN
dpc-3520	134	10	is	be	AUX
dpc-3520	134	11	similar	similar	ADJ
dpc-3520	134	12	to	to	ADP
dpc-3520	134	13	our	our	PRON
dpc-3520	134	14	previous	previous	ADJ
dpc-3520	134	15	study	study	NOUN
dpc-3520	134	16	about	about	ADP
dpc-3520	134	17	the	the	DET
dpc-3520	134	18	role	role	NOUN
dpc-3520	134	19	of	of	ADP
dpc-3520	134	20	il-38	il-38	NOUN
dpc-3520	134	21	in	in	ADP
dpc-3520	134	22	bechet	bechet	ADJ
dpc-3520	134	23	disease	disease	NOUN
dpc-3520	134	24	(	(	PUNCT
dpc-3520	134	25	unpublished	unpublished	ADJ
dpc-3520	134	26	data	datum	NOUN
dpc-3520	134	27	)	)	PUNCT
dpc-3520	134	28	in	in	ADP
dpc-3520	134	29	which	which	PRON
dpc-3520	134	30	a	a	DET
dpc-3520	134	31	significant	significant	ADJ
dpc-3520	134	32	lower	low	ADJ
dpc-3520	134	33	il-38	il-38	NOUN
dpc-3520	134	34	levels	level	NOUN
dpc-3520	134	35	in	in	ADP
dpc-3520	134	36	patients	patient	NOUN
dpc-3520	134	37	compared	compare	VERB
dpc-3520	134	38	to	to	ADP
dpc-3520	134	39	controls	control	NOUN
dpc-3520	134	40	was	be	AUX
dpc-3520	134	41	found	find	VERB
dpc-3520	134	42	.	.	PUNCT
dpc-3520	135	1	in	in	ADP
dpc-3520	135	2	addition	addition	NOUN
dpc-3520	135	3	,	,	PUNCT
dpc-3520	135	4	in	in	ADP
dpc-3520	135	5	various	various	ADJ
dpc-3520	135	6	studies	study	NOUN
dpc-3520	135	7	the	the	DET
dpc-3520	135	8	elevated	elevated	ADJ
dpc-3520	135	9	levels	level	NOUN
dpc-3520	135	10	of	of	ADP
dpc-3520	135	11	several	several	ADJ
dpc-3520	135	12	inflammatory	inflammatory	ADJ
dpc-3520	135	13	cytokines	cytokine	NOUN
dpc-3520	135	14	such	such	ADJ
dpc-3520	135	15	as	as	ADP
dpc-3520	135	16	il-1β	il-1β	PROPN
dpc-3520	135	17	,	,	PUNCT
dpc-3520	135	18	il-8	il-8	NOUN
dpc-3520	135	19	,	,	PUNCT
dpc-3520	135	20	il-17	il-17	NUM
dpc-3520	135	21	and	and	CCONJ
dpc-3520	135	22	ifn	ifn	PROPN
dpc-3520	135	23	-	-	PUNCT
dpc-3520	135	24	γ	γ	NOUN
dpc-3520	135	25	in	in	ADP
dpc-3520	135	26	sera	sera	NOUN
dpc-3520	135	27	of	of	ADP
dpc-3520	135	28	vitiligo	vitiligo	ADJ
dpc-3520	135	29	patients	patient	NOUN
dpc-3520	135	30	compared	compare	VERB
dpc-3520	135	31	to	to	ADP
dpc-3520	135	32	healthy	healthy	ADJ
dpc-3520	135	33	controls	control	NOUN
dpc-3520	135	34	have	have	AUX
dpc-3520	135	35	been	be	AUX
dpc-3520	135	36	shown	show	VERB
dpc-3520	135	37	[	[	PUNCT
dpc-3520	135	38	7	7	NUM
dpc-3520	135	39	-	-	SYM
dpc-3520	135	40	10	10	NUM
dpc-3520	135	41	]	]	PUNCT
dpc-3520	135	42	.	.	PUNCT
dpc-3520	136	1	according	accord	VERB
dpc-3520	136	2	to	to	ADP
dpc-3520	136	3	these	these	DET
dpc-3520	136	4	data	datum	NOUN
dpc-3520	136	5	vitiligo	vitiligo	NOUN
dpc-3520	136	6	is	be	AUX
dpc-3520	136	7	proposed	propose	VERB
dpc-3520	136	8	as	as	ADP
dpc-3520	136	9	an	an	DET
dpc-3520	136	10	auto	auto	NOUN
dpc-3520	136	11	inflammatory	inflammatory	ADJ
dpc-3520	136	12	disease	disease	NOUN
dpc-3520	136	13	.	.	PUNCT
dpc-3520	137	1	thus	thus	ADV
dpc-3520	137	2	,	,	PUNCT
dpc-3520	137	3	lower	low	ADJ
dpc-3520	137	4	levels	level	NOUN
dpc-3520	137	5	of	of	ADP
dpc-3520	137	6	il-38	il-38	NOUN
dpc-3520	137	7	which	which	PRON
dpc-3520	137	8	seems	seem	VERB
dpc-3520	137	9	to	to	PART
dpc-3520	137	10	be	be	AUX
dpc-3520	137	11	an	an	DET
dpc-3520	137	12	anti	anti	ADJ
dpc-3520	137	13	-	-	ADJ
dpc-3520	137	14	inflammatory	inflammatory	ADJ
dpc-3520	137	15	cytokine	cytokine	NOUN
dpc-3520	137	16	,	,	PUNCT
dpc-3520	137	17	in	in	ADP
dpc-3520	137	18	these	these	DET
dpc-3520	137	19	patients	patient	NOUN
dpc-3520	137	20	would	would	AUX
dpc-3520	137	21	be	be	AUX
dpc-3520	137	22	expected	expect	VERB
dpc-3520	137	23	and	and	CCONJ
dpc-3520	137	24	support	support	VERB
dpc-3520	137	25	the	the	DET
dpc-3520	137	26	inflammatory	inflammatory	ADJ
dpc-3520	137	27	nature	nature	NOUN
dpc-3520	137	28	of	of	ADP
dpc-3520	137	29	this	this	DET
dpc-3520	137	30	disease	disease	NOUN
dpc-3520	137	31	.	.	PUNCT
dpc-3520	138	1	on	on	ADP
dpc-3520	138	2	evaluation	evaluation	NOUN
dpc-3520	138	3	of	of	ADP
dpc-3520	138	4	the	the	DET
dpc-3520	138	5	relation	relation	NOUN
dpc-3520	138	6	of	of	ADP
dpc-3520	138	7	il-38	il-38	NOUN
dpc-3520	138	8	level	level	NOUN
dpc-3520	138	9	to	to	ADP
dpc-3520	138	10	patients	patient	NOUN
dpc-3520	138	11	characteristics	characteristic	NOUN
dpc-3520	138	12	,	,	PUNCT
dpc-3520	138	13	we	we	PRON
dpc-3520	138	14	found	find	VERB
dpc-3520	138	15	a	a	DET
dpc-3520	138	16	weak	weak	ADJ
dpc-3520	138	17	negative	negative	ADJ
dpc-3520	138	18	correlation	correlation	NOUN
dpc-3520	138	19	figure	figure	NOUN
dpc-3520	138	20	1	1	NUM
dpc-3520	138	21	.	.	NOUN
dpc-3520	138	22	il-38	il-38	NOUN
dpc-3520	138	23	serum	serum	NOUN
dpc-3520	138	24	level	level	NOUN
dpc-3520	138	25	differences	difference	NOUN
dpc-3520	138	26	between	between	ADP
dpc-3520	138	27	generalized	generalized	ADJ
dpc-3520	138	28	vitiligo	vitiligo	NOUN
dpc-3520	138	29	patients	patient	NOUN
dpc-3520	138	30	and	and	CCONJ
dpc-3520	138	31	healthy	healthy	ADJ
dpc-3520	138	32	controls	control	NOUN
dpc-3520	138	33	;	;	PUNCT
dpc-3520	138	34	*	*	SYM
dpc-3520	138	35	p<0.05	p<0.05	NOUN
dpc-3520	138	36	.	.	PUNCT
dpc-3520	139	1	data	datum	NOUN
dpc-3520	139	2	are	be	AUX
dpc-3520	139	3	represented	represent	VERB
dpc-3520	139	4	as	as	ADP
dpc-3520	139	5	mean±	mean±	PROPN
dpc-3520	139	6	standard	standard	PROPN
dpc-3520	139	7	deviation	deviation	NOUN
dpc-3520	139	8	.	.	PUNCT
dpc-3520	140	1	figure	figure	NOUN
dpc-3520	140	2	2	2	NUM
dpc-3520	140	3	.	.	PUNCT
dpc-3520	140	4	correlation	correlation	NOUN
dpc-3520	140	5	between	between	ADP
dpc-3520	140	6	the	the	DET
dpc-3520	140	7	age	age	NOUN
dpc-3520	140	8	of	of	ADP
dpc-3520	140	9	vitiligo	vitiligo	ADJ
dpc-3520	140	10	male	male	ADJ
dpc-3520	140	11	patients	patient	NOUN
dpc-3520	140	12	and	and	CCONJ
dpc-3520	140	13	their	their	PRON
dpc-3520	140	14	il-38	il-38	NOUN
dpc-3520	140	15	serum	serum	NOUN
dpc-3520	140	16	levels	level	NOUN
dpc-3520	140	17	;	;	PUNCT
dpc-3520	141	1	p	p	NOUN
dpc-3520	141	2	=	=	NOUN
dpc-3520	141	3	0.058	0.058	NUM
dpc-3520	141	4	,	,	PUNCT
dpc-3520	141	5	r	r	NOUN
dpc-3520	141	6	=	=	NOUN
dpc-3520	141	7	-0.38	-0.38	NOUN
dpc-3520	141	8	figure	figure	NOUN
dpc-3520	141	9	3	3	NUM
dpc-3520	141	10	.	.	NOUN
dpc-3520	141	11	il-38	il-38	NOUN
dpc-3520	141	12	serum	serum	NOUN
dpc-3520	141	13	level	level	NOUN
dpc-3520	141	14	differences	difference	NOUN
dpc-3520	141	15	between	between	ADP
dpc-3520	141	16	female	female	ADJ
dpc-3520	141	17	and	and	CCONJ
dpc-3520	141	18	male	male	ADJ
dpc-3520	141	19	patients	patient	NOUN
dpc-3520	141	20	with	with	ADP
dpc-3520	141	21	skin	skin	NOUN
dpc-3520	141	22	types	type	NOUN
dpc-3520	141	23	iii	iii	NUM
dpc-3520	141	24	and	and	CCONJ
dpc-3520	141	25	iv	iv	X
dpc-3520	141	26	.	.	PUNCT
dpc-3520	142	1	*	*	PUNCT
dpc-3520	142	2	:	:	PUNCT
dpc-3520	142	3	p	p	X
dpc-3520	142	4	<	<	X
dpc-3520	142	5	0.05	0.05	NUM
dpc-3520	142	6	.	.	PUNCT
dpc-3520	143	1	data	datum	NOUN
dpc-3520	143	2	are	be	AUX
dpc-3520	143	3	represented	represent	VERB
dpc-3520	143	4	as	as	ADP
dpc-3520	143	5	mean	mean	NOUN
dpc-3520	143	6	±	±	NUM
dpc-3520	143	7	standard	standard	ADJ
dpc-3520	143	8	deviation	deviation	NOUN
dpc-3520	143	9	.	.	PUNCT
dpc-3520	144	1	6	6	NUM
dpc-3520	144	2	original	original	ADJ
dpc-3520	144	3	article	article	NOUN
dpc-3520	144	4	|	|	ADV
dpc-3520	144	5	dermatol	dermatol	ADJ
dpc-3520	144	6	pract	pract	NOUN
dpc-3520	144	7	concept	concept	NOUN
dpc-3520	144	8	.	.	PUNCT
dpc-3520	145	1	2024;14(1):e2024027	2024;14(1):e2024027	NUM
dpc-3520	145	2	8	8	NUM
dpc-3520	145	3	.	.	PUNCT
dpc-3520	146	1	ezzedine	ezzedine	PROPN
dpc-3520	146	2	s	s	PROPN
dpc-3520	146	3	,	,	PUNCT
dpc-3520	146	4	el	el	PROPN
dpc-3520	146	5	rewiny	rewiny	VERB
dpc-3520	146	6	em	em	PRON
dpc-3520	146	7	,	,	PUNCT
dpc-3520	146	8	abozied	abozie	VERB
dpc-3520	146	9	aa	aa	NOUN
dpc-3520	146	10	,	,	PUNCT
dpc-3520	146	11	samna	samna	VERB
dpc-3520	146	12	asm	asm	NOUN
dpc-3520	146	13	.	.	PUNCT
dpc-3520	147	1	evaluation	evaluation	NOUN
dpc-3520	147	2	of	of	ADP
dpc-3520	147	3	serum	serum	PROPN
dpc-3520	147	4	interferon	interferon	ADJ
dpc-3520	147	5	-	-	PUNCT
dpc-3520	147	6	gamma	gamma	NOUN
dpc-3520	147	7	level	level	NOUN
dpc-3520	147	8	in	in	ADP
dpc-3520	147	9	vitiligo	vitiligo	NOUN
dpc-3520	147	10	patients	patient	NOUN
dpc-3520	147	11	.	.	PUNCT
dpc-3520	148	1	egyptian	egyptian	ADJ
dpc-3520	148	2	journal	journal	PROPN
dpc-3520	148	3	of	of	ADP
dpc-3520	148	4	hospital	hospital	NOUN
dpc-3520	148	5	medicine	medicine	NOUN
dpc-3520	148	6	.	.	PUNCT
dpc-3520	149	1	2018;73(10):7806	2018;73(10):7806	X
dpc-3520	149	2	-	-	SYM
dpc-3520	149	3	7813	7813	NUM
dpc-3520	149	4	.	.	PUNCT
dpc-3520	150	1	doi	doi	NOUN
dpc-3520	150	2	:	:	PUNCT
dpc-3520	150	3	10.21608	10.21608	NUM
dpc-3520	150	4	/	/	SYM
dpc-3520	150	5	ejhm.2018.20346	ejhm.2018.20346	ADJ
dpc-3520	150	6	.	.	PUNCT
dpc-3520	151	1	9	9	X
dpc-3520	151	2	.	.	X
dpc-3520	151	3	levandowski	levandowski	PROPN
dpc-3520	151	4	cb	cb	PROPN
dpc-3520	151	5	,	,	PUNCT
dpc-3520	151	6	mailloux	mailloux	VERB
dpc-3520	151	7	cm	cm	NOUN
dpc-3520	151	8	,	,	PUNCT
dpc-3520	151	9	ferrara	ferrara	NOUN
dpc-3520	151	10	tm	tm	PROPN
dpc-3520	151	11	,	,	PUNCT
dpc-3520	151	12	gowan	gowan	PROPN
dpc-3520	151	13	k	k	PROPN
dpc-3520	151	14	,	,	PUNCT
dpc-3520	151	15	ben	ben	PROPN
dpc-3520	151	16	s	s	PROPN
dpc-3520	151	17	,	,	PUNCT
dpc-3520	151	18	jin	jin	PROPN
dpc-3520	151	19	y	y	PROPN
dpc-3520	151	20	,	,	PUNCT
dpc-3520	151	21	mcfann	mcfann	PROPN
dpc-3520	151	22	kk	kk	PROPN
dpc-3520	151	23	,	,	PUNCT
dpc-3520	151	24	et	et	PROPN
dpc-3520	151	25	al	al	PROPN
dpc-3520	151	26	.	.	PUNCT
dpc-3520	152	1	nlrp1	nlrp1	NOUN
dpc-3520	152	2	haplotypes	haplotype	NOUN
dpc-3520	152	3	associated	associate	VERB
dpc-3520	152	4	with	with	ADP
dpc-3520	152	5	vitiligo	vitiligo	NOUN
dpc-3520	152	6	and	and	CCONJ
dpc-3520	152	7	autoimmunity	autoimmunity	NOUN
dpc-3520	152	8	increase	increase	NOUN
dpc-3520	152	9	interleukin-1β	interleukin-1β	PUNCT
dpc-3520	152	10	processing	processing	NOUN
dpc-3520	152	11	via	via	ADP
dpc-3520	152	12	the	the	DET
dpc-3520	152	13	nlrp1	nlrp1	NOUN
dpc-3520	152	14	inflammasome	inflammasome	NOUN
dpc-3520	152	15	.	.	PUNCT
dpc-3520	153	1	proc	proc	PROPN
dpc-3520	153	2	natl	natl	PROPN
dpc-3520	153	3	acad	acad	PROPN
dpc-3520	153	4	sci	sci	PROPN
dpc-3520	153	5	u	u	PROPN
dpc-3520	153	6	s	s	NOUN
dpc-3520	153	7	a.	a.	NOUN
dpc-3520	153	8	2013;110(8	2013;110(8	NUM
dpc-3520	153	9	):	):	PUNCT
dpc-3520	153	10	2952	2952	NUM
dpc-3520	153	11	-	-	SYM
dpc-3520	153	12	2956	2956	NUM
dpc-3520	153	13	.	.	PUNCT
dpc-3520	154	1	doi	doi	NOUN
dpc-3520	154	2	:	:	PUNCT
dpc-3520	154	3	10.1073	10.1073	NUM
dpc-3520	154	4	/	/	SYM
dpc-3520	154	5	pnas.1222808110	pnas.1222808110	PROPN
dpc-3520	154	6	.	.	PUNCT
dpc-3520	155	1	pmid	pmid	NOUN
dpc-3520	155	2	:	:	PUNCT
dpc-3520	155	3	23382179	23382179	NUM
dpc-3520	155	4	.	.	PUNCT
dpc-3520	156	1	pmcid	pmcid	ADJ
dpc-3520	156	2	:	:	PUNCT
dpc-3520	156	3	pmc3581876	pmc3581876	NOUN
dpc-3520	156	4	.	.	PUNCT
dpc-3520	157	1	10	10	NUM
dpc-3520	157	2	.	.	PUNCT
dpc-3520	157	3	farag	farag	PROPN
dpc-3520	157	4	ag	ag	PROPN
dpc-3520	157	5	,	,	PUNCT
dpc-3520	157	6	marae	marae	X
dpc-3520	157	7	ah	ah	INTJ
dpc-3520	157	8	,	,	PUNCT
dpc-3520	157	9	habib	habib	PROPN
dpc-3520	157	10	mse	mse	PROPN
dpc-3520	157	11	,	,	PUNCT
dpc-3520	157	12	mahfouz	mahfouz	PROPN
dpc-3520	157	13	rz	rz	PROPN
dpc-3520	157	14	,	,	PUNCT
dpc-3520	157	15	elnaidany	elnaidany	NOUN
dpc-3520	157	16	nf	nf	PROPN
dpc-3520	157	17	,	,	PUNCT
dpc-3520	157	18	youssef	youssef	PROPN
dpc-3520	157	19	si	si	PROPN
dpc-3520	157	20	,	,	PUNCT
dpc-3520	157	21	et	et	PROPN
dpc-3520	157	22	al	al	PROPN
dpc-3520	157	23	.	.	PROPN
dpc-3520	157	24	il-8	il-8	PUNCT
dpc-3520	157	25	mrna	mrna	PROPN
dpc-3520	157	26	and	and	CCONJ
dpc-3520	157	27	serum	serum	NOUN
dpc-3520	157	28	levels	level	NOUN
dpc-3520	157	29	in	in	ADP
dpc-3520	157	30	vitiligo	vitiligo	ADJ
dpc-3520	157	31	patients	patient	NOUN
dpc-3520	157	32	:	:	PUNCT
dpc-3520	157	33	a	a	DET
dpc-3520	157	34	case	case	NOUN
dpc-3520	157	35	control	control	NOUN
dpc-3520	157	36	study	study	NOUN
dpc-3520	157	37	.	.	PUNCT
dpc-3520	158	1	journal	journal	PROPN
dpc-3520	158	2	of	of	ADP
dpc-3520	158	3	clinical	clinical	PROPN
dpc-3520	158	4	&	&	CCONJ
dpc-3520	158	5	diagnostitaher	diagnostitaher	PROPN
dpc-3520	158	6	za	za	PROPN
dpc-3520	158	7	,	,	PUNCT
dpc-3520	158	8	lauzon	lauzon	NOUN
dpc-3520	158	9	g	g	NOUN
dpc-3520	158	10	,	,	PUNCT
dpc-3520	158	11	maguiness	maguiness	NOUN
dpc-3520	158	12	s	s	NOUN
dpc-3520	158	13	,	,	PUNCT
dpc-3520	158	14	dytoc	dytoc	PROPN
dpc-3520	158	15	mt	mt	PROPN
dpc-3520	158	16	.	.	PROPN
dpc-3520	159	1	analysis	analysis	NOUN
dpc-3520	159	2	of	of	ADP
dpc-3520	159	3	interleukin-10	interleukin-10	ADJ
dpc-3520	159	4	levels	level	NOUN
dpc-3520	159	5	in	in	ADP
dpc-3520	159	6	lesions	lesion	NOUN
dpc-3520	159	7	of	of	ADP
dpc-3520	159	8	vitiligo	vitiligo	NOUN
dpc-3520	159	9	following	follow	VERB
dpc-3520	159	10	treatment	treatment	NOUN
dpc-3520	159	11	with	with	ADP
dpc-3520	159	12	topical	topical	ADJ
dpc-3520	159	13	tacrolimus	tacrolimus	NOUN
dpc-3520	159	14	.	.	PUNCT
dpc-3520	160	1	br	br	PROPN
dpc-3520	160	2	j	j	PROPN
dpc-3520	160	3	dermatol	dermatol	NOUN
dpc-3520	160	4	.	.	PUNCT
dpc-3520	161	1	2009;161(3):654	2009;161(3):654	NUM
dpc-3520	161	2	-	-	SYM
dpc-3520	161	3	659	659	NUM
dpc-3520	161	4	.	.	PUNCT
dpc-3520	162	1	doi	doi	NOUN
dpc-3520	162	2	:	:	PUNCT
dpc-3520	162	3	10.1111	10.1111	NUM
dpc-3520	162	4	/	/	SYM
dpc-3520	162	5	j.1365	j.1365	PROPN
dpc-3520	162	6	-	-	PUNCT
dpc-3520	162	7	2133.2009.09217.x	2133.2009.09217.x	NOUN
dpc-3520	162	8	.	.	PUNCT
dpc-3520	163	1	pmid	pmid	NOUN
dpc-3520	163	2	:	:	PUNCT
dpc-3520	163	3	19438859	19438859	NUM
dpc-3520	163	4	.	.	PUNCT
dpc-3520	164	1	11	11	NUM
dpc-3520	164	2	.	.	PUNCT
dpc-3520	165	1	lin	lin	PROPN
dpc-3520	165	2	h	h	PROPN
dpc-3520	165	3	,	,	PUNCT
dpc-3520	165	4	ho	ho	PROPN
dpc-3520	165	5	as	as	ADP
dpc-3520	165	6	,	,	PUNCT
dpc-3520	165	7	haley	haley	NOUN
dpc-3520	165	8	-	-	PUNCT
dpc-3520	165	9	vicente	vicente	PROPN
dpc-3520	165	10	d	d	PROPN
dpc-3520	165	11	,	,	PUNCT
dpc-3520	165	12	et	et	PROPN
dpc-3520	165	13	al	al	PROPN
dpc-3520	165	14	.	.	PUNCT
dpc-3520	165	15	cloning	cloning	NOUN
dpc-3520	165	16	and	and	CCONJ
dpc-3520	165	17	characterization	characterization	NOUN
dpc-3520	165	18	of	of	ADP
dpc-3520	165	19	il-1hy2	il-1hy2	PROPN
dpc-3520	165	20	,	,	PUNCT
dpc-3520	165	21	a	a	DET
dpc-3520	165	22	novel	novel	ADJ
dpc-3520	165	23	interleukin-1	interleukin-1	NUM
dpc-3520	165	24	family	family	NOUN
dpc-3520	165	25	member	member	NOUN
dpc-3520	165	26	.	.	PUNCT
dpc-3520	166	1	j	j	PROPN
dpc-3520	166	2	biol	biol	PROPN
dpc-3520	166	3	chem	chem	NOUN
dpc-3520	166	4	.	.	PUNCT
dpc-3520	167	1	2001;276(23):20597	2001;276(23):20597	NUM
dpc-3520	167	2	-	-	SYM
dpc-3520	167	3	602	602	NUM
dpc-3520	167	4	.	.	PUNCT
dpc-3520	168	1	doi	doi	NOUN
dpc-3520	168	2	:	:	PUNCT
dpc-3520	168	3	10.1074	10.1074	NUM
dpc-3520	168	4	/	/	SYM
dpc-3520	168	5	jbc	jbc	PROPN
dpc-3520	168	6	.m010095200	.m010095200	PROPN
dpc-3520	168	7	.	.	PUNCT
dpc-3520	169	1	pmid	pmid	NOUN
dpc-3520	169	2	:	:	PUNCT
dpc-3520	169	3	11278614	11278614	NUM
dpc-3520	169	4	.	.	PUNCT
dpc-3520	170	1	12	12	NUM
dpc-3520	170	2	.	.	PUNCT
dpc-3520	171	1	nicklin	nicklin	PROPN
dpc-3520	171	2	mj	mj	PROPN
dpc-3520	171	3	,	,	PUNCT
dpc-3520	171	4	barton	barton	PROPN
dpc-3520	171	5	jl	jl	PROPN
dpc-3520	171	6	,	,	PUNCT
dpc-3520	171	7	nguyen	nguyen	PROPN
dpc-3520	171	8	m	m	PROPN
dpc-3520	171	9	,	,	PUNCT
dpc-3520	171	10	fitzgerald	fitzgerald	PROPN
dpc-3520	171	11	mg	mg	PROPN
dpc-3520	171	12	,	,	PUNCT
dpc-3520	171	13	duff	duff	PROPN
dpc-3520	171	14	gw	gw	PROPN
dpc-3520	171	15	,	,	PUNCT
dpc-3520	171	16	kornman	kornman	PROPN
dpc-3520	171	17	k.	k.	PROPN
dpc-3520	172	1	a	a	DET
dpc-3520	172	2	sequence	sequence	NOUN
dpc-3520	172	3	-	-	PUNCT
dpc-3520	172	4	based	base	VERB
dpc-3520	172	5	map	map	NOUN
dpc-3520	172	6	of	of	ADP
dpc-3520	172	7	the	the	DET
dpc-3520	172	8	nine	nine	NUM
dpc-3520	172	9	genes	gene	NOUN
dpc-3520	172	10	of	of	ADP
dpc-3520	172	11	the	the	DET
dpc-3520	172	12	human	human	ADJ
dpc-3520	172	13	interleukin-1	interleukin-1	NOUN
dpc-3520	172	14	cluster	cluster	NOUN
dpc-3520	172	15	.	.	PUNCT
dpc-3520	173	1	genomics	genomic	NOUN
dpc-3520	173	2	.	.	PUNCT
dpc-3520	174	1	2002;79(5):718	2002;79(5):718	NUM
dpc-3520	174	2	-	-	SYM
dpc-3520	174	3	725	725	PROPN
dpc-3520	174	4	.	.	PUNCT
dpc-3520	174	5	doi	doi	NOUN
dpc-3520	174	6	:	:	PUNCT
dpc-3520	174	7	10.1006	10.1006	NUM
dpc-3520	174	8	/	/	SYM
dpc-3520	174	9	geno.2002.6751	geno.2002.6751	NOUN
dpc-3520	174	10	.	.	PUNCT
dpc-3520	175	1	pmid	pmid	NOUN
dpc-3520	175	2	:	:	PUNCT
dpc-3520	175	3	11991722	11991722	NUM
dpc-3520	175	4	.	.	PUNCT
dpc-3520	176	1	13	13	NUM
dpc-3520	176	2	.	.	PUNCT
dpc-3520	177	1	bensen	bensen	PROPN
dpc-3520	177	2	jt	jt	PROPN
dpc-3520	177	3	,	,	PUNCT
dpc-3520	177	4	dawson	dawson	PROPN
dpc-3520	177	5	pa	pa	PROPN
dpc-3520	177	6	,	,	PUNCT
dpc-3520	177	7	mychaleckyj	mychaleckyj	PROPN
dpc-3520	177	8	jc	jc	PROPN
dpc-3520	177	9	,	,	PUNCT
dpc-3520	177	10	bowden	bowden	PROPN
dpc-3520	177	11	dw	dw	PROPN
dpc-3520	177	12	.	.	PROPN
dpc-3520	177	13	identification	identification	NOUN
dpc-3520	177	14	of	of	ADP
dpc-3520	177	15	a	a	DET
dpc-3520	177	16	novel	novel	ADJ
dpc-3520	177	17	human	human	ADJ
dpc-3520	177	18	cytokine	cytokine	NOUN
dpc-3520	177	19	gene	gene	NOUN
dpc-3520	177	20	in	in	ADP
dpc-3520	177	21	the	the	DET
dpc-3520	177	22	interleukin	interleukin	NOUN
dpc-3520	177	23	gene	gene	NOUN
dpc-3520	177	24	cluster	cluster	NOUN
dpc-3520	177	25	on	on	ADP
dpc-3520	177	26	chromosome	chromosome	NOUN
dpc-3520	177	27	2q12	2q12	NUM
dpc-3520	177	28	-	-	SYM
dpc-3520	177	29	14	14	NUM
dpc-3520	177	30	.	.	PUNCT
dpc-3520	178	1	j	j	PROPN
dpc-3520	178	2	interferon	interferon	PROPN
dpc-3520	178	3	cytokine	cytokine	NOUN
dpc-3520	178	4	res	re	NOUN
dpc-3520	178	5	.	.	PUNCT
dpc-3520	179	1	2001;21(11):899	2001;21(11):899	PROPN
dpc-3520	179	2	-	-	PUNCT
dpc-3520	179	3	904	904	NUM
dpc-3520	179	4	.	.	PUNCT
dpc-3520	180	1	doi	doi	NOUN
dpc-3520	180	2	:	:	PUNCT
dpc-3520	180	3	10.1089/107999001753289505	10.1089/107999001753289505	NUM
dpc-3520	180	4	.	.	PUNCT
dpc-3520	181	1	pmid	pmid	NOUN
dpc-3520	181	2	:	:	PUNCT
dpc-3520	181	3	11747621	11747621	NUM
dpc-3520	181	4	.	.	PUNCT
dpc-3520	182	1	14	14	NUM
dpc-3520	182	2	.	.	PUNCT
dpc-3520	183	1	gabay	gabay	PROPN
dpc-3520	183	2	c	c	PROPN
dpc-3520	183	3	,	,	PUNCT
dpc-3520	183	4	towne	towne	PROPN
dpc-3520	183	5	je	je	PROPN
dpc-3520	183	6	.	.	PUNCT
dpc-3520	183	7	regulation	regulation	NOUN
dpc-3520	183	8	and	and	CCONJ
dpc-3520	183	9	function	function	NOUN
dpc-3520	183	10	of	of	ADP
dpc-3520	183	11	interleukin-36	interleukin-36	NOUN
dpc-3520	183	12	cytokines	cytokine	NOUN
dpc-3520	183	13	in	in	ADP
dpc-3520	183	14	homeostasis	homeostasis	NOUN
dpc-3520	183	15	and	and	CCONJ
dpc-3520	183	16	pathological	pathological	ADJ
dpc-3520	183	17	conditions	condition	NOUN
dpc-3520	183	18	.	.	PUNCT
dpc-3520	184	1	j	j	PROPN
dpc-3520	184	2	leukoc	leukoc	VERB
dpc-3520	184	3	biol	biol	PROPN
dpc-3520	184	4	.	.	PUNCT
dpc-3520	185	1	2015;97(4):645	2015;97(4):645	NUM
dpc-3520	185	2	-	-	PUNCT
dpc-3520	185	3	652	652	NUM
dpc-3520	185	4	.	.	PUNCT
dpc-3520	186	1	doi	doi	NOUN
dpc-3520	186	2	:	:	PUNCT
dpc-3520	186	3	10.1189	10.1189	NUM
dpc-3520	186	4	/	/	SYM
dpc-3520	186	5	jlb.3ri1014	jlb.3ri1014	NOUN
dpc-3520	186	6	-	-	PUNCT
dpc-3520	186	7	495r	495r	NOUN
dpc-3520	186	8	.	.	PUNCT
dpc-3520	187	1	pmid	pmid	NOUN
dpc-3520	187	2	:	:	PUNCT
dpc-3520	187	3	25673295	25673295	NUM
dpc-3520	187	4	.	.	PUNCT
dpc-3520	188	1	15	15	NUM
dpc-3520	188	2	.	.	PUNCT
dpc-3520	189	1	hahn	hahn	PROPN
dpc-3520	189	2	m	m	PROPN
dpc-3520	189	3	,	,	PUNCT
dpc-3520	189	4	frey	frey	PROPN
dpc-3520	189	5	s	s	PART
dpc-3520	189	6	,	,	PUNCT
dpc-3520	189	7	hueber	hueber	PROPN
dpc-3520	189	8	aj	aj	PROPN
dpc-3520	189	9	.	.	PUNCT
dpc-3520	190	1	the	the	DET
dpc-3520	190	2	novel	novel	ADJ
dpc-3520	190	3	interleukin-1	interleukin-1	NUM
dpc-3520	190	4	cytokine	cytokine	NOUN
dpc-3520	190	5	family	family	NOUN
dpc-3520	190	6	members	member	NOUN
dpc-3520	190	7	in	in	ADP
dpc-3520	190	8	inflammatory	inflammatory	ADJ
dpc-3520	190	9	diseases	disease	NOUN
dpc-3520	190	10	.	.	PUNCT
dpc-3520	191	1	curr	curr	PROPN
dpc-3520	191	2	opin	opin	PROPN
dpc-3520	191	3	rheumatol	rheumatol	NOUN
dpc-3520	191	4	.	.	PUNCT
dpc-3520	192	1	2017;29(2):208	2017;29(2):208	NUM
dpc-3520	192	2	-	-	PUNCT
dpc-3520	192	3	213	213	NUM
dpc-3520	192	4	.	.	PUNCT
dpc-3520	193	1	doi	doi	NOUN
dpc-3520	193	2	:	:	PUNCT
dpc-3520	193	3	10.1097	10.1097	NUM
dpc-3520	193	4	/	/	SYM
dpc-3520	193	5	bor.0000000000000361	bor.0000000000000361	NOUN
dpc-3520	193	6	.	.	PUNCT
dpc-3520	194	1	pmid	pmid	NOUN
dpc-3520	194	2	:	:	PUNCT
dpc-3520	194	3	27926540	27926540	NUM
dpc-3520	194	4	.	.	PUNCT
dpc-3520	195	1	16	16	NUM
dpc-3520	195	2	.	.	PUNCT
dpc-3520	196	1	guo	guo	PROPN
dpc-3520	196	2	zs	zs	PROPN
dpc-3520	196	3	,	,	PUNCT
dpc-3520	196	4	li	li	PROPN
dpc-3520	196	5	c	c	PROPN
dpc-3520	196	6	,	,	PUNCT
dpc-3520	196	7	lin	lin	PROPN
dpc-3520	196	8	zm	zm	PROPN
dpc-3520	196	9	,	,	PUNCT
dpc-3520	196	10	et	et	PROPN
dpc-3520	196	11	al	al	PROPN
dpc-3520	196	12	.	.	PROPN
dpc-3520	196	13	association	association	PROPN
dpc-3520	196	14	of	of	ADP
dpc-3520	196	15	il-1	il-1	PUNCT
dpc-3520	196	16	gene	gene	NOUN
dpc-3520	196	17	complex	complex	ADJ
dpc-3520	196	18	members	member	NOUN
dpc-3520	196	19	with	with	ADP
dpc-3520	196	20	ankylosing	ankylose	VERB
dpc-3520	196	21	spondylitis	spondylitis	NOUN
dpc-3520	196	22	in	in	ADP
dpc-3520	196	23	chinese	chinese	ADJ
dpc-3520	196	24	han	han	PROPN
dpc-3520	196	25	population	population	PROPN
dpc-3520	196	26	.	.	PUNCT
dpc-3520	197	1	int	int	PROPN
dpc-3520	197	2	j	j	PROPN
dpc-3520	197	3	immunogenet	immunogenet	PROPN
dpc-3520	197	4	.	.	PUNCT
dpc-3520	198	1	2010;37(1):33	2010;37(1):33	NUM
dpc-3520	198	2	-	-	SYM
dpc-3520	198	3	37	37	NUM
dpc-3520	198	4	.	.	PUNCT
dpc-3520	199	1	doi	doi	NOUN
dpc-3520	199	2	:	:	PUNCT
dpc-3520	199	3	10.1111	10.1111	NUM
dpc-3520	199	4	/	/	SYM
dpc-3520	199	5	j.1744313x.2009.00889.x	j.1744313x.2009.00889.x	PROPN
dpc-3520	199	6	.	.	PUNCT
dpc-3520	200	1	pmid	pmid	NOUN
dpc-3520	200	2	:	:	PUNCT
dpc-3520	200	3	19930406	19930406	NUM
dpc-3520	200	4	.	.	PUNCT
dpc-3520	201	1	17	17	NUM
dpc-3520	201	2	.	.	PUNCT
dpc-3520	202	1	jung	jung	PROPN
dpc-3520	202	2	my	my	PRON
dpc-3520	202	3	,	,	PUNCT
dpc-3520	202	4	kang	kang	PROPN
dpc-3520	202	5	sw	sw	PROPN
dpc-3520	202	6	,	,	PUNCT
dpc-3520	202	7	kim	kim	PROPN
dpc-3520	202	8	sk	sk	PROPN
dpc-3520	202	9	,	,	PUNCT
dpc-3520	202	10	et	et	PROPN
dpc-3520	202	11	al	al	PROPN
dpc-3520	202	12	.	.	PUNCT
dpc-3520	203	1	the	the	DET
dpc-3520	203	2	interleukin-1	interleukin-1	NUM
dpc-3520	203	3	family	family	NOUN
dpc-3520	203	4	gene	gene	NOUN
dpc-3520	203	5	polymorphisms	polymorphism	NOUN
dpc-3520	203	6	in	in	ADP
dpc-3520	203	7	korean	korean	ADJ
dpc-3520	203	8	patients	patient	NOUN
dpc-3520	203	9	with	with	ADP
dpc-3520	203	10	rheumatoid	rheumatoid	NOUN
dpc-3520	203	11	arthritis	arthritis	NOUN
dpc-3520	203	12	.	.	PUNCT
dpc-3520	204	1	scand	scand	PROPN
dpc-3520	204	2	j	j	PROPN
dpc-3520	204	3	rheumatol	rheumatol	NOUN
dpc-3520	204	4	.	.	PUNCT
dpc-3520	205	1	2010;39(3):190	2010;39(3):190	PROPN
dpc-3520	205	2	-	-	PUNCT
dpc-3520	205	3	196	196	NUM
dpc-3520	205	4	.	.	PUNCT
dpc-3520	206	1	doi	doi	NOUN
dpc-3520	206	2	:	:	PUNCT
dpc-3520	206	3	10.3109	10.3109	NUM
dpc-3520	206	4	/03009740903447028	/03009740903447028	PUNCT
dpc-3520	206	5	.	.	PUNCT
dpc-3520	207	1	pmid	pmid	NOUN
dpc-3520	207	2	:	:	PUNCT
dpc-3520	207	3	20141484	20141484	NUM
dpc-3520	207	4	.	.	PUNCT
dpc-3520	208	1	18	18	NUM
dpc-3520	208	2	.	.	PUNCT
dpc-3520	209	1	rahman	rahman	PROPN
dpc-3520	209	2	p	p	PROPN
dpc-3520	209	3	,	,	PUNCT
dpc-3520	209	4	sun	sun	PROPN
dpc-3520	209	5	s	s	PART
dpc-3520	209	6	,	,	PUNCT
dpc-3520	209	7	peddle	peddle	PROPN
dpc-3520	209	8	l	l	PROPN
dpc-3520	209	9	,	,	PUNCT
dpc-3520	209	10	et	et	PROPN
dpc-3520	209	11	al	al	PROPN
dpc-3520	209	12	association	association	PROPN
dpc-3520	209	13	between	between	ADP
dpc-3520	209	14	the	the	DET
dpc-3520	209	15	interleukin-1	interleukin-1	NUM
dpc-3520	209	16	family	family	NOUN
dpc-3520	209	17	gene	gene	NOUN
dpc-3520	209	18	cluster	cluster	NOUN
dpc-3520	209	19	and	and	CCONJ
dpc-3520	209	20	psoriatic	psoriatic	ADJ
dpc-3520	209	21	arthritis	arthritis	NOUN
dpc-3520	209	22	.	.	PUNCT
dpc-3520	210	1	arthritis	arthritis	NOUN
dpc-3520	210	2	rheum	rheum	NOUN
dpc-3520	210	3	.	.	PUNCT
dpc-3520	211	1	2006;54(7):2321	2006;54(7):2321	NUM
dpc-3520	211	2	-	-	SYM
dpc-3520	211	3	2325	2325	NUM
dpc-3520	211	4	.	.	PUNCT
dpc-3520	212	1	doi	doi	NOUN
dpc-3520	212	2	:	:	PUNCT
dpc-3520	212	3	10.1002	10.1002	NUM
dpc-3520	212	4	/	/	SYM
dpc-3520	212	5	art.21928	art.21928	NOUN
dpc-3520	212	6	.	.	PUNCT
dpc-3520	213	1	pmid	pmid	NOUN
dpc-3520	213	2	:	:	PUNCT
dpc-3520	213	3	16918024	16918024	NUM
dpc-3520	213	4	.	.	PUNCT
dpc-3520	214	1	19	19	NUM
dpc-3520	214	2	.	.	PUNCT
dpc-3520	215	1	d	d	PROPN
dpc-3520	215	2	dehghan	dehghan	PROPN
dpc-3520	215	3	a	a	PRON
dpc-3520	215	4	,	,	PUNCT
dpc-3520	215	5	dupuis	dupuis	PROPN
dpc-3520	215	6	j	j	PROPN
dpc-3520	215	7	,	,	PUNCT
dpc-3520	215	8	barbalic	barbalic	PROPN
dpc-3520	215	9	m	m	PROPN
dpc-3520	215	10	,	,	PUNCT
dpc-3520	215	11	et	et	PROPN
dpc-3520	215	12	al	al	PROPN
dpc-3520	215	13	.	.	PUNCT
dpc-3520	216	1	meta	meta	VERB
dpc-3520	216	2	-	-	PUNCT
dpc-3520	216	3	analysis	analysis	NOUN
dpc-3520	216	4	of	of	ADP
dpc-3520	216	5	genome	genome	NOUN
dpc-3520	216	6	-	-	PUNCT
dpc-3520	216	7	wide	wide	ADJ
dpc-3520	216	8	association	association	NOUN
dpc-3520	216	9	studies	study	NOUN
dpc-3520	216	10	in	in	ADP
dpc-3520	216	11	>	>	SYM
dpc-3520	216	12	80	80	NUM
dpc-3520	216	13	000	000	NUM
dpc-3520	216	14	subjects	subject	NOUN
dpc-3520	216	15	identifies	identify	VERB
dpc-3520	216	16	multiple	multiple	ADJ
dpc-3520	216	17	loci	locus	NOUN
dpc-3520	216	18	for	for	ADP
dpc-3520	216	19	c	c	NOUN
dpc-3520	216	20	-	-	PUNCT
dpc-3520	216	21	reactive	reactive	ADJ
dpc-3520	216	22	protein	protein	NOUN
dpc-3520	216	23	levels	level	NOUN
dpc-3520	216	24	.	.	PUNCT
dpc-3520	217	1	circulation	circulation	NOUN
dpc-3520	217	2	.	.	PUNCT
dpc-3520	218	1	2011;123(7):731	2011;123(7):731	NUM
dpc-3520	218	2	-	-	SYM
dpc-3520	218	3	738	738	NUM
dpc-3520	218	4	.	.	PUNCT
dpc-3520	219	1	doi	doi	NOUN
dpc-3520	219	2	:	:	PUNCT
dpc-3520	219	3	10.1161	10.1161	NUM
dpc-3520	219	4	/	/	SYM
dpc-3520	219	5	circulationaha.110	circulationaha.110	PROPN
dpc-3520	219	6	.948570	.948570	NOUN
dpc-3520	219	7	.	.	PUNCT
dpc-3520	220	1	pmid	pmid	NOUN
dpc-3520	220	2	:	:	PUNCT
dpc-3520	220	3	21300955	21300955	NUM
dpc-3520	220	4	.	.	PUNCT
dpc-3520	221	1	pmcid	pmcid	NOUN
dpc-3520	221	2	:	:	PUNCT
dpc-3520	221	3	pmc3147232	pmc3147232	NOUN
dpc-3520	221	4	.	.	PUNCT
dpc-3520	222	1	20	20	NUM
dpc-3520	222	2	.	.	X
dpc-3520	223	1	rudloff	rudloff	PROPN
dpc-3520	223	2	i	i	PRON
dpc-3520	223	3	,	,	PUNCT
dpc-3520	223	4	godsell	godsell	PROPN
dpc-3520	223	5	j	j	PROPN
dpc-3520	223	6	,	,	PUNCT
dpc-3520	223	7	nold	nold	VERB
dpc-3520	223	8	-	-	PUNCT
dpc-3520	223	9	petry	petry	NOUN
dpc-3520	223	10	ca	ca	PROPN
dpc-3520	223	11	,	,	PUNCT
dpc-3520	223	12	et	et	PROPN
dpc-3520	223	13	al	al	PROPN
dpc-3520	223	14	.	.	PROPN
dpc-3520	223	15	brief	brief	PROPN
dpc-3520	223	16	report	report	NOUN
dpc-3520	223	17	:	:	PUNCT
dpc-3520	223	18	interleukin-38	interleukin-38	PROPN
dpc-3520	223	19	exerts	exert	VERB
dpc-3520	223	20	antiinflammatory	antiinflammatory	NOUN
dpc-3520	223	21	functions	function	NOUN
dpc-3520	223	22	and	and	CCONJ
dpc-3520	223	23	is	be	AUX
dpc-3520	223	24	associated	associate	VERB
dpc-3520	223	25	with	with	ADP
dpc-3520	223	26	disease	disease	NOUN
dpc-3520	223	27	activity	activity	NOUN
dpc-3520	223	28	in	in	ADP
dpc-3520	223	29	systemic	systemic	ADJ
dpc-3520	223	30	lupus	lupus	PROPN
dpc-3520	223	31	erythematosus	erythematosus	PROPN
dpc-3520	223	32	.	.	PUNCT
dpc-3520	224	1	arthritis	arthritis	NOUN
dpc-3520	224	2	rheumatol	rheumatol	NOUN
dpc-3520	224	3	.	.	PUNCT
dpc-3520	225	1	2015;67(12):3219	2015;67(12):3219	NUM
dpc-3520	225	2	-	-	SYM
dpc-3520	225	3	3225	3225	NUM
dpc-3520	225	4	.	.	PUNCT
dpc-3520	226	1	doi	doi	NOUN
dpc-3520	226	2	:	:	PUNCT
dpc-3520	226	3	10.1002	10.1002	NUM
dpc-3520	226	4	/	/	SYM
dpc-3520	226	5	art	art	NOUN
dpc-3520	226	6	.39328	.39328	PROPN
dpc-3520	226	7	.	.	PUNCT
dpc-3520	227	1	pmid	pmid	NOUN
dpc-3520	227	2	:	:	PUNCT
dpc-3520	227	3	26314375	26314375	NUM
dpc-3520	227	4	.	.	PUNCT
dpc-3520	228	1	between	between	ADP
dpc-3520	228	2	the	the	DET
dpc-3520	228	3	age	age	NOUN
dpc-3520	228	4	of	of	ADP
dpc-3520	228	5	male	male	ADJ
dpc-3520	228	6	patients	patient	NOUN
dpc-3520	228	7	and	and	CCONJ
dpc-3520	228	8	their	their	PRON
dpc-3520	228	9	il-38serum	il-38serum	ADJ
dpc-3520	228	10	levels	level	NOUN
dpc-3520	228	11	,	,	PUNCT
dpc-3520	228	12	so	so	SCONJ
dpc-3520	228	13	that	that	SCONJ
dpc-3520	228	14	this	this	DET
dpc-3520	228	15	cytokine	cytokine	NOUN
dpc-3520	228	16	showed	show	VERB
dpc-3520	228	17	a	a	DET
dpc-3520	228	18	decreased	decrease	VERB
dpc-3520	228	19	level	level	NOUN
dpc-3520	228	20	with	with	ADP
dpc-3520	228	21	increased	increase	VERB
dpc-3520	228	22	age	age	NOUN
dpc-3520	228	23	of	of	ADP
dpc-3520	228	24	the	the	DET
dpc-3520	228	25	patients	patient	NOUN
dpc-3520	228	26	.	.	PUNCT
dpc-3520	229	1	this	this	DET
dpc-3520	229	2	correlation	correlation	NOUN
dpc-3520	229	3	was	be	AUX
dpc-3520	229	4	not	not	PART
dpc-3520	229	5	found	find	VERB
dpc-3520	229	6	in	in	ADP
dpc-3520	229	7	female	female	ADJ
dpc-3520	229	8	patients	patient	NOUN
dpc-3520	229	9	as	as	ADV
dpc-3520	229	10	well	well	ADV
dpc-3520	229	11	as	as	ADP
dpc-3520	229	12	male	male	ADJ
dpc-3520	229	13	and	and	CCONJ
dpc-3520	229	14	female	female	ADJ
dpc-3520	229	15	controls	control	NOUN
dpc-3520	229	16	.	.	PUNCT
dpc-3520	230	1	we	we	PRON
dpc-3520	230	2	investigated	investigate	VERB
dpc-3520	230	3	the	the	DET
dpc-3520	230	4	relation	relation	NOUN
dpc-3520	230	5	of	of	ADP
dpc-3520	230	6	il-38	il-38	NOUN
dpc-3520	230	7	level	level	NOUN
dpc-3520	230	8	to	to	ADP
dpc-3520	230	9	patients	patient	NOUN
dpc-3520	230	10	disease	disease	NOUN
dpc-3520	230	11	activity	activity	NOUN
dpc-3520	230	12	and	and	CCONJ
dpc-3520	230	13	found	find	VERB
dpc-3520	230	14	no	no	DET
dpc-3520	230	15	significant	significant	ADJ
dpc-3520	230	16	result	result	NOUN
dpc-3520	230	17	.	.	PUNCT
dpc-3520	231	1	analysis	analysis	NOUN
dpc-3520	231	2	of	of	ADP
dpc-3520	231	3	il-38	il-38	NOUN
dpc-3520	231	4	level	level	NOUN
dpc-3520	231	5	in	in	ADP
dpc-3520	231	6	patients	patient	NOUN
dpc-3520	231	7	with	with	ADP
dpc-3520	231	8	various	various	ADJ
dpc-3520	231	9	stages	stage	NOUN
dpc-3520	231	10	of	of	ADP
dpc-3520	231	11	depigmentation	depigmentation	NOUN
dpc-3520	231	12	and	and	CCONJ
dpc-3520	231	13	vida	vida	PROPN
dpc-3520	231	14	score	score	NOUN
dpc-3520	231	15	did	do	AUX
dpc-3520	231	16	not	not	PART
dpc-3520	231	17	also	also	ADV
dpc-3520	231	18	reach	reach	VERB
dpc-3520	231	19	to	to	PART
dpc-3520	231	20	be	be	AUX
dpc-3520	231	21	significant	significant	ADJ
dpc-3520	231	22	.	.	PUNCT
dpc-3520	232	1	these	these	DET
dpc-3520	232	2	data	datum	NOUN
dpc-3520	232	3	may	may	AUX
dpc-3520	232	4	suggest	suggest	VERB
dpc-3520	232	5	that	that	DET
dpc-3520	232	6	il-38	il-38	NOUN
dpc-3520	232	7	have	have	VERB
dpc-3520	232	8	no	no	DET
dpc-3520	232	9	important	important	ADJ
dpc-3520	232	10	role	role	NOUN
dpc-3520	232	11	in	in	ADP
dpc-3520	232	12	the	the	DET
dpc-3520	232	13	pathogenesis	pathogenesis	NOUN
dpc-3520	232	14	and	and	CCONJ
dpc-3520	232	15	activity	activity	NOUN
dpc-3520	232	16	of	of	ADP
dpc-3520	232	17	vitiligo	vitiligo	NOUN
dpc-3520	232	18	.	.	PUNCT
dpc-3520	233	1	collectively	collectively	ADV
dpc-3520	233	2	,	,	PUNCT
dpc-3520	233	3	we	we	PRON
dpc-3520	233	4	could	could	AUX
dpc-3520	233	5	indicate	indicate	VERB
dpc-3520	233	6	the	the	DET
dpc-3520	233	7	difference	difference	NOUN
dpc-3520	233	8	of	of	ADP
dpc-3520	233	9	il-38	il-38	NOUN
dpc-3520	233	10	in	in	ADP
dpc-3520	233	11	sera	sera	NOUN
dpc-3520	233	12	of	of	ADP
dpc-3520	233	13	vitiligo	vitiligo	ADJ
dpc-3520	233	14	patients	patient	NOUN
dpc-3520	233	15	and	and	CCONJ
dpc-3520	233	16	healthy	healthy	ADJ
dpc-3520	233	17	controls	control	NOUN
dpc-3520	233	18	,	,	PUNCT
dpc-3520	233	19	as	as	ADP
dpc-3520	233	20	the	the	DET
dpc-3520	233	21	first	first	ADJ
dpc-3520	233	22	report	report	NOUN
dpc-3520	233	23	of	of	ADP
dpc-3520	233	24	the	the	DET
dpc-3520	233	25	lower	low	ADJ
dpc-3520	233	26	level	level	NOUN
dpc-3520	233	27	of	of	ADP
dpc-3520	233	28	this	this	DET
dpc-3520	233	29	cytokine	cytokine	NOUN
dpc-3520	233	30	in	in	ADP
dpc-3520	233	31	the	the	DET
dpc-3520	233	32	context	context	NOUN
dpc-3520	233	33	of	of	ADP
dpc-3520	233	34	vitiligo	vitiligo	NOUN
dpc-3520	233	35	.	.	PUNCT
dpc-3520	234	1	the	the	DET
dpc-3520	234	2	reason	reason	NOUN
dpc-3520	234	3	of	of	ADP
dpc-3520	234	4	this	this	DET
dpc-3520	234	5	difference	difference	NOUN
dpc-3520	234	6	remains	remain	VERB
dpc-3520	234	7	to	to	PART
dpc-3520	234	8	be	be	AUX
dpc-3520	234	9	clarified	clarify	VERB
dpc-3520	234	10	;	;	PUNCT
dpc-3520	234	11	as	as	SCONJ
dpc-3520	234	12	there	there	PRON
dpc-3520	234	13	are	be	VERB
dpc-3520	234	14	not	not	PART
dpc-3520	234	15	sufficient	sufficient	ADJ
dpc-3520	234	16	study	study	NOUN
dpc-3520	234	17	reports	report	NOUN
dpc-3520	234	18	revealing	reveal	VERB
dpc-3520	234	19	the	the	DET
dpc-3520	234	20	role	role	NOUN
dpc-3520	234	21	of	of	ADP
dpc-3520	234	22	gender	gender	NOUN
dpc-3520	234	23	,	,	PUNCT
dpc-3520	234	24	ethnicity	ethnicity	NOUN
dpc-3520	234	25	and	and	CCONJ
dpc-3520	234	26	inflammation	inflammation	NOUN
dpc-3520	234	27	on	on	ADP
dpc-3520	234	28	the	the	DET
dpc-3520	234	29	cytokine	cytokine	ADJ
dpc-3520	234	30	network	network	NOUN
dpc-3520	234	31	in	in	ADP
dpc-3520	234	32	the	the	DET
dpc-3520	234	33	context	context	NOUN
dpc-3520	234	34	of	of	ADP
dpc-3520	234	35	vitiligo	vitiligo	PROPN
dpc-3520	234	36	.	.	PUNCT
dpc-3520	235	1	acknowledgement	acknowledgement	PROPN
dpc-3520	235	2	research	research	NOUN
dpc-3520	235	3	reported	report	VERB
dpc-3520	235	4	in	in	ADP
dpc-3520	235	5	this	this	DET
dpc-3520	235	6	publication	publication	NOUN
dpc-3520	235	7	was	be	AUX
dpc-3520	235	8	supported	support	VERB
dpc-3520	235	9	by	by	ADP
dpc-3520	235	10	elite	elite	ADJ
dpc-3520	235	11	researcher	researcher	NOUN
dpc-3520	235	12	grant	grant	PROPN
dpc-3520	235	13	committee	committee	PROPN
dpc-3520	235	14	under	under	ADP
dpc-3520	235	15	award	award	NOUN
dpc-3520	235	16	number	number	NOUN
dpc-3520	235	17	[	[	X
dpc-3520	235	18	971223	971223	NUM
dpc-3520	235	19	]	]	PUNCT
dpc-3520	235	20	from	from	ADP
dpc-3520	235	21	the	the	DET
dpc-3520	235	22	national	national	PROPN
dpc-3520	235	23	institute	institute	PROPN
dpc-3520	235	24	for	for	ADP
dpc-3520	235	25	medical	medical	ADJ
dpc-3520	235	26	research	research	NOUN
dpc-3520	235	27	development	development	NOUN
dpc-3520	235	28	(	(	PUNCT
dpc-3520	235	29	nimad	nimad	NOUN
dpc-3520	235	30	)	)	PUNCT
dpc-3520	235	31	,	,	PUNCT
dpc-3520	235	32	tehran	tehran	PROPN
dpc-3520	235	33	,	,	PUNCT
dpc-3520	235	34	iran	iran	PROPN
dpc-3520	235	35	references	reference	VERB
dpc-3520	235	36	1	1	NUM
dpc-3520	235	37	.	.	PUNCT
dpc-3520	235	38	gianfaldoni	gianfaldoni	PROPN
dpc-3520	235	39	s	s	PROPN
dpc-3520	235	40	,	,	PUNCT
dpc-3520	235	41	tchernev	tchernev	PROPN
dpc-3520	235	42	g	g	NOUN
dpc-3520	235	43	,	,	PUNCT
dpc-3520	235	44	wollina	wollina	NOUN
dpc-3520	235	45	u	u	PROPN
dpc-3520	235	46	,	,	PUNCT
dpc-3520	236	1	et	et	PROPN
dpc-3520	236	2	al	al	PROPN
dpc-3520	236	3	.	.	PROPN
dpc-3520	236	4	vitiligo	vitiligo	PROPN
dpc-3520	236	5	in	in	ADP
dpc-3520	236	6	children	child	NOUN
dpc-3520	236	7	:	:	PUNCT
dpc-3520	236	8	a	a	DET
dpc-3520	236	9	better	well	ADJ
dpc-3520	236	10	understanding	understanding	NOUN
dpc-3520	236	11	of	of	ADP
dpc-3520	236	12	the	the	DET
dpc-3520	236	13	disease	disease	NOUN
dpc-3520	236	14	.	.	PUNCT
dpc-3520	237	1	open	open	ADJ
dpc-3520	237	2	access	access	NOUN
dpc-3520	237	3	maced	mace	VERB
dpc-3520	237	4	j	j	PROPN
dpc-3520	237	5	med	med	PROPN
dpc-3520	237	6	sci	sci	PROPN
dpc-3520	237	7	.	.	PUNCT
dpc-3520	238	1	2018;6(1):181	2018;6(1):181	X
dpc-3520	238	2	-	-	SYM
dpc-3520	238	3	184	184	NUM
dpc-3520	238	4	.	.	PUNCT
dpc-3520	239	1	doi	doi	NOUN
dpc-3520	239	2	:	:	PUNCT
dpc-3520	239	3	10.3889	10.3889	NUM
dpc-3520	239	4	/	/	SYM
dpc-3520	239	5	oamjms.2018.040	oamjms.2018.040	NOUN
dpc-3520	239	6	.	.	PUNCT
dpc-3520	240	1	pmid	pmid	NOUN
dpc-3520	240	2	:	:	PUNCT
dpc-3520	240	3	29484022	29484022	NUM
dpc-3520	240	4	.	.	PUNCT
dpc-3520	241	1	pmcid	pmcid	NOUN
dpc-3520	241	2	:	:	PUNCT
dpc-3520	241	3	pmc5816297	pmc5816297	NOUN
dpc-3520	241	4	.	.	PUNCT
dpc-3520	242	1	2	2	X
dpc-3520	242	2	.	.	X
dpc-3520	242	3	silverberg	silverberg	PROPN
dpc-3520	242	4	nb	nb	PROPN
dpc-3520	242	5	.	.	PUNCT
dpc-3520	243	1	the	the	DET
dpc-3520	243	2	epidemiology	epidemiology	NOUN
dpc-3520	243	3	of	of	ADP
dpc-3520	243	4	vitiligo	vitiligo	NOUN
dpc-3520	243	5	.	.	PUNCT
dpc-3520	244	1	current	current	ADJ
dpc-3520	244	2	dermatology	dermatology	NOUN
dpc-3520	244	3	reports	report	NOUN
dpc-3520	244	4	.	.	PUNCT
dpc-3520	245	1	2015;4(1):36	2015;4(1):36	NUM
dpc-3520	245	2	-	-	SYM
dpc-3520	245	3	43	43	NUM
dpc-3520	245	4	.	.	PUNCT
dpc-3520	246	1	3	3	X
dpc-3520	246	2	.	.	NUM
dpc-3520	246	3	rodrigues	rodrigues	PROPN
dpc-3520	246	4	m	m	PROPN
dpc-3520	246	5	,	,	PUNCT
dpc-3520	246	6	ezzedine	ezzedine	PROPN
dpc-3520	246	7	k	k	NOUN
dpc-3520	246	8	,	,	PUNCT
dpc-3520	246	9	hamzavi	hamzavi	PROPN
dpc-3520	246	10	i	i	PRON
dpc-3520	246	11	,	,	PUNCT
dpc-3520	246	12	pandya	pandya	PROPN
dpc-3520	246	13	ag	ag	PROPN
dpc-3520	246	14	,	,	PUNCT
dpc-3520	246	15	harris	harris	PROPN
dpc-3520	246	16	je	je	PROPN
dpc-3520	246	17	;	;	PUNCT
dpc-3520	246	18	vitiligo	vitiligo	PROPN
dpc-3520	246	19	working	working	NOUN
dpc-3520	246	20	group	group	NOUN
dpc-3520	246	21	.	.	PUNCT
dpc-3520	247	1	new	new	ADJ
dpc-3520	247	2	discoveries	discovery	NOUN
dpc-3520	247	3	in	in	ADP
dpc-3520	247	4	the	the	DET
dpc-3520	247	5	pathogenesis	pathogenesis	NOUN
dpc-3520	247	6	and	and	CCONJ
dpc-3520	247	7	classification	classification	NOUN
dpc-3520	247	8	of	of	ADP
dpc-3520	247	9	vitiligo	vitiligo	NOUN
dpc-3520	247	10	.	.	PUNCT
dpc-3520	248	1	j	j	PROPN
dpc-3520	248	2	am	be	AUX
dpc-3520	248	3	acad	acad	ADJ
dpc-3520	248	4	dermatol	dermatol	NOUN
dpc-3520	248	5	.	.	PUNCT
dpc-3520	249	1	2017;77(1):1	2017;77(1):1	NUM
dpc-3520	249	2	-	-	SYM
dpc-3520	249	3	13	13	NUM
dpc-3520	249	4	.	.	PUNCT
dpc-3520	250	1	doi	doi	NOUN
dpc-3520	250	2	:	:	PUNCT
dpc-3520	250	3	10.1016	10.1016	NUM
dpc-3520	250	4	/	/	SYM
dpc-3520	250	5	j.jaad.2016.10.048	j.jaad.2016.10.048	PROPN
dpc-3520	250	6	.	.	PUNCT
dpc-3520	251	1	pmid	pmid	NOUN
dpc-3520	251	2	:	:	PUNCT
dpc-3520	251	3	28619550	28619550	NUM
dpc-3520	251	4	.	.	PUNCT
dpc-3520	252	1	4	4	X
dpc-3520	252	2	.	.	X
dpc-3520	252	3	rahman	rahman	PROPN
dpc-3520	252	4	r	r	PROPN
dpc-3520	252	5	,	,	PUNCT
dpc-3520	252	6	hasija	hasija	VERB
dpc-3520	252	7	y.	y.	NOUN
dpc-3520	252	8	exploring	explore	VERB
dpc-3520	252	9	vitiligo	vitiligo	NOUN
dpc-3520	252	10	susceptibility	susceptibility	NOUN
dpc-3520	252	11	and	and	CCONJ
dpc-3520	252	12	management	management	NOUN
dpc-3520	252	13	:	:	PUNCT
dpc-3520	252	14	a	a	DET
dpc-3520	252	15	brief	brief	ADJ
dpc-3520	252	16	review	review	NOUN
dpc-3520	252	17	.	.	PUNCT
dpc-3520	253	1	biomedical	biomedical	ADJ
dpc-3520	253	2	dermatology	dermatology	NOUN
dpc-3520	253	3	.	.	PUNCT
dpc-3520	254	1	2018;2(1):20	2018;2(1):20	NUM
dpc-3520	254	2	.	.	NOUN
dpc-3520	255	1	5	5	NUM
dpc-3520	255	2	.	.	X
dpc-3520	255	3	kemp	kemp	PROPN
dpc-3520	255	4	eh	eh	PROPN
dpc-3520	255	5	,	,	PUNCT
dpc-3520	255	6	emhemad	emhemad	ADJ
dpc-3520	255	7	s	s	PART
dpc-3520	255	8	,	,	PUNCT
dpc-3520	255	9	akhtar	akhtar	PROPN
dpc-3520	255	10	s	s	PROPN
dpc-3520	255	11	,	,	PUNCT
dpc-3520	255	12	watson	watson	PROPN
dpc-3520	255	13	pf	pf	PROPN
dpc-3520	255	14	,	,	PUNCT
dpc-3520	255	15	gawkrodger	gawkrodger	NOUN
dpc-3520	255	16	dj	dj	PROPN
dpc-3520	255	17	,	,	PUNCT
dpc-3520	255	18	weetman	weetman	PROPN
dpc-3520	255	19	ap	ap	PROPN
dpc-3520	255	20	.	.	PUNCT
dpc-3520	256	1	autoantibodies	autoantibody	NOUN
dpc-3520	256	2	against	against	ADP
dpc-3520	256	3	tyrosine	tyrosine	NOUN
dpc-3520	256	4	hydroxylase	hydroxylase	NOUN
dpc-3520	256	5	in	in	ADP
dpc-3520	256	6	patients	patient	NOUN
dpc-3520	256	7	with	with	ADP
dpc-3520	256	8	non	non	ADJ
dpc-3520	256	9	-	-	ADJ
dpc-3520	256	10	segmental	segmental	ADJ
dpc-3520	256	11	(	(	PUNCT
dpc-3520	256	12	generalised	generalised	ADJ
dpc-3520	256	13	)	)	PUNCT
dpc-3520	256	14	vitiligo	vitiligo	NOUN
dpc-3520	256	15	.	.	PUNCT
dpc-3520	257	1	exp	exp	NOUN
dpc-3520	257	2	dermatol	dermatol	NOUN
dpc-3520	257	3	.	.	PUNCT
dpc-3520	258	1	2011;20(1):35	2011;20(1):35	X
dpc-3520	258	2	-	-	SYM
dpc-3520	258	3	40	40	NUM
dpc-3520	258	4	.	.	PUNCT
dpc-3520	259	1	doi	doi	NOUN
dpc-3520	259	2	:	:	PUNCT
dpc-3520	259	3	10.1111	10.1111	NUM
dpc-3520	259	4	/	/	SYM
dpc-3520	259	5	j.1600	j.1600	NOUN
dpc-3520	259	6	-	-	PUNCT
dpc-3520	259	7	0625.2010.01181.x	0625.2010.01181.x	NOUN
dpc-3520	259	8	.	.	PUNCT
dpc-3520	260	1	pmid	pmid	NOUN
dpc-3520	260	2	:	:	PUNCT
dpc-3520	260	3	21158937	21158937	NUM
dpc-3520	260	4	.	.	PUNCT
dpc-3520	261	1	6	6	X
dpc-3520	261	2	.	.	X
dpc-3520	261	3	llang	llang	PROPN
dpc-3520	261	4	ks	ks	PROPN
dpc-3520	261	5	,	,	PUNCT
dpc-3520	261	6	caroli	caroli	PROPN
dpc-3520	261	7	cc	cc	PROPN
dpc-3520	261	8	,	,	PUNCT
dpc-3520	261	9	muhm	muhm	PROPN
dpc-3520	261	10	a	a	X
dpc-3520	261	11	,	,	PUNCT
dpc-3520	261	12	et	et	PROPN
dpc-3520	261	13	al	al	PROPN
dpc-3520	261	14	.	.	PROPN
dpc-3520	261	15	hla	hla	PROPN
dpc-3520	261	16	-	-	PUNCT
dpc-3520	261	17	a2	a2	NOUN
dpc-3520	261	18	restricted	restrict	VERB
dpc-3520	261	19	,	,	PUNCT
dpc-3520	261	20	melanocyte	melanocyte	NOUN
dpc-3520	261	21	-	-	PUNCT
dpc-3520	261	22	specific	specific	ADJ
dpc-3520	261	23	cd8(+	cd8(+	PROPN
dpc-3520	261	24	)	)	PUNCT
dpc-3520	261	25	t	t	PROPN
dpc-3520	261	26	lymphocytes	lymphocyte	NOUN
dpc-3520	261	27	detected	detect	VERB
dpc-3520	261	28	in	in	ADP
dpc-3520	261	29	vitiligo	vitiligo	NOUN
dpc-3520	261	30	patients	patient	NOUN
dpc-3520	261	31	are	be	AUX
dpc-3520	261	32	related	relate	VERB
dpc-3520	261	33	to	to	ADP
dpc-3520	261	34	disease	disease	NOUN
dpc-3520	261	35	activity	activity	NOUN
dpc-3520	261	36	and	and	CCONJ
dpc-3520	261	37	are	be	AUX
dpc-3520	261	38	predominantly	predominantly	ADV
dpc-3520	261	39	directed	direct	VERB
dpc-3520	261	40	against	against	ADP
dpc-3520	261	41	melana	melana	PROPN
dpc-3520	261	42	/	/	SYM
dpc-3520	261	43	mart1	mart1	PROPN
dpc-3520	261	44	.	.	PUNCT
dpc-3520	262	1	j	j	PROPN
dpc-3520	262	2	invest	invest	VERB
dpc-3520	262	3	dermatol	dermatol	NOUN
dpc-3520	262	4	.	.	PUNCT
dpc-3520	263	1	2001	2001	NUM
dpc-3520	263	2	;	;	PUNCT
dpc-3520	263	3	116(6):891	116(6):891	NUM
dpc-3520	263	4	-	-	SYM
dpc-3520	263	5	897	897	NUM
dpc-3520	263	6	.	.	PUNCT
dpc-3520	264	1	doi	doi	NOUN
dpc-3520	264	2	:	:	PUNCT
dpc-3520	264	3	10.1046	10.1046	NUM
dpc-3520	264	4	/	/	SYM
dpc-3520	264	5	j.1523	j.1523	NOUN
dpc-3520	264	6	-	-	PUNCT
dpc-3520	264	7	1747.2001.01363.x	1747.2001.01363.x	NUM
dpc-3520	264	8	.	.	PUNCT
dpc-3520	265	1	pmid	pmid	NOUN
dpc-3520	265	2	:	:	PUNCT
dpc-3520	265	3	11407977	11407977	NUM
dpc-3520	265	4	.	.	PUNCT
dpc-3520	266	1	7	7	X
dpc-3520	266	2	.	.	X
dpc-3520	266	3	sushama	sushama	PROPN
dpc-3520	266	4	s	s	PART
dpc-3520	266	5	,	,	PUNCT
dpc-3520	266	6	dixit	dixit	PROPN
dpc-3520	266	7	n	n	CCONJ
dpc-3520	266	8	,	,	PUNCT
dpc-3520	266	9	gautam	gautam	PROPN
dpc-3520	266	10	rk	rk	PROPN
dpc-3520	266	11	,	,	PUNCT
dpc-3520	266	12	arora	arora	PROPN
dpc-3520	266	13	p	p	PROPN
dpc-3520	266	14	,	,	PUNCT
dpc-3520	266	15	khurana	khurana	PROPN
dpc-3520	266	16	a	a	X
dpc-3520	266	17	,	,	PUNCT
dpc-3520	266	18	anubhuti	anubhuti	NOUN
dpc-3520	266	19	a.	a.	NOUN
dpc-3520	266	20	cytokine	cytokine	NOUN
dpc-3520	266	21	profile	profile	NOUN
dpc-3520	266	22	(	(	PUNCT
dpc-3520	266	23	il-2	il-2	NUM
dpc-3520	266	24	,	,	PUNCT
dpc-3520	266	25	il-6	il-6	NUM
dpc-3520	266	26	,	,	PUNCT
dpc-3520	266	27	il-17	il-17	X
dpc-3520	266	28	,	,	PUNCT
dpc-3520	266	29	il-22	il-22	NOUN
dpc-3520	266	30	,	,	PUNCT
dpc-3520	266	31	and	and	CCONJ
dpc-3520	266	32	tnf	tnf	PROPN
dpc-3520	266	33	-	-	PUNCT
dpc-3520	266	34	α	α	NOUN
dpc-3520	266	35	)	)	PUNCT
dpc-3520	266	36	in	in	ADP
dpc-3520	266	37	vitiligo	vitiligo	ADJ
dpc-3520	266	38	new	new	ADJ
dpc-3520	266	39	insight	insight	NOUN
dpc-3520	266	40	into	into	ADP
dpc-3520	266	41	pathogenesis	pathogenesis	NOUN
dpc-3520	266	42	of	of	ADP
dpc-3520	266	43	disease	disease	NOUN
dpc-3520	266	44	.	.	PUNCT
dpc-3520	267	1	j	j	PROPN
dpc-3520	267	2	cosmet	cosmet	PROPN
dpc-3520	267	3	dermatol	dermatol	NOUN
dpc-3520	267	4	.	.	PUNCT
dpc-3520	268	1	2019;18(1):337	2019;18(1):337	NUM
dpc-3520	268	2	-	-	PUNCT
dpc-3520	268	3	341	341	NUM
dpc-3520	268	4	.	.	PUNCT
dpc-3520	268	5	doi	doi	NOUN
dpc-3520	268	6	:	:	PUNCT
dpc-3520	268	7	10.1111	10.1111	NUM
dpc-3520	268	8	/	/	SYM
dpc-3520	268	9	jocd.12517	jocd.12517	PROPN
dpc-3520	268	10	.	.	PUNCT
dpc-3520	269	1	pmid	pmid	NOUN
dpc-3520	269	2	:	:	PUNCT
dpc-3520	269	3	29504235	29504235	NUM
dpc-3520	269	4	.	.	PUNCT
dpc-3520	270	1	original	original	ADJ
dpc-3520	270	2	article	article	NOUN
dpc-3520	270	3	|	|	ADV
dpc-3520	270	4	dermatol	dermatol	ADJ
dpc-3520	270	5	pract	pract	NOUN
dpc-3520	270	6	concept	concept	NOUN
dpc-3520	270	7	.	.	PUNCT
dpc-3520	271	1	2024;14(1):e2024027	2024;14(1):e2024027	NUM
dpc-3520	271	2	7	7	NUM
dpc-3520	271	3	25	25	NUM
dpc-3520	271	4	.	.	PUNCT
dpc-3520	271	5	ezzedine	ezzedine	PROPN
dpc-3520	272	1	k	k	PROPN
dpc-3520	272	2	,	,	PUNCT
dpc-3520	272	3	lim	lim	PROPN
dpc-3520	272	4	hw	hw	PROPN
dpc-3520	272	5	,	,	PUNCT
dpc-3520	272	6	suzuki	suzuki	PROPN
dpc-3520	272	7	t	t	PROPN
dpc-3520	272	8	,	,	PUNCT
dpc-3520	272	9	et	et	PROPN
dpc-3520	272	10	al	al	PROPN
dpc-3520	272	11	.	.	PROPN
dpc-3520	272	12	revised	revise	VERB
dpc-3520	272	13	classification/	classification/	NUM
dpc-3520	272	14	nomenclature	nomenclature	NOUN
dpc-3520	272	15	of	of	ADP
dpc-3520	272	16	vitiligo	vitiligo	ADJ
dpc-3520	272	17	and	and	CCONJ
dpc-3520	272	18	related	related	ADJ
dpc-3520	272	19	issues	issue	NOUN
dpc-3520	272	20	:	:	PUNCT
dpc-3520	272	21	the	the	DET
dpc-3520	272	22	vitiligo	vitiligo	ADJ
dpc-3520	272	23	global	global	ADJ
dpc-3520	272	24	issues	issue	NOUN
dpc-3520	272	25	consensus	consensus	NOUN
dpc-3520	272	26	conference	conference	NOUN
dpc-3520	272	27	.	.	PUNCT
dpc-3520	273	1	pigment	pigment	ADJ
dpc-3520	273	2	cell	cell	NOUN
dpc-3520	273	3	melanoma	melanoma	NOUN
dpc-3520	273	4	res	re	NOUN
dpc-3520	273	5	.	.	PUNCT
dpc-3520	274	1	2012;25(3):e1	2012;25(3):e1	NUM
dpc-3520	274	2	-	-	PUNCT
dpc-3520	274	3	e13	e13	NOUN
dpc-3520	274	4	.	.	PUNCT
dpc-3520	275	1	doi	doi	NOUN
dpc-3520	275	2	:	:	PUNCT
dpc-3520	275	3	10.1111	10.1111	NUM
dpc-3520	275	4	/	/	SYM
dpc-3520	275	5	j.1755	j.1755	NOUN
dpc-3520	275	6	-	-	PUNCT
dpc-3520	275	7	148x.2012.00997.x	148x.2012.00997.x	NOUN
dpc-3520	275	8	.	.	PUNCT
dpc-3520	276	1	pmid	pmid	NOUN
dpc-3520	276	2	:	:	PUNCT
dpc-3520	276	3	22417114	22417114	NUM
dpc-3520	276	4	.	.	PUNCT
dpc-3520	277	1	pmcid	pmcid	ADJ
dpc-3520	277	2	:	:	PUNCT
dpc-3520	277	3	pmc3511780	pmc3511780	NOUN
dpc-3520	277	4	.	.	PUNCT
dpc-3520	278	1	26	26	NUM
dpc-3520	278	2	.	.	PUNCT
dpc-3520	278	3	sachdeva	sachdeva	PROPN
dpc-3520	278	4	s.	s.	PROPN
dpc-3520	278	5	fitzpatrick	fitzpatrick	PROPN
dpc-3520	278	6	skin	skin	PROPN
dpc-3520	278	7	typing	typing	NOUN
dpc-3520	278	8	:	:	PUNCT
dpc-3520	278	9	applications	application	NOUN
dpc-3520	278	10	in	in	ADP
dpc-3520	278	11	dermatology	dermatology	NOUN
dpc-3520	278	12	.	.	PUNCT
dpc-3520	279	1	indian	indian	PROPN
dpc-3520	279	2	j	j	PROPN
dpc-3520	279	3	dermatol	dermatol	PROPN
dpc-3520	279	4	venereol	venereol	ADJ
dpc-3520	279	5	leprol	leprol	NOUN
dpc-3520	279	6	.	.	PUNCT
dpc-3520	280	1	2009;75(1):93	2009;75(1):93	NUM
dpc-3520	280	2	-	-	SYM
dpc-3520	280	3	96	96	NUM
dpc-3520	280	4	.	.	PUNCT
dpc-3520	281	1	doi	doi	NOUN
dpc-3520	281	2	:	:	PUNCT
dpc-3520	281	3	10.4103/0378	10.4103/0378	NUM
dpc-3520	281	4	-	-	PUNCT
dpc-3520	281	5	6323.45238	6323.45238	NOUN
dpc-3520	281	6	.	.	PUNCT
dpc-3520	282	1	pmid	pmid	NOUN
dpc-3520	282	2	:	:	PUNCT
dpc-3520	282	3	19172048	19172048	NUM
dpc-3520	282	4	.	.	PUNCT
dpc-3520	283	1	27	27	NUM
dpc-3520	283	2	.	.	PUNCT
dpc-3520	284	1	xu	xu	PROPN
dpc-3520	285	1	wd	wd	PROPN
dpc-3520	285	2	,	,	PUNCT
dpc-3520	285	3	su	su	PROPN
dpc-3520	285	4	lc	lc	PROPN
dpc-3520	285	5	,	,	PUNCT
dpc-3520	285	6	he	he	PRON
dpc-3520	285	7	cs	cs	PROPN
dpc-3520	285	8	,	,	PUNCT
dpc-3520	285	9	huang	huang	PROPN
dpc-3520	285	10	af	af	PROPN
dpc-3520	285	11	.	.	PUNCT
dpc-3520	286	1	plasma	plasma	PROPN
dpc-3520	286	2	interleukin-38	interleukin-38	PROPN
dpc-3520	286	3	in	in	ADP
dpc-3520	286	4	patients	patient	NOUN
dpc-3520	286	5	with	with	ADP
dpc-3520	286	6	rheumatoid	rheumatoid	NOUN
dpc-3520	286	7	arthritis	arthritis	NOUN
dpc-3520	286	8	.	.	PUNCT
dpc-3520	287	1	int	int	PROPN
dpc-3520	287	2	immunopharmacol	immunopharmacol	PROPN
dpc-3520	287	3	.	.	PUNCT
dpc-3520	288	1	2018;65:1	2018;65:1	NUM
dpc-3520	288	2	-	-	SYM
dpc-3520	288	3	7	7	NUM
dpc-3520	288	4	.	.	PUNCT
dpc-3520	288	5	doi	doi	NOUN
dpc-3520	288	6	:	:	PUNCT
dpc-3520	288	7	10.1016	10.1016	NUM
dpc-3520	288	8	/	/	SYM
dpc-3520	288	9	j.intimp.2018.09.028	j.intimp.2018.09.028	PROPN
dpc-3520	288	10	.	.	PUNCT
dpc-3520	289	1	pmid	pmid	NOUN
dpc-3520	289	2	:	:	PUNCT
dpc-3520	289	3	30268016	30268016	NUM
dpc-3520	289	4	.	.	PUNCT
dpc-3520	290	1	28	28	NUM
dpc-3520	290	2	.	.	PUNCT
dpc-3520	291	1	mahmoud	mahmoud	PROPN
dpc-3520	291	2	marie	marie	PROPN
dpc-3520	291	3	re	re	PROPN
dpc-3520	291	4	,	,	PUNCT
dpc-3520	291	5	adel	adel	PROPN
dpc-3520	291	6	am	am	PROPN
dpc-3520	291	7	,	,	PUNCT
dpc-3520	291	8	abd	abd	PROPN
dpc-3520	291	9	el	el	PROPN
dpc-3520	291	10	-	-	PUNCT
dpc-3520	291	11	fadeal	fadeal	PROPN
dpc-3520	291	12	nm	nm	PROPN
dpc-3520	291	13	,	,	PUNCT
dpc-3520	291	14	eyada	eyada	PROPN
dpc-3520	291	15	mmk	mmk	PROPN
dpc-3520	291	16	.	.	PUNCT
dpc-3520	292	1	interleukin	interleukin	NOUN
dpc-3520	292	2	38	38	NUM
dpc-3520	292	3	serum	serum	NOUN
dpc-3520	292	4	level	level	NOUN
dpc-3520	292	5	is	be	AUX
dpc-3520	292	6	increased	increase	VERB
dpc-3520	292	7	in	in	ADP
dpc-3520	292	8	patients	patient	NOUN
dpc-3520	292	9	with	with	ADP
dpc-3520	292	10	vitiligo	vitiligo	NOUN
dpc-3520	292	11	,	,	PUNCT
dpc-3520	292	12	correlated	correlate	VERB
dpc-3520	292	13	with	with	ADP
dpc-3520	292	14	disease	disease	NOUN
dpc-3520	292	15	severity	severity	NOUN
dpc-3520	292	16	,	,	PUNCT
dpc-3520	292	17	and	and	CCONJ
dpc-3520	292	18	associated	associate	VERB
dpc-3520	292	19	with	with	ADP
dpc-3520	292	20	signs	sign	NOUN
dpc-3520	292	21	of	of	ADP
dpc-3520	292	22	disease	disease	NOUN
dpc-3520	292	23	activity	activity	NOUN
dpc-3520	292	24	.	.	PUNCT
dpc-3520	293	1	j	j	PROPN
dpc-3520	293	2	cosmet	cosmet	PROPN
dpc-3520	293	3	dermatol	dermatol	NOUN
dpc-3520	293	4	.	.	PUNCT
dpc-3520	294	1	2022;21(8):35153521	2022;21(8):35153521	NUM
dpc-3520	294	2	.	.	PUNCT
dpc-3520	295	1	doi	doi	NOUN
dpc-3520	295	2	:	:	PUNCT
dpc-3520	295	3	10.1111	10.1111	NUM
dpc-3520	295	4	/	/	SYM
dpc-3520	295	5	jocd.14612	jocd.14612	PROPN
dpc-3520	295	6	.	.	PUNCT
dpc-3520	296	1	pmid	pmid	PROPN
dpc-3520	296	2	:	:	PUNCT
dpc-3520	296	3	34783147	34783147	NUM
dpc-3520	296	4	.	.	PUNCT
dpc-3520	297	1	21	21	NUM
dpc-3520	297	2	.	.	PUNCT
dpc-3520	298	1	wang	wang	PROPN
dpc-3520	298	2	m	m	PROPN
dpc-3520	298	3	,	,	PUNCT
dpc-3520	298	4	wang	wang	PROPN
dpc-3520	298	5	b	b	PROPN
dpc-3520	298	6	,	,	PUNCT
dpc-3520	298	7	ma	ma	PROPN
dpc-3520	298	8	z	z	PROPN
dpc-3520	298	9	,	,	PUNCT
dpc-3520	298	10	et	et	PROPN
dpc-3520	298	11	al	al	PROPN
dpc-3520	298	12	.	.	PUNCT
dpc-3520	299	1	detection	detection	NOUN
dpc-3520	299	2	of	of	ADP
dpc-3520	299	3	the	the	DET
dpc-3520	299	4	novel	novel	NOUN
dpc-3520	299	5	il-1	il-1	ADP
dpc-3520	299	6	family	family	NOUN
dpc-3520	299	7	cytokines	cytokine	NOUN
dpc-3520	299	8	by	by	ADP
dpc-3520	299	9	qah	qah	NOUN
dpc-3520	299	10	-	-	PUNCT
dpc-3520	299	11	il1f-1	il1f-1	NOUN
dpc-3520	299	12	assay	assay	NOUN
dpc-3520	299	13	in	in	ADP
dpc-3520	299	14	rheumatoid	rheumatoid	NOUN
dpc-3520	299	15	arthritis	arthritis	NOUN
dpc-3520	299	16	.	.	PUNCT
dpc-3520	300	1	cell	cell	NOUN
dpc-3520	300	2	mol	mol	ADP
dpc-3520	300	3	biol	biol	PROPN
dpc-3520	300	4	(	(	PUNCT
dpc-3520	300	5	noisy	noisy	ADV
dpc-3520	300	6	-	-	PUNCT
dpc-3520	300	7	le	le	NOUN
dpc-3520	300	8	-	-	ADJ
dpc-3520	300	9	grand	grand	NOUN
dpc-3520	300	10	)	)	PUNCT
dpc-3520	300	11	.	.	PUNCT
dpc-3520	301	1	2016;62(4):31	2016;62(4):31	NUM
dpc-3520	301	2	-	-	SYM
dpc-3520	301	3	34	34	NUM
dpc-3520	301	4	.	.	PUNCT
dpc-3520	302	1	pmid	pmid	NOUN
dpc-3520	302	2	:	:	PUNCT
dpc-3520	302	3	27188731	27188731	NUM
dpc-3520	302	4	.	.	PUNCT
dpc-3520	303	1	22	22	NUM
dpc-3520	303	2	.	.	PUNCT
dpc-3520	304	1	zhong	zhong	PROPN
dpc-3520	304	2	y	y	PROPN
dpc-3520	304	3	,	,	PUNCT
dpc-3520	304	4	yu	yu	PROPN
dpc-3520	304	5	k	k	PROPN
dpc-3520	304	6	,	,	PUNCT
dpc-3520	304	7	wang	wang	PROPN
dpc-3520	304	8	x	x	PROPN
dpc-3520	304	9	,	,	PUNCT
dpc-3520	304	10	wang	wang	PROPN
dpc-3520	304	11	x	x	PROPN
dpc-3520	304	12	,	,	PUNCT
dpc-3520	304	13	ji	ji	PROPN
dpc-3520	304	14	q	q	PROPN
dpc-3520	304	15	,	,	PUNCT
dpc-3520	304	16	zeng	zeng	PROPN
dpc-3520	304	17	q.	q.	PROPN
dpc-3520	304	18	elevated	elevated	PROPN
dpc-3520	304	19	plasma	plasma	NOUN
dpc-3520	304	20	il-38	il-38	NOUN
dpc-3520	304	21	concentrations	concentration	NOUN
dpc-3520	304	22	in	in	ADP
dpc-3520	304	23	patients	patient	NOUN
dpc-3520	304	24	with	with	ADP
dpc-3520	304	25	acute	acute	PROPN
dpc-3520	304	26	st	st	PROPN
dpc-3520	304	27	-	-	PUNCT
dpc-3520	304	28	segment	segment	NOUN
dpc-3520	304	29	elevation	elevation	NOUN
dpc-3520	304	30	myocardial	myocardial	ADJ
dpc-3520	304	31	infarction	infarction	NOUN
dpc-3520	304	32	and	and	CCONJ
dpc-3520	304	33	their	their	PRON
dpc-3520	304	34	dynamics	dynamic	NOUN
dpc-3520	304	35	after	after	ADP
dpc-3520	304	36	reperfusion	reperfusion	NOUN
dpc-3520	304	37	treatment	treatment	NOUN
dpc-3520	304	38	.	.	PUNCT
dpc-3520	305	1	mediators	mediator	NOUN
dpc-3520	305	2	inflamm	inflamm	NOUN
dpc-3520	305	3	.	.	PUNCT
dpc-3520	306	1	2015;2015:490120	2015;2015:490120	NUM
dpc-3520	306	2	.	.	PUNCT
dpc-3520	307	1	doi	doi	NOUN
dpc-3520	307	2	:	:	PUNCT
dpc-3520	307	3	10.1155/2015/490120	10.1155/2015/490120	NUM
dpc-3520	307	4	.	.	PUNCT
dpc-3520	308	1	pmid	pmid	NOUN
dpc-3520	308	2	:	:	PUNCT
dpc-3520	308	3	26819499	26819499	NUM
dpc-3520	308	4	.	.	PUNCT
dpc-3520	309	1	pmcid	pmcid	NOUN
dpc-3520	309	2	:	:	PUNCT
dpc-3520	309	3	pmc4706979	pmc4706979	NOUN
dpc-3520	309	4	.	.	PUNCT
dpc-3520	310	1	23	23	NUM
dpc-3520	310	2	.	.	PUNCT
dpc-3520	310	3	chu	chu	PROPN
dpc-3520	310	4	m	m	PROPN
dpc-3520	310	5	,	,	PUNCT
dpc-3520	310	6	chu	chu	PROPN
dpc-3520	310	7	i	i	PRON
dpc-3520	310	8	m	m	PROPN
dpc-3520	310	9	,	,	PUNCT
dpc-3520	310	10	yung	yung	PROPN
dpc-3520	310	11	ec	ec	PROPN
dpc-3520	310	12	,	,	PUNCT
dpc-3520	310	13	et	et	PROPN
dpc-3520	310	14	al	al	PROPN
dpc-3520	310	15	.	.	PROPN
dpc-3520	310	16	aberrant	aberrant	ADJ
dpc-3520	310	17	expression	expression	NOUN
dpc-3520	310	18	of	of	ADP
dpc-3520	310	19	novel	novel	ADJ
dpc-3520	310	20	cytokine	cytokine	NOUN
dpc-3520	310	21	il-38	il-38	NOUN
dpc-3520	310	22	and	and	CCONJ
dpc-3520	310	23	regulatory	regulatory	ADJ
dpc-3520	310	24	t	t	NOUN
dpc-3520	310	25	lymphocytes	lymphocyte	VERB
dpc-3520	310	26	in	in	ADP
dpc-3520	310	27	childhood	childhood	NOUN
dpc-3520	310	28	asthma	asthma	NOUN
dpc-3520	310	29	.	.	PUNCT
dpc-3520	311	1	molecules	molecule	NOUN
dpc-3520	311	2	.	.	PUNCT
dpc-3520	312	1	2016;21(7):933	2016;21(7):933	NUM
dpc-3520	312	2	.	.	PUNCT
dpc-3520	313	1	doi	doi	PROPN
dpc-3520	313	2	:	:	PUNCT
dpc-3520	313	3	10.3390	10.3390	NUM
dpc-3520	313	4	/	/	SYM
dpc-3520	313	5	molecules	molecule	NOUN
dpc-3520	313	6	21070933	21070933	NUM
dpc-3520	313	7	.	.	PUNCT
dpc-3520	314	1	pmid	pmid	NOUN
dpc-3520	314	2	:	:	PUNCT
dpc-3520	314	3	27438823	27438823	NUM
dpc-3520	314	4	.	.	PUNCT
dpc-3520	315	1	pmcid	pmcid	NOUN
dpc-3520	315	2	:	:	PUNCT
dpc-3520	315	3	pmc6274345	pmc6274345	X
dpc-3520	315	4	.	.	PUNCT
dpc-3520	316	1	24	24	NUM
dpc-3520	316	2	.	.	PUNCT
dpc-3520	316	3	feily	feily	ADV
dpc-3520	316	4	a.	a.	NOUN
dpc-3520	316	5	vitiligo	vitiligo	PROPN
dpc-3520	316	6	extent	extent	NOUN
dpc-3520	316	7	tensity	tensity	NOUN
dpc-3520	316	8	index	index	NOUN
dpc-3520	316	9	(	(	PUNCT
dpc-3520	316	10	veti	veti	PROPN
dpc-3520	316	11	)	)	PUNCT
dpc-3520	316	12	score	score	NOUN
dpc-3520	316	13	:	:	PUNCT
dpc-3520	316	14	a	a	DET
dpc-3520	316	15	new	new	ADJ
dpc-3520	316	16	definition	definition	NOUN
dpc-3520	316	17	,	,	PUNCT
dpc-3520	316	18	assessment	assessment	NOUN
dpc-3520	316	19	and	and	CCONJ
dpc-3520	316	20	treatment	treatment	NOUN
dpc-3520	316	21	evaluation	evaluation	NOUN
dpc-3520	316	22	criteria	criterion	NOUN
dpc-3520	316	23	in	in	ADP
dpc-3520	316	24	vitiligo	vitiligo	NOUN
dpc-3520	316	25	.	.	PUNCT
dpc-3520	317	1	dermatol	dermatol	NOUN
dpc-3520	317	2	pract	pract	PROPN
dpc-3520	317	3	concept	concept	NOUN
dpc-3520	317	4	.	.	PUNCT
dpc-3520	318	1	2014;4(4):81	2014;4(4):81	NUM
dpc-3520	318	2	-	-	SYM
dpc-3520	318	3	84	84	NUM
dpc-3520	318	4	.	.	PUNCT
dpc-3520	319	1	doi	doi	NOUN
dpc-3520	319	2	:	:	PUNCT
dpc-3520	319	3	10.5826	10.5826	NUM
dpc-3520	319	4	/	/	SYM
dpc-3520	319	5	dpc.0404a18	dpc.0404a18	NOUN
dpc-3520	319	6	.	.	PUNCT
dpc-3520	320	1	pmid	pmid	NOUN
dpc-3520	320	2	:	:	PUNCT
dpc-3520	320	3	25396094	25396094	NUM
dpc-3520	320	4	.	.	PUNCT
dpc-3520	321	1	pmcid	pmcid	NOUN
dpc-3520	321	2	:	:	PUNCT
dpc-3520	321	3	pmc4230268	pmc4230268	X
dpc-3520	321	4	.	.	PUNCT